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This thesis describes studies on curative and prophylactic effects
of diminazene aceturate and isometamidium chloride and development of
sterile immunity in rabbits infected with Trypanosoma congolense by
bites from infected Glossina morsitans morsitans or by intradermal
inoculation of cultured metacyclic trypanosomes.
It was shown that chemotherapy influences the development of the
trypanosome chancre. Rabbits treated with 7 mg/kg diminazene acetur¬
ate at up to three days after infective tsetse bite did not develop
chancres, while in animals treated 4-7 days post-infection, chancres
appeared but were reduced in size and persisted for a short while.
Treatment at 8-10 days after infection did not influence chancre size
appreciably.
There were indications that efficacy of chemotherapy was related
to the timing of treatment after infection and hence the stage of
development of parasites in the trypanosome chancre. Thus 50% of
rabbits treated with 7 mg/kg diminazene aceturate at 8-10 days post¬
infection had relapses in parasitaemia, whereas animals treated with
a similar dose of the drug at 0-7 or 12-42 days after infection were
invariably cured.
There was indirect evidence that in drug treated rabbits in which
relapses in parasitaemia occurred, trypanosomes may have originated
from extravascular sites in the skin. This was indicated by develop¬
ment of secondary chancres in some treated animals which later showed
relapse parasitaemia.
The mode of action of diminazene aceturate on chancre trypanosomes
was studied. There was no detectable increase in parasitaemia, following
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treatment at the time of maximum trypanosome development in chancres.
This indicated that diminazene aceturate does not act on chancre
trypanosomes by causing their release into the circulatory system.
In addition, intact and degenerating trypanosomes could be detected
histologically in chancres removed at three hours and at 24 hours
post-treatment but not at 2-4 days post-treatment. As there was no
evidence of phagocytosis of trypanosomes it was concluded that dimin¬
azene aceturate kills chancre trypanosomes in situ.
Studies on the prophylactic effects of diminazene aceturate and
isometamidium chloride showed that 7 mg/kg diminazene aceturate has
no prophylactic effect against cyclically transmitted T. congolense
even at three hours after treatment, and isometamidium chloride had a
prophylactic effect of less than three weeks. In some animals under
isometamidium or diminazene prophylaxis, chancres developed without
subsequent development of parasitaemia.
Immunity to homologous challenge with T. congolense after infection
and treatment with diminazene aceturate was shown to depend on the tim¬
ing of treatment in relation to the primary infection. Rabbits treated
at day 0-12 days after infective tsetse bite were susceptible, whereas
those treated at 14 or more days after infective tsetse bite, when
parasitaemia was readily detectable, were immune. Similar results
were obtained using cultured metacyclic trypanosomes. It was shown
that effective immunity against homologous challenge by infected tsetse
flies developed in animals treated at 14 days but not at 7 days after
infection with cultured metacyclic trypanosomes. This development of
immunity following inoculation of cultured metacyclic trypanosomes points
to their potential use in immunisation against trypanosomiasis.
iii.
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Few diseases of man and his domesticated animals have as much
influence on health and economic development as the tsetse-borne
trypanosomiases of Africa. About 35 million people and 25 million
cattle are exposed to the risk of trypanosomiasis in countries
affected by the disease (Anon, 1979). Some seven million square
kilometres of land is available within the general area of tsetse
distribution between latitudes 15°N and 21°S, on which, potentially,
an extra.120 million cattle or 400 million small ruminants could be
raised if the risk of the tsetse-transmitted trypanosomiases could
be removed (Finelle, 1974; 1980; Griffin, 1978). Even if only a
fraction of this potential increase in livestock production could be
realised due to other constraints such as alternative land-use
priorities, scarcity of water, malnutrition and other infections, any
increase would go a long way to improving the general nutrition in
countries where the annual per capita consumption of animal protein
is below the level required for normal growth and development
(Jasiorowski, 1972).
The tsetse-transmitted trypanosomes are parasites of wild animals
which infect man and his domesticated livestock when they intrude into
the tsetse wildlife ecosystem. "Tsetse-fly" is the common name for
flies of the genus Glossiqa, which are found only in Africa. There
are 22 species of Glossina, all potentially capable of transmitting
trypanosomes (Mulligan, 1970; Ford, 1971). Each Glossina sp. occurs
in a fairly well-defined vegetational zone and feeds preferentially
on a small number of different species of wildlife. Hence, some species
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of tsetse fly are more important than others in terms of disease
transmission to man and domestic animals. Flies belonging to the
morsitans group ((3. morsitans, _G. swynertoni, G. longipalpis, G.
pallidipes and G. austeni) are particularly important in disease
transmission because they are widely distributed in savannah areas
where contact with wild animals, man and domestic animals is facili¬
tated. Other Glossina spp. important in transmitting trypanosomes
belong to the palpalis group (G. palpalis, G. fuscipes and G. tachi—
noides) which is associated with riverine-type vegetation. The third
group of tsetse flies, the fusca group which includes G. fusca of
forest-edge areas and G. tabaniformis of riverine-forest areas is the
least important in disease transmission because there is generally
less opportunity for contact with man and his domesticated animals.
All trypanosomes are classified under the genus Trypanosoma Gruby,
1843. The trypanosomes affecting mammals have been divided into two
major groups, namely Section Stercoraria and Section Salivaria, accord¬
ing to their mode of development and route of transmission by the
vectors (Hoare, 1972). The tsetse-borne trypanosomes belong to Section
Salivaria whose members are transmitted by inoculative means in the
saliva in the course of feeding by the vector.
The infections caused by tsetse-borne trypanosomes are generally
known as the African trypanosomiases. Each infection by a particular
trypanosome species in a particular animal host can be regarded as a
distinct disease entity (Mulligan, 1970; Losos and Ikede, 1972).
Man is susceptible to two sub-species of Trypanosoma brucei, some¬
times regarded as nosodemes of each other. T. brucei rhodesiense causes
an acute form of human trypanosomiasis in East and Central Africa while
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T. b. gambiense causes a more chronic form of disease in West Africa.
Cattle and pigs are the most important livestock affected by
tsetse-borne trypanosomiases. The pathogenic species of trypanosomes
involved are T. vivax and T. congolense in cattle and T. simiae in pigs.
T. brucei sspp are generally regarded to be of little pathogenic im¬
portance in both cattle and pigs but may be important in the epidemiol¬
ogy of human trypanosomiasis since T_. brucei rhodesiense has been
isolated from cattle while isoenzyme studies have incriminated the pig
as a reservoir host of T. b_. gambiense (Onyango et ad. , 1966; Mehlitz
et al. , 1982). Dogs, equines and small ruminants are more affected by
T. brucei sspp.
The animal trypanosomiases affect human health in that losses in
meat and milk production lead to protein deficiencies and associated
diseases of malnutrition. Even on purely medical grounds, the effects
of animal trypanosomiases are possibly of a greater problem than human
trypanosomiasis (Willett, 1970).
Animal trypanosomiases can result in deaths and abortions, but
more frequently, direct losses are due to chronic disease resulting in
infertility, reduced growth rate and milk production. Indirect losses
result from limitations in the use of imported breeds and draught
animals (Finelle, 1980).
It is generally held that trypanosomiasis has contributed to the
preservation of natural resources, particularly in areas where G. mor-
sitans is prevalent and it has been suggested that ill-considered and
unplanned control of trypanosomiasis in livestock is a potential threat
to grazing lands because of the likely explosive increase in cattle
population. The consequent overgrazing may contribute to an increase
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in surface albedo which has been linked with a decrease in Sahelian
rainfall (Ormerod, 1976) . On the other hand, it has been argued that
tsetse eradication and trypanosomiasis control will provide additional
grazing areas thus reducing the overgrazing problem in the currently
tsetse-free areas (MacLennan, 1980).
Trypanosomiasis control measures are aimed either at destruction
of the vector or at eliminating trypanosomes in the host, but usually
the two measures are carried out simultaneously. In the past, tsetse
control schemes have included bush clearing to render the habitat
unsuitable and extermination of wild animals known to be preferential
hosts of the tsetse to remove a food source. Bush clearing for
trypanosomiasis control has declined due to rising costs and fear of
adverse environmental effects (Finelle, 1974; MacLennan, 1980). Its
present use is in the creation of barriers to fly advances into areas
where eradication is being carried out by other means. Extermination
of wild animals, even on a selective scale, is no longer acceptable
on account of its ineffectiveness, unless carried out rapidly, and
because of mounting concern for the preservation of wildlife (Finelle,
1974).
At present, the most commonly used method of tsetse control is
the application of insecticides from the ground and/or from the air.
Considerable success with this method has been obtained in Nigeria .
and Botswana (Finelle, 1980). Elsewhere, success has been limited by
cost and difficulties in preventing reinvasion of pockets of land from
which tsetse have been eradicated. In addition, chemicals applied
cause unwanted pollution and may adversely affect non-target species
(Finelle, 1974; 1980). New methods for controlling tsetse flies are
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under experimentation. The most promising are the sterile insect
release method (Dame et al. , 1980; Williamson et al., 1983) and
the use of pheromones and tsetse traps (Langley, 1983; Anon, 1984).
Chemotherapy and chemoprophylaxis constitute the other commonly
used method for controlling trypanosomiasis and there has been an
increasing demand for the use of trypanocidal drugs (MacLennan, 1980).
Unfortunately effective drugs available for this purpose are few in
number and for nearly all of them drug resistance is already a problem.
Since 1960, no new trypanocidal drug has gone beyond the experi¬
mental stage (Anon, 1979). The development of new drugs for field
use is becoming increasingly more difficult and costly. This is
largely due to the lack of metabolic leads for drug design, making
the search for new compounds necessarily empirical (Williamson, 1970) .
Even modes of action of the currently used drugs are not known with
certainty.
In the past, the efficacy of the different trypanocides against
the different salivarian trypanosome species has been related to the
distribution of trypanosomes in the body. In general, trypanocides
have been more effective against the haematic parasites T. congolense
and T. vivax than against the humoral T. brucei group, possibly be¬
cause of the lower levels of drug found in tissue fluids than in
plasma (Williamson, 1970; Losos and Ikede, 1972). However, the recent
finding that T. congolense occurs extravascularly in the early stages
of cyclical infection points to the possibility of drug failure due
to causes other than drug resistance (Gray and Luckins, 1980; Emery
and Moloo, 1981) .
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The success of chemotherapy and chemoprophylaxis as a method of
trypanosomiasis control is also limited by the cost of the drug and
its application. Many control schemes involving the use of chemo¬
therapy are hampered by erratic supplies of imported drugs, syringes
and needles (Holmes and Scott, 1982). Indeed, the inability of
affected countries to purchase trypanocidal drugs has made development
of new trypanocidal drugs an unattractive venture for drug companies
(Williamson, 1976) .
Another problem associated with the use of chemotherapy and
chemoprophylaxis is the possible presence of drug residues in meat
and milk. This is particularly true of phenanthridium compounds
(Anon, 1979). For example, Braide and Eghianruwa (1976) have shown
that isometamidium can still be detected in liver and kidney four weeks
after treatment designed to protect animals en route to slaughter. The
long term effects in humans consuming products with trypanocidal drug
residues has not been investigated.
Immunological methods of controlling trypanosomiasis would be
preferable to the use of chemotherapy because of its lower cost and
lack of residue problems. The methods currently being considered are
the use of trypanotolerant animals, vaccination and the use of chemo¬
therapy to foster immunity.
Trypanotolerant breeds of livestock are those which, despite
infection with trypanosomes show few clinical signs of disease. They
include game animals and the indigenous West African humpless Bos
taurus cattle. The breeds of cattle in which trypanotolerance has been
observed and studied in most detail are N'dama and Muturu. These breeds
are known to develop lower parasitaemias than susceptible breeds of
Bos indicus. However, trypanotolerant animals acquire and maintain
their resistance to disease only when subjected to constant challenge
from trypanosome-infected flies (Murray et al., 1979; 1982; Vickerman
and Barry, 1982). In addition, trypanotolerance may break down in
the face of high challenge or other stress factors. Other disadvant¬
ages of the utilization of trypanotolerant animals include limitation
of breeding stock and possible unacceptability of the breeds by
pastoralists more used to the larger Zebu cattle.
Immunization against trypanosomiasis would be the ideal method
for controlling the disease, but presently vaccination appears to be
a method of the distant future. This is due to the complexity of
trypanosome antigens. In both metacyclic and bloodstream stages
trypanosomes are covered with a protective glycoprotein surface coat
containing variant antigens which alter throughout the course of in¬
fection in the vertebrate host (Vickerman, 1969a; 1978). Antibodies
are produced against the main antigenic type (homotype) of a popul¬
ation of trypanosomes which is heterogenous antigenically. When the
homotype is eliminated by antibody, one of the heterotypes multiplies
and becomes the new homotype against which more antibodies are pro¬
duced. This process, which continues throughout infection, is known
as antigenic variation. Animals can develop immunity against trypano¬
somiasis, but it is specific to the variable antigen types .(VATs)
inoculated. The number of VATs which can appear in the course of
infection with a single trypanosome has been said to be limited only
by the duration for which the infected host survives (Gray, 1965b).
For example, the number of antigens expressed by a clone of T. equi-
perdum has been shown to exceed one hundred (Capbern et al., 1977) .
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The hope that animals may be vaccinated against trypanosomiasis
in spite of antigenic variation came from the early findings that when
trypanosomes develop in the tsetse fly each serodeme reverts to what
has been termed "basic antigens" (Broom and Brown, 1940; Gray, 1965a).
In addition, in the early stage of infections transmitted mechanically
by syringe, certain antigen types termed "predominant antigens" tended
to appear in a predictable manner (Gray, 1965b). Thus, the choice of
antigens to be used in vaccination could possibly be restricted to
those comprising basic antigens. However, basic antigens are sero¬
deme specific and it is not known how many different serodemes of each
trypanosome species exist in nature. In addition, methods of obtaining
large amounts of metacyclic trypanosomes are still under experiment¬
ation. Tsetse flies extrude only small numbers of metacyclics and
thus cultural methods would have to be resorted to, in order to pro¬
duce the numbers required. There has been success in culturing meta¬
cyclics of T. brucei, T. congolense and T_. vivax (Hirumi et ad. , 1977;
1983; Gray et_ al., 1981) but many more stocks have to be cultivated
before antigens for vaccination can be selected.
In the past, experimental immunization of animals has been
carried out using various procedures. These have included inoculation
of killed or irradiated bloodstream forms as well as infection and
treatment (Reviewed by Gray and Luckins, 1976; Murray and Urquhart,
1977; Holmes, 1980). Infection and treatment has been the most inter¬
esting technique because of its possible application in the field.
Laboratory studies have shown that following chemotherapy, cattle are
immune to the serodemes of trypanosomes which initiated the infections
(Cunningham, 1968; Wilson, 1971). Field studies have shown that cattle
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undergoing treatment acquire immunity, but this depended on the drug
regime (Wilson et al. , 1975; 1975). Animals treated on an individual
basis after showing signs of the disease developed immunity while
those treated as a group whenever one animal in the group required
treatment, never developed immunity.
Relatively little work has been done on the development of
immunity to trypanosomes following drug treatment particularly in
animals with cyclically transmitted infections. Syringe transmitted
infections of bloodstream forms of T. congolense in cattle have been
shown to differ from cyclically-transmitted infections in that follow¬
ing bites by infected flies, local skin reactions or chancres develop,
whereas bloodstream forms do not induce chancres (Akol and Murray,
1982). This has also been shown to be the case in rabbits (Luckins,
Gray and Rae, 1983). The local skin reaction which develops at the
site of infective tsetse bites is a site of localisation and multipli¬
cation of the metacyclics extruded by the probing tsetse fly (Willett
and Gordon, 1957; Gray and Luckins, 1980; Emery and Moloo, 1981). It
is possible that abrogation of the chancre could influence subsequent
development of immunity. For instance, in cattle it has been shown
that treatment with diminazene aceturate at 15 days post-infection leads
to development of immunity while treatment at 5 or 10 days after in¬
fection was ineffective (Emery et al., 1980). However, other studies
have indicated that in rabbits treated with homidium chloride at day 7
after cyclical infection, long lasting immunity develops (Luckins,
personal communication 1981; Luckins, Rae and Gray, 1983).
In the following work, some aspects of the effects of chemother¬
apy on infections with T. congolense in rabbits were investigated, in
10.
order to provide insight into some of the factors influencing effi¬
cacy of treatment and development of immunity in animals infected




2.1 Classification and Nomenclature
Trypanosomas are classified under the genus Trypanosoma Gruby,
1843 and are members of the sub-kingdom Protozoa, order Kinetoplastida
Honigberg, 1963 emend Vickerman, 1976, and family Trypanosomatidae
Doflein, 1901 emend Grobben, 1905 (Anon, 1980; Molyneux and Ashford,
1983). Table 2.1 (After Molyneux and Ashford, 1983) sets out the
systematic classification of the various members of the family Trypano¬
somatidae .
2.1.1 Genus Trypanosoma Gruby, 1843
The genus Trypanosoma Gruby, 1843 comprises flagellates which
exist as digenetic parasites of vertebrates and haematophagous inverte¬
brates. The type species is the frog trypanosome Trypanosoma rotatorium
(Mayer, 1843) Gruby, 1843, previously named Amoeba rotatoria and Try¬
panosoma sanguinis in 1843 by Mayer and Gruby respectively (Hoare, 1972) .
Hoare (1964) proposed the now widely accepted grouping of different
species of trypanosomes of mammals into two sections, Stercoraria and
Salivaria according to their mode of development in the vector.
The section Stercoraria contains species in which transmission is
by contaminative means, occurring when infected vector faeces are
deposited on abraded skin or on mucous membranes of the host. It con¬
tains only one species of pathogenic importance, Trypanosoma (Schizo-
trypanum) cruzi which causes Chagas1 disease (also known as American
trypanosomiasis) of man in Central and South America. The cosmopolitan
species T. (Megatrypanum) theileri of cattle and T. (M) melophagium
of sheep, though non-pathogenic may have diagnostic importance.
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Trypanosomes in section Salivaria are transmitted by inoculative
means in the saliva of the vector in the course of feeding. They are
classified into four subgenera according to their morphology in the
mammalian host and -whether developmental sites in the insect vector
include proboscis only (subgenus Duttonella), midgut and proboscis
(subgenus Nannomonas) or midgut and salivary glands (subgenera Try-
panozoon and Pycnomonas). The type species are T. (Duttonella) vivax,
T. (Nannomonas) congolense, T. (Trypanozoon) brucei and T. (Pycnomonas)
suis. In the subgenera Duttonella and Trypanozoon, there are species
which have lost dependence on cyclical transmission by Glossina and
are capable of being transmitted non-cyclically. T. (ID) vivax viennei
and T. (T) evansi may be transmitted mechanically by biting flies such
as Tabanus and Stomoxys while T. (T) equiperdum is transmitted venereally.
(a) Speciation in section Salivaria: The criteria for classifying
trypanosomes to the species level are still rather inadequate in spite
of recent developments in isoenzyme characterization, particularly with
the trypanosomes responsible for causing trypanosomiasis in man in both
the Old and New Worlds. Speciation is still assessed on the basis of
morphology, host specificity and pathogenicity. Hoare (1972) argues
that on the basis of the intergradation of behavioural characteristics
each subgenus in the section Salivaria should be regarded as monospecific
but for practical purposes the previously recognised and long accepted
speciation in the two subgenera Duttonella and Nannomonas are retained;
hence T. (D) vivax, T. (D) uniforme, T. (N) congolense and T_. (N) simiae.
On the other hand, in the subgenus Trypanozoon, Hoare (1972) recognises
three species, T. evansi, T. equiperdum and T. brucei with three sub-
species, T. brucei brucei, T. la. rhodesiense and T. b_. gambiense which
were previously recognised as separate species.
Due to the inadequate present criteria for speciation it has been
recommended that each salivarian subgenus be regarded as unispecific
with subspeciation being allowed for on the basis of behaviour in hosts
of special interest such as man and domesticated animals (Anon, 1979).
Accordingly, a Salivarian species has been defined as an assemblage of
organisms which can be distinguished from other species by one or more
stable discontinuous morphological characters, while a Salivarian sub¬
species has been defined as an assemblage of organisms within a species
which cannot be separated from each other by morphological characters,
but only by other stable characters (Anon, 1979). However, to date,
the recommendation that each salivarian subgenus be regarded as unispe¬
cific does not appear to have been put into practice. Table 2.2 shows
a recent classification of mammalian trypanosomes, still based on the
recommendations of Hoare (1972).
(b) Morphological identification of salivarian species: The morpho
logical characters on which speciation of salivarian trypanosomes is
based are those of the trypomastigote bloodstream form. These forms
are basically lanceolate in shape, resembling an elongated flattened
blade which is elliptical or oval in the transverse sections while its
ends taper to a point. The diagnostic features used for species differ
entiation are total length, position and size of kinetoplast, presence
or absence of a free flagellum and extent of convolution of the undul¬
ating membrane (Hoare, 1972). These features are best seen in Giemsa-
stained smears. The morphological features of the different salivarian
species are described by Hoare (1970; 1972).
Table2.1
ClassificationofKinetoplastida.
Kingdom Subkingdom Phylum Subphylum Class Order Suborder Family Genus
Apicomplexa Opalinata Phytomastigophorca Bodonina
Protista Protozoa SarcomastigophoraMi ro pora Mastigophora Zoomastigophorca Kinetoplastida Trypanosomatina Trypanosomatidac
Sarcodina
Ciliophora













In the insect vector salivarian trypanosomes exist as trypomasti-
gote and epimastigote forms. In the vertebrate host only .the trypo-
mastigote stage exists but there are claims that other morphological
types such as amastigotes can occur.
2.1.2 Subgenus Nannomonas Hoare, 1964
Trypanosomes of the subgenus Nannomonas are represented by rela¬
tively small organisms measuring 8-24 p.m in total length and are char¬
acterized by a subterminal, marginal kinetoplast, an inconspicuous
undulating membrane and lack of a free flagellum (Hoare, 1972).
(a) Trypanosoma congolense Broden, 1904: In 1904, Broden working
in Leopoldville, Congo, found unusually small trypanosomes without a
free flagellum, in the blood of sheep and a donkey. The name T. congo¬
lense was given to this new trypanosome species (Hoare, 1972). The
historical aspects of its nomenclature (Reviewed by Hoare, 1972) is
interesting particularly with regard to the changing status of T. di-
morphon now regarded as a synonym of T. congolense.
T. aimorphon Laveran and Mesnil, 1904, was the name given to a
dimorphic trypanosome isolated in a rat which had been inoculated with
blood of a horse from the Gambia (Hoare, 1972). It was differentiated
from T_. congolense on the basis of its greater mean length and the pro¬
portions of long, short and intermediate forms.
Hoare (1970) suggests that because of the inadequate first des¬
cription of T. dimorphon, the name was frequently misused and trypano¬
somes of both types were for many years cited indiscriminately as T?.
congolense and/or T. dimorphon. lb dimorphon gradually passed out of
general usage and became a synonym of Tb congolense. In a morphological
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and biometric revision of T_. dimorphon and T. congolense based on the
original material studied by Laveran and Mesnil in 1904, Hoare (1959)
restored T. dimorphon to the status of a distinct species. This
decision was based on the finding that statistical analysis of the
mean lengths showed a definite difference between the mean lengths of
T. congolense (12.2-14.4 |im) and T. dimorphon (15.3-17.6 urn).
Godfrey (1960) and Fairbairn (1962) found stocks of T. congolense
with mean lengths between those of T. congolense and T. dimorphon. It
was proposed that T. congolense be subdivided into three distinct sub¬
groups , the congolense type, the intermediate type and the dimorphon
type based on the differences in mean lengths (Godfrey, 1960; Fairbairn,
1962).
Huisenga (1969), in another study of the original material of
Laveran and Mesnil (1904) and material supplied by Hoare, found that
when measured exclusively in the initial stages of division, both T.
congolense and T. dimorphon have the same mean lengths, implying that
there is no justification for distinguishing subspecies or types on the
basis of mean lengths. Hoare (1972) interpreted this finding as show¬
ing that in all stocks of T. congolense divisions are restricted to
individuals of the same mean lengths and that these trypanosomes then
differentiate into adult trypanosomal populations conforming to congo¬
lense , intermediate or dimorphon types.
Nantulya, Doyle and Jenni (1978a) showed that the three different
morphological forms of T_. congolense described by Godfrey (1960) and
Fairbairn (1962) could be found at different stages of infections
initiated with a single organism. The morphological appearance of the
cloned trypanosomes in mice was found to undergo gradual change in the
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course of a parasitaemic wave. On day 5 after infection, the picture
was that attributable to intermediate type. At peak parasitaemia
seven to eight days after infection the trypanosome population was
highly pleomorphic with long forms predominating and the overall pic¬
ture was that attributable to a dimorphon type of T. congolense. Rapid
syringe passage at 3-4 day intervals resulted in the trypanosome pop¬
ulation transforming to a short, congolense type.
(b) Trypanosoma simiae Bruce et al., 1912: T. simiae was the name
given by Bruce et ad. (1912) to a trypanosome isolated from a monkey
infected by bites from wild caught tsetse flies. A short time later,
a trypanosome now known to be the same species was similarly isolated
by Kinghorn and York (1912) and named T. ignotum. After it was demon¬
strated that T. simiae was very virulent to domestic pigs, reports of
its natural occurrence started appearing. Stephen (1966) and Hoare
(1972) have reviewed the nomenclature of this trypanosome. From the
literature, it appears that T. simiae has been distinguished from T.
congolense by its greater mean length (15.3-19.7 urn) compared to that
of T. congolense (11.2-15.7 |im), the marked pathogenicity of T. simiae
for the pig and its lack of infectivity for cattle, mice and rats.
Also, T. simiae is regarded as refractory to most chemotherapeutic drugs
available.
There are now doubts as to the validity of T. simiae as a distinct
species on present criteria. Roberts (1971) found that the length of
T. simiae was influenced by the host species. A behaviourally defined
T. simiae when passaged in sheep was found to have a mean length which
fell within the T. congolense range.
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Janssen and Wijers (1974) found that the species of Glossina
responsible for transmitting T. simiae can also influence the degree
of pathogenicity in pigs. Thus when a stock of T. simiae was trans¬
mitted by G. brevipalpis it was more virulent to pigs than the same
stock when transmitted by G. pallidipes.
(c) Taxonomic status of Trypanosoma congolense and Trypanosoma
simiae: Godfrey (1977) on the basis of the morphological and behavioural
criteria used to distinguish T. simiae from T. congolense concluded
that the subgenus Nannomonas is best regarded as comprising many types
which could be divided into organisms that have a strong tendency to
be naturally restricted to pigs and those organisms that do not. The
morphological and behavioural differences between T. congolense and
T. simiae seem to intergrade to such an extent that they can be regarded
as clines of a single species (Trypanosoma congolense Broden, 1904) not
warranting even subspecific distinction (Anon, 1978) . It is for this
reason that the subgenus Nannomonas should be regarded as unispecific,
with two subspecies T. congolense congolense and T. congolense simiae
(Anon, 1979). However, this view has not found popular approval and
in the following account the generally accepted nomenclature will be
used.
2.2 Development of Trypanqsoma congolense in the Vector
In nature, the transmission of T. congolense is by bites of
infected Glossina spp. Accounts of the complete cycle of development
of T. congolense in tsetse flies first appeared as early as 1912
(Reviewed in Hoare, 1972). An outline of development of T. congolense
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in Glossina spp. has been given by Hoare (1972). Ingested trypano-
somes transform into elongated trypomastigotes and multiply within
the endoperitrophic space of the midgut, then escape into the ecto-
peritrophic space and migrate via the soft proventriculus and oeso¬
phagus into the proboscis. Here they attach to the walls of the labium
and transform into epimastigotes. These enter the hypopharynx and
complete the cycle by transforming into metatrypanosomes, which are
infective to the vertebrate host. The whole life cycle was held to
take 19-53 days. More recently Nantulya et al. (1978) found that the
entire life cycle can take 7-40 days, 45% of infected flies becoming
infective by day 12 and 76% by day 18.
Several Glossina spp. are capable of transmitting T. congolense
(Hoare, 1972). Infection rates in the field average 2% compared to
5-15% in the laboratory (ILRAD, 1982). The species of Glossina has
been shown to influence infection rates. Harley and Wilson (1968) com¬
pared G. morsitans, G. pallidipes and G. fuscipes as vectors of T.
congolense and found infection rates of 11.6%, 13.2% and 2.9% respect¬
ively .
There have been several investigations into factors which influence
trypanosome infection rates in tsetse flies. Godfrey (1958, 1959)
found that when the temperature at which Glossina pupae were incubated
was raised from normal to 28°C the infection rates in the flies rose
from 15.5% to 35%. Dipeolu (1975) raised the maintenance temperature
for adult G. m. morsitans from 26°C to 31°C and found that this did not
influence their susceptibility to T. congolense.
The influence of level of parasitaemia in the infective blood
meal on subsequent fly infection rates was investigated and found not
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to affect the infection rates (Dipeolu, 1975). Recently, Nantulya
et al. (1978b) showed that teneral G. morsitans fed on mice with peak
parasitaemia of T?. congolense had higher infection rates compared
with those fed before or after peak parasitaemia. Infection rates of
7.1%, 22.4% and 6.6% were obtained for flies fed on log phase of
rising parasitaemia, peak parasitaemia and following phase of parasit-
aemic wave respectively.
The influence of the host species on infection rates has also
been investigated (Moloo, 1981). G. m. morsitans maintained on goat
or rabbit were found to have higher infection rates than those main¬
tained on the rat or mouse.
There is new evidence to show that tsetse flies may be bred for
high or low trypanosome infection rates. The maternal phenotype of
G. m. morsitans has been shown to influence their susceptibility to
T. congolense (Maudlin, 1982).
2.3 Development of Trypanosoma congolense in the Vertebrate Host
The initial development of Tb congolense in the vertebrate host
depends on whether the infective metacyclic forms are deposited intra-
dermally or elsewhere. Cyclically transmitted T. congolense has now
been shown to induce local skin reactions, or chancres, at sites where
infected tsetse flies have fed (Roberts, Gray and Gray, 1969; Luckins
and Gray, 1978; Gray and Luckins, 1980; Emery and Moloo, 1981; Akol
and Murray, 1982) . Chancres in which trypanosomes undergo multipli¬
cation were first seen in T. brucei infections and much of the earlier
work on the nature of this local skin reaction was carried out with
T. brucei subspecies organisms.
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2.3.1 Development of trypanosomes in the local skin reaction - the
trypanosome chancre
The first description of chancres is usually associated with Graf
(Apted, 1970) who described them in man. The lesion appears two to
three days after an infective tsetse bite as an erythematous and
tender swelling. Later, it becomes a circumscript rubbery induration
which disappears in 2-3 weeks (Anon, 1979). It is now well recog¬
nised as the first symptom of sleeping sickness (Gelfand, 1966; Willett,
1966; Apted, 1970).
(a) Chancres caused by Trypanosoma brucelsubspecies: Early
experimental studies in man showed that bloodstream forms of T. rhod-
esiense inoculated intradermally could also initiate trypanosome chancres
(Corson, 1932; Fairbairn, 1933). Willett (1956) inoculated human
volunteers subcutaneously with T. brucei spp. and found that there was
a constant mean interval of 2.6 days between appearance of the reaction
at the site of inoculation and the first appearance of trypanosomes in
the blood.
In studies aimed at determining where metacyclics are deposited
by the feeding fly, Gordon, Crewe and Willett (1956) found that saliva
was ejected frequently in the course of probing and feeding and was
widely distributed in the host tissues throughout a hemispherical area
reached by the labium of the feeding fly. Some saliva could be expected
to find its way direct into the lumen of the torn capillary but most
would remain at the bite site.
Earlier speculation that it is necessary for trypanosomes to
develop in the local skin reaction before they can invade the blood¬
stream was disproved by the studies of Willett and Gordon (1957). Rats
23.
inoculated with T. brucei intradermally or subcutaneously and guinea
pigs bitten by infected tsetse flies did not develop chancres, but
the general circulation was rapidly invaded. Intravenous inoculation
of metacyclics of T. rhodesiense into rabbits lead to persistence and
multiplication of trypanosomes in the blood. Rabbits, unlike rats
and guinea pigs, were shown to develop typical chancres when blood¬
stream forms of T. rhodesiense were inoculated intradermally: the
greater the number of trypanosomes inoculated, the earlier the chancre
tended to appear. From these studies it appears that there is no
evidence of any process or cycle of development from metacyclic to
bloodstream form, other than the direct conversion of the former to
the latter and their subsequent multiplication by binary fission
(Willett and Gordon, 1957).
Fairbairn and Godfrey (1957) carried out a single experiment in
which T. rhodesiense-infected tsetse flies were allowed to feed on a
volunteer whose blood was subinoculated into rats one hour later, and
daily thereafter up to day 10. Positive subinoculations were obtained
starting from day 9 post-infection when a typical chancre was seen at
the site of tsetse bite. Puncture fluid from this reaction revealed
bloodstream forms of T. rhodesiense; a biopsy taken for histological
examination on day 10 revealed trypanosomes and cellular reaction in
the dermis. All these findings were considered as evidence that in
man, metacyclics inoculated by the tsetse fly remain at the site of
inoculation, multiply and develop into blood forms which later over¬
flow into the general circulation.
Vickerman (1969a) suggested that the surface coat which metacyclic
trypanosomes acquire while in the fly, preadapt them for life in the
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bloodstream without needing to adapt extravascularly in the trypano-
some chancre. Barry and Hajduk (1979) injected single metacyclics
of T. brucei intravenously into rabbits and found that infections
developed in all five rabbits inoculated, thus corroborating Vicker-
»
man's hypothesis.
Early studies showed that trypanosomes multiply in the chancre.
Willett and Gordon (1957) observed that in rabbits bitten by an infected
tsetse fly, trypanosomes were not seen at the site of inoculation until
72 hours after the bite. The trypanosome counts, in tissue from chancres
which subsequently developed, increased both in number and density to
Q
concentrations exceeding 1 x 10 /ml in histological sections of skin
obtained at day 5-7 after the infective tsetse bite.
(b) Development of Trypanosoma congolense in local skin reactions:
The development of local skin reactions to infections with T_. congolense
in domestic animals was first reported by Roberts et al. (1969) , in
cattle and sheep, at sites bitten by experimentally infected G. morsitans
and G. tachinoides as well as wild-caught G. morsitans. Reactions
appeared 4-12 days before patent parasitaemia as determined by micro¬
scopical examination of wet blood smears. Chancre fluid examined
microscopically revealed trypanosomes morphologically indistinguishable
from bloodstream forms and also organisms similar to forms from the
midgut and proboscis of the infected tsetse fly.
T. congolense is usually regarded as a strict haematic parasite
(Losos and Ikede, 1972; Losos, Paris, Wilson and Dar, 1973). The local
skin reaction to Th congolense was shown to be an exception to this
haematic distribution when it was found by light and electron microscopy
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that T. congolense develops in the connective tissue in local skin
reactions (Luckins and Gray, 1978). Evidence of trypanosomal multi¬
plication in this site was provided by the presence of dividing
trypanosomes.
Gray and Luckins (1980) carried out extensive histological studies
of chancres induced by T. congolense in rabbits, calves and sheep.
Chancres removed from rabbits at day 7 post-infection revealed numer¬
ous trypanosomes associated with, or inside collagen bundles in the
deep dermis. More trypanosomes were seen in reactions removed at
day 9 post-infection but by day 11 the number was decreasing. A
similar trend was seen in reactions from calves at 8, 10 and 12 days
after infection.
Emery and Moloo (1981) quantified both the development of try¬
panosomes and the cellular reaction in local skin reactions from goats
infected with T. congolense. Between days 7 and 15 after infection
moderate numbers of parasites were seen between collagen fibres and
throughout the inflammatory oedema. In histological studies of T.
congolense chancres in cattle, trypanosomes were also seen in colla¬
gen bundles and inflammatory oedema separating the collagen bundles
as well as in dilated lymphatics of pillary dermis and hypodermis
(Akol and Murray, 1982). Bloodstream forms of T. congolense, unlike
those of T_. brucei, failed to induce local skin reactions when inoc¬
ulated intradermally into the skin of susceptible hosts (Awad, Magaji
and Mshelbwala, 1969; Luckins, Rae and Gray, 1981). This has been
confirmed in goats (Emery et al_. , 1980) and in cattle (Akol and Murray,
1982) .
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Losos and Ikede (1972) and Losos (1979) suggested that trypano-
some chancres in domestic animals are an experimental phenomenon
since there have been no reports of its natural occurrence in the
field. Nevertheless Roberts et al. (1969) induced chancres in
experimental cattle using wild-caught G. morsitans infected with
T. congolense. Among the factors which could contribute to the
lack of field observations of trypanosome chancres in domestic ani¬
mals , is the interference phenomenon observed by Morrison et_ al.
(1982b), Luckins and Gray (1983) and Luckins, Rae and Gray (1983).
It was found that concurrent infection with T. congolense inhibited
induction of chancres following bites by flies infected with an anti-
genically dissimilar stock. Also, the frequent use of chemotherapy
in the field may also influence the appearance of trypanosome chancres.
However, no experimental observations on this latter aspect have been
carried out.
2.3.2 Tissue forms of Trypanosoma congolense
It is not known what causes trypanosomes in the collagen to leave
their site of development but Akol and Murray (1982) have suggested
that the disappearance of T. congolense from the lesion is related to
biological changes associated with their maturation to bloodstream
forms.
The route of migration of trypanosomes from the chancre into the
bloodstream is probably via the local lymphatic drainage system.
Trypanosomes have been observed in the sinuses of lymph nodes of a
calf and sheep ten days after cyclical infection when they were absent
in blood (Luckins and Gray, 1979b). In contrast, trypanosomes have
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been reported to be scarce or absent in the lymph fluid of animals
with T. congolense infections initiated by bloodstream forms
(Ssenyonga and Adams, 1975; Tizard, Hay and Wilkie, 1978).
Once trypanosomes reach the bloodstream multiplication is con¬
tinuous and is by binary fission of trypomastigotes (Hoare, 1972).
However, there has always been argument for the existence of a
secondary stage of development of salivarian trypanosomes involving
an amastigote stage in the vertebrate host.
Observation of amastigote, promastigote, epimastigote and
multinucleate forms of T?. congolense and T. brucei in impression
smears from mice and rabbits has been reported (Soltys and Woo, 1969).
Forms which passed through filters of pore size 0.8-1.2 pm were shown
to be present in liver and spleen but not blood (Soltys, Woo and
Gillick, 1969; Soltys and Woo, 1970). These observations have, how¬
ever, not generally been accepted as evidence of the existence of
trypanosome tissue forms (Ormerod, 1979) .
Histological evidence for the existence of an amastigote stage
in salivarian trypanosomes has been presented (Ormerod and Venkatesan,
1971). These forms were seen in choroid plexuses of T. brucei-
infected rats. Recent ultrastructural studies of choroid plexuses
of rats infected with T. brucei rhodesiense showed that multiple
division of trypomastigotes takes place in the ependymal cells form¬
ing the blood-brain barrier (Abolarin et al., 1982). However, the
viability and importance of these forms in the trypanosome life cycle
has yet to be shown.
Suggestions that an amastigote or a multinucleate stage in the
brain may be responsible for relapses after chemotherapy have come
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from studies in mice infected with T. brucei and treated with dimi-
nazene aceturate alone or in combination with nitroimidazole (Jennings
et al., 1977; 1979; 1980). However it has been suggested that these
amastigote and multinucleate forms claimed to be the source of re¬
lapsing trypanosomes after chemotherapy may actually have little role
in the trypanosome life cycle and may simply be the product of degen¬
erate or aberrant morphogenesis (Vickerman and Tetley, 1979). This
is also the view of Fiennes (1970) who considers that there is no
evidence that any form of tissue development takes place in the
vertebrate body analogous to that which occurs with T_. cruzi. The
forms that many workers have described as amastigote are thus pro¬
bably degenerating trypanosomes, described as "trypanosomes en boule"
by Laveran (1911).
2.3.3 Systemic distribution of Trypanosoma congolense
There is evidence that the distribution of T_. congolense in the
circulatory system is not uniform. Hornby and Bailey (1931) found
that there were more trypanosomes in the capillaries than in arteries
and veins and that superficial vessels contained more trypanosomes
when the animal was cool. A rise in external temperature or treat¬
ment with trypanocidal drugs increased temporarily the numbers of
trypanosomes in the veins.
Krampitz (1970) reported that in zebu cattle experimentally
infected with T. congolense, parasitaemia in the superficial veins
could be ten times that in the jugular vein. This concentration of
T. congolense in capillaries was confirmed by Banks (1978) who reported
that in stained preparations of mesenteric microvasculature of infected
rats and rabbits, there were 4-1400 times more trypanosomes than in
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cardiac blood. Vessels examined microscopically in the living animal
(Banks, 1978) revealed trypanosomes adhering by their anterior ends
to the vessel wall. Trypanocidal drugs effective against ]T. congo-
lense have been reported to release trypanosomes from the sites of
adherence on vessel walls, into central blood circulation (Hornby
and Bailey, 1931; Maxie and Losos, 1977; Mills, Valli and Forsberg,
1980; Kalu, 1983; Kalu, Ayandele and Aina, 1983).
Th congolense has also been shown to have a predilection for
the capillaries of certain organs. Losos et al. (1973) found that
T. congolense accumulated in the microvasculature of the brain, heart
and skeletal muscles. Mills et al. (1980) reported that cerebral-
cortical capillaries in calves infected with T. congolense showed
more trypanosomes than capillaries in muscles or liver.
2.4 Pathogenesis of Trypanosoma congolense
African trypanosomiasis in laboratory and domestic animals is
characterised by development of anaemia, tissue lesions and immuno¬
suppression. Anaemia has been considered the cardinal sign of
African trypanosomiasis (Murray, 1979). Others have suggested that
immunosuppression is the single most important pathogenic mechanism
in trypanosomiasis, because infected individuals generally die, not
as a direct result of trypanosome activity, but as a result of second¬
ary bacterial and viral infection (Tizard, Mellors and Nielsen, 1980) .
2.4.1 Anaemia
The anaemia in bovine trypanosomiasis can be divided into three
phases (Reviewed by Losos and Chouinard, 1979; Urquhart, 1980). The
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initial or acute phase is characterised by rapid fall in packed cell
volume due to erythrocyte destruction, possibly accentuated by haemo-
dilution from expanded plasma volume (Holmes, 1976). The extent of
erythrocyte destruction correlates with parasitaemia and is reversed
by chemotherapy. The cause of this erythrocyte destruction is not
known precisely. Causative factors thought to be involved are pro¬
duction of a haemolysin, immune complexes, expansion of mononuclear
phagocytic system and fever (Losos and Chouinard, 1979; Urquhart,
1980) .
The second phase or chronic phase is characterised by arrest
of the fall in packed cell volume, through a compensatory response
in the production of more cells from the bone marrow. The extent of
erythropoiesis does not, however, match the degree of anaemia and
the packed cell volume remains low. It is thought that this is due
to failure of iron transport from the massive haemosiderin deposits
in mononuclear phagocytic system to the erythropoietic centres
(Dargie et al_. , 1979) . In contrast to anaemia in the first phase
this anaemia is associated with scanty parasitaemia and is not re¬
versed by chemotherapy (Losos and Chouinard, 1979; Urquhart, 1980).
In the third phase of anaemia associated with bovine trypano¬
somiasis the packed cell volume may return to normal but it can re¬
main low, leading to eventual death of the animal. The low packed
cell volume, as in the second phase, is also thought to be due to a
failure to re-utilize iron (Dargie et ad., 1979) .
2.4.2 Immunosuppression
Immunosuppression is now an established feature of African try¬
panosomiasis. Goodwin, Green, Guy and Voller (1972) showed that
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injection of sheep red blood cells (SRBCs) into mice and rabbits in¬
fected with T. brucei led to the production of lower anti-SRBC agglu¬
tinin levels than in uninfected control animals similarly treated
with SRBCs. Numerous studies have confirmed the recurrence of
marked depression in antibody responses to heterologous non-trypano-
somal antigen in murine trypanosomiasis (e.g. Hudson and Terry, 1979;
Roelants et ad., 1979; Baltz et al., 1981).
Evidence that immunosuppression also occurs in bovine trypano¬
somiasis was provided when Holmes _et ad. (1974) showed that cattle
infected with T. congolense developed lower secondary responses to
polyvalent clostridial vaccines than uninfected controls. Subsequent
studies confirmed the immunodepressive effects of trypanosomal in¬
fection in cattle immunized with other antigens including Brucella ab¬
ortus (Rurangirwa et al■, 1979b; 1983), Leptospira biflexa (Rurangirwa,
1979b; 1980b), Mycoplasma mycoides (Rurangirwa et al., 1978; Ilemobade
et al. , 1982) and Foot-and-Mouth Disease virus (Scott et al., 1977;
Sharpe et al., 1982) .
The earlier fears that immunosuppression associated with bovine
trypanosomiasis may interfere with responses to vaccination have not
been confirmed. It has been shown that the primary and secondary
antibody responses to foot-and-mouth disease virus vaccine in cattle
with naturally acquired trypanosomiasis or experimental Id congolense
infections, were generally above the level considered adequate to
confer 95% protection against challenge (Scott et al. , 1977; Sharpe
et al. , 1982). With rinderpest vaccination it was shown that infection
with Id congolense and T. vivax did not significantly depress the
neutralizing antibody response of cattle to live rinderpest virus when
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vaccination was carried out at eight or 25 days after infection
(Rurangirwa et ad., 1980a).
However, immunosuppression may be important in relation to
pathogenicity since animals often die as a result of secondary
bacterial and viral infection. It may also explain why animals do
not rapidly acquire solid immunity to all the local strains of
trypanosomes, since it has been shown that trypanosome-infected
cattle are also immunosuppressed to concurrent infection with other
trypanosome stocks (Nantulya et al., 1982). Similar impairment of
antitrypanosomal immune responses have been observed in trypanosom¬
iasis infection in mice (e.g. Sacks et al. , 1980; Sacks and Askonas,
1980) and rabbits (Luckins and Gray, 1983; Luckins et al., 1983).
The mechanism of immunosuppression is not known with certainty
(Losos and Chouinard, 1979). It is likely that in cattle it requires
the presence of live trypanosomes as it has been shown that immune
competence is spontaneously restored upon trypanocidal treatment
(Rurangirwa, Tabel and Losos, 1979a). In contrast, in mice it has
been shown that even killed trypanosomes or their subcellular mem¬
brane fractions can cause immunosuppression (Clayton, Sacks, Ogilvie
and Askonas, 1979). Other studies have suggested that antigenic
competition may be responsible for low antibody response to some clones
when cattle are simultaneously or subsequently challenged with anti¬
gens of more than one clone of T. congolense or T. brucei (Nantulya
et al. , 1982) .
It has also been suggested that complement depletion in the
course of trypanosome infection contributes to the immunosuppression
associated with trypanosomiasis. It is now held however, that low
complement levels probably contribute more to predisposition of
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infected animals to secondary infection rather than actual immuno¬





Male and female New Zealand white (NZW) rabbits or Sandylop
rabbits obtained from the Centre for Laboratory Animals, Edinburgh
University, were used in studies on the development of local skin re¬
actions, immunity, chemotherapy and for maintenance of tsetse flies.
Rabbits were used at 8-10 months of age when they weighed 2-3 kg.
Each was kept in an individual metal cage with food (Rabbit pellets
- S.G.I, Oxoid Laboratory Animal Diets) and water ad libitum. Rabbits
were identified by numbered ear tags or by marking with picric acid
in the case of animals whose ears were used for maintenance of tsetse
flies.
Female, albino, random-bred CFl mice, obtained from the Centre
for Laboratory Animals, Edinburgh University, were used for drug
sensitivity assays, for passaging stocks of T. congolense, for infect¬
ing tsetse flies and for antigen and stabilate preparation. Mice
6-8 weeks old, weighing 20-30 g were kept in plastic cages with metal
tops through which food (Rat cake - Oxoid Laboratory Animal Diets)
and water were offered ad libitum. Up to five were kept in one cage
on wood shavings and water absorbent granules - "Oakite" (Oakite Ltd.,
Retford, Nottinghamshire, England). Each animal was individually
marked with picric acid.
3.2 Handling of Animals
Intravenous and intramuscular injections into rabbits were
carried out with the help of an assistant in restraining the animal.
Intramuscular injections in the rear legs were done using a 25 gauge
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16 mm needle (Becton Dickinson) into and along the length of the
semitendinosus or semimembranosus muscle. For intravenous inocul¬
ation and for bleeding from the marginal ear vein, 20 gauge, 25 mm
needles were used. For bleeding from the ear vein, rabbits were
wrapped up firmly in a towel; blood was collected by allowing it to
drop directly into a glass universal bottle or a glass vial contain¬
ing EDTA. To facilitate bleeding, the ear was rubbed with a little
xylene at the distal end to cause distension of the marginal blood
vessels.
For routine tail-bleeding and subcutaneous or intraperitoneal
injection, mice were handled without anaesthesia. To reduce the
chances of accidental intraviscus inoculation in the course of intra¬
peritoneal injection with trypanocidal drugs, mice were starved for
24 hours before use. For collection of blood for subinoculation or
stabilation, mice were exsanguinated under ether anaesthesia.
3.3 Serum Preparation
Blood for serum preparation was allowed to clot by standing
for one hour at room temperature and one hour at 37°C followed by
18-24 hours at 4°C. The serum was then separated from the clot by
centrifugation at 1500 g for 30 minutes at 4°C and stored at -20°C
until needed.
3.4 Trypanosome Stocks
The trypanosome stocks were derived by mouse passage from two
stabilates, T. congolense TREU 1457 and T. congolense TREU 1468 which
were cloned derivatives of stocks ZARIA/67/LUMP/79 and SERENGETI/66/
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LUMP/12 respectively. Stabilates T. congolense TREU 1613, TREU 1690
and TREU 1725 were derived from T. congolense TREU 1457 (Figure 3.1).
Stabilate T. congolense TREU 1682 was derived from T. congolense TREU
1468 as shown in the pedigree chart Figure 3.2. Plate 3.1A shows
trypanosomes in a Giemsa stained smear from a mouse infected with T.
congolense TREU 1457.
3.5 Culture Metacyclics
These were derived from T. congolense TREU 1457 and maintained
in culture by the methods described by Gray et a_l. (1981). The
culture metacyclics were obtained by courtesy of Dr. C.A. Ross of
the Protozoology Section, C.T.V.M. Metacyclic forms were separated
from epimastigotes on equilibrated ion-exchange resin Diethylamino-
ethyl cellulose (DE52, Whatman Chromedia), by elution with phosphate
buffered saline glucose pH 8.0 (PBSG) using techniques described by
Lanham and Godfrey (1970). Trypanosomes were concentrated by centri-
fugation at 500 g for 15 minutes at 4°C. Plate 3.IB shows Giemsa-
stained culture metacyclics of Th congolense TREU 1457.
3.6 Stabilation and Retrieval of Stabilates from Cryobank
Stabilates were maintained in liquid nitrogen. The process
of stabilation and retrieval was essentially that described by
Lumsden, Herbert and McNeillage (1973). Mice used to subpassage
trypanosomes for stabilation were immunosuppressed by treatment with
300 mg/kg cyclophosphamide (Koch-Light) intraperitoneally, 18-24 hours
before infection. Trypanosomes were subpassaged at 3-6 day intervals
and stabilated when mice had developed a fulminating parasitaemia.
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Blood for stabilation was collected from the hearts of mice
under ether anaesthesia into a 1.0 ml syringe containing 0.1 ml
heparin (50 IU/ml). Usually 0.5-1.0 ml of blood could be obtained
from one mouse. The volume of blood was noted and then transferred
into sterile bijou bottles kept cool in an ice-bath. Sufficient
50% glycerol in phosphate buffered saline (PBS) pH 8.0 was then
added to the cooled blood with a micropipette (Gilson Pipetman,
Anachem Ltd., Luton, England), to achieve a glycerol concentration
of 7.5%. After gentle mixing the blood was transferred into sterile
glass capillary tubes 100 mm long, using a Pasteur pipette. The
capillary tubes were held in a metal rack kept on an ice-cold slab
(KRYRACK - Streck Laboratories Inc., Omaha, NE, U.S.A.), during the
filling and sealing processes. Tubes were filled with blood up to
two-fifths of the total length and were then transferred into a per¬
forated plastic tube which was immediately transferred into an insul¬
ating jacket (Lumsden ert al_. , 1973) for slow cooling overnight in an
ice-box containing solid carbon dioxide.
After 18 hours at -79°C the plastic tube containing capillary tubes
was transferred onto a pre-cooled metal cane which was immediately
placed into a canister in a liquid nitrogen flask. A sample capi¬
llary tube was removed and checked for motility and viability of the
trypanosomes. Stabilates were given TREU numbers and documented as
suggested by Lumsden et al. (1973).
For initiating infections in mice, the contents of a capillary tube




Parasitaemias in mice were monitored by examination of tail
blood by phase contrast microscopy using a x40 objective, xlO ocular
in a Vickers M15C Microscope (Vickers Instruments, England). The
quantity of blood used was just sufficient to fill the area of a
6 x 22 mm coverslip. At least 20 high power fields (HPF) were exam¬
ined with the x40 objective for the presence of trypanosomes.
In rabbits, parasitaemia was monitored by the microhaematocrit
phase-contrast, buffy coat technique (Murray, Murray and Mclntyre,
1977). Peripheral blood was collected from the ear vein into hep-
arinised glass capillary tubes (Heparinised Benjamin Haematocrit
Tubes, Harshaw Chemicals Ltd., Daventry, England) which were sealed
at one end with plasticine and then centrifuged for four minutes in
a microhaematocrit centrifuge (Hawksley, England). A section of the
capillary tube containing the buffy coat together with red blood
cells up to 1 mm below and plasma up to 30 mm above was cut with a
diamond tipped pencil and the contents expressed onto three areas
on a slide, mixed and covered with 22 x 22 mm coverslips. At least
20 HPFs were examined in the area of each coverslip.
3.8 Separation of Trypanosomes from Blood and Cultures
One hundred grams of pre-swollen (DE52) was equilibrated by
mixing with 5 litres PBS pH 8.0 and adjusting the pH of the resulting
suspension with 5% v/v Analar orthophosphoric acid (British Drug
Houses). When equilibrated to pH 8.0 the ion-exchange cellulose
suspension was stored at +4°C for short periods or at -20°C for longer
periods.
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When required for separation, equilibrated DE52 was packed
with Whatman 3-piece Filtration Unit in which a Whatman No. 4 filter
paper had been placed. Packing was done by allowing fluid from the
cellulose suspension to drain away slowly, aiming at obtaining a
horizontal top surface. This surface was then covered with another
Whatman filter paper No. 4. PBSG was then run through and the pH
of the eluate checked to confirm that it was registering pH 8.0
before applying blood or culture medium containing trypanosomes.
Blood collected from mice with fulminating infections was
immediately diluted 50:50 v/v with ice-cold PBSG and then layered
on top of the equilibrated DE52. Trypanosomes were eluted with ice-
cold PBSG collected in a sterile polystyrene universal bottle, and
then concentrated by centrifugation at 4°C for 30 minutes at 1500 g_.
Cultured metacyclic trypanosomes were separated by applying
culture fluid containing trypanosomes onto the top of equilibrated
DE52 column and eluting with PBSG as above. The separated culture
metacyclics were then concentrated by centrifugation at 1500 g_ for
15 minutes.
3.9 Trypanocidal Drugs
Three drugs were used in this work: Diminazene aceturate B.
vet.C. (BERENIL, Farbwerke Hoechst AG, Frankfurt-Main), Homidium
bromide B.vet.C. (ETHIDIUM, The Boots Company Ltd., Nottingham,
England) and Isometamidium chloride B.vet.C. (SAMORIN, May and Baker
Ltd., Dagenham, England).
Diminazene aceturate was a gift from Hoechst U.K. Ltd. (courtesy
of Mr. J.M.B. Best, Marketing Manager). It was supplied in 2.36 g
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sachets containing 1.05 g active principle, the rest being an anti-
pyrene used as stabilizer to extend the shelf life of made-up
solutions. However, in all experiments only freshly prepared
solutions were used. For rabbits, solutions containing 3.5% active
principle were prepared in 5 or 10 ml volumetric flasks. For mice,
0.01-0.20% solutions were prepared in 10, 20 or 25 ml volumetric
flasks and diluted so that the required dose per gram body weight
was contained in 0.01 ml.
In the rabbit, drugs were administered by deep intramuscular
injection, dividing the dose so that each hindlimb received less than
0.6 ml. In the mouse the drug was inoculated intraperitoneally.
Homidium bromide was supplied as tablets containing 250 mg of
active principle. Each tablet was crushed and then dissolved in
distilled water at room temperature, for preparation of 2.5% solutions
in volumetric flasks. Fresh drug solutions were used in all experi¬
ments . Route of administration in the rabbit was by deep intra¬
muscular injection, the dose being divided so that each hindlimb
received less than 0.6 ml. Mice were inoculated intraperitoneally.
Isometamidium chloride was a gift from May and Baker Ltd.,
Dagenham, England (courtesy of Mr. D.A. Hutchings). It was used as
a 1% solution made up by dissolving the drug in water at room temper¬
ature in 5 or 10 ml volumetric flasks. It was used only in rabbits




G. m. morsitans pupae were supplied by courtesy of Dr. A.M.
Jordan, Tsetse Research Laboratory, Langford, Bristol. On receipt,
the pupae were immediately placed in humid jars and incubated at 28°C.
Flies emerged 20-26 days after larviposition. Six to 18 hours after
emerging, the teneral flies were transferred into Geigy-1 fly cages
which were then placed in a humidified room at 25°C and 75-80% rela¬
tive humidity. Handling during the transfer to individual cages was
facilitated by chilling the flies for up to five minutes in the
freezer compartment of a domestic refrigerator.
3.11 Infection and Maintenance of Tsetse Flies
Teneral flies were fed within 24-36 hours of emergence on
mice infected with T. congolense TREU 1690 or TREU 1682.- Control
flies were fed on uninfected mice. The mice were individually re¬
strained in the perforated barrel of a 60 ml plastic syringe on
which a window covered with mosquito gauze had been cut for locat¬
ing the Geigy-1 (Figure 3.3).
Flies were fed on mice which had been infected 2-8 days
previously. The levels of parasitaemia varied between 1/20 field
and 60-100/HPFs depending on the time after infection. Flies which
did not feed within 36 hours of emergence were discarded.
All subsequent maintenance feeds were made at 2-3 day intervals
on rabbits' ears (Plate 3.2). For each fly a record was made of its
sex, number of days post-larviposition when it emerged, approximate
age in hours, at which infected blood meal was taken and the days
on which a maintenance feed was taken. Flies were tested for infect-
ivity 21-28 days after feeding on the infected mice.
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3.12 Identification of Infected Flies
The probe method for identifying infected tsetse flies
(Burtt, 1946b) could not be relied upon because it often took too
long before a fly probed and metacyclics were easily washed from
the slide when an attempt was made to fix and stain them. Since
the two stocks used in the experiments were known to regularly
produce local skin reactions in rabbits (Luckins and Gray, 1979)
infected flies were identified by this method and later confirmed
by dissection at the end of the experiments. Individual infected
flies were fed in groups of 12-24 on the shaven backs of NZW rabbits,
each fly being placed on an area marked out by picric acid. Positive
reactions were confirmed by microscopical examination of chancre
fluid for presence of trypanosomes.
3.13 Monitoring Skin Reactions
The development of local skin reactions was monitored by
measurement of the diameters of hyperaemia and induration around the
infective tsetse bite site. For each reaction, the diameter was
measured in two or three directions and the mean value determined.
Examination of the bite site and measurement of any visible reactions
was usually carried out every day at 09.00-11.00 hours for up to 28
days for untreated rabbits or longer for rabbits which had been treated
with trypanocidal drugs.
3.14 Histology of Skin
Material for histological examination was removed from rabbits
which had been killed by cervical dislocation,skin containing the
43.
local reaction, as well as skin on which uninfected flies had fed,
was marked out with picric acid in living rabbits and then removed
immediately after death. It was then trimmed, placed in Bouin's
fixative for 24 hours, dehydrated through alcohol and finally embedded
in paraffin wax. Sections 5 hm thick were cut and stained using
Giemsa colophonium (Appendix 2).
3.15 Estimation of Antibody Levels in Serum and Tissue Fluid
Determination of trypanosomal antibodies was made using an
enzyme immunoassay and neutralization of infectivity test.
3.15.1 Enzyme-linked immunosorbent assay (ELISA)
The ELISA test used was essentially that described by Silayo,
Gray and Luckins (1980).
(a) Antigen preparation: Antigen was prepared from trypanosomes
obtained from mice infected with T. congolense TREU 1690. Blood from
heavily infected mice was applied to a column of DE52 and the separ¬
ated trypanosomes were concentrated by centrifugation at 1500 g_ and
4°C. Several trypanosome pellets were pooled and washed twice with
0.1M PBS pH 7.4 and stored at -20°C until used. For preparation of
soluble antigen, the frozen trypanosome pellet was thawed, diluted
1/4 with ice-cold PBS, pH 7.4 and then subjected to 2 x 20 seconds
ultrasonication at maximum amplitude on an MSE 100W ultrasonic dis¬
integrator. During the sonication process the trypanosome suspension
was jacketed in an ice-bath to prevent local overheating. Soluble
antigen was separated from cell debris by ultracentrifugation at 4°C
for 30 minutes at 100,000 g in a Beckman L2-65B ultracentrifuge with
SW 65L swing-out rotor. The protein concentration of the supernatant
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was determined by ultraviolet spectrophotometry (Warburg and Christian,
1941) using a Pye Unicam SP 1800 Spectrophotometer. Protein concen¬
trations of 100-300 ng/ml were obtained. The soluble antigen pre¬
paration was diluted with PBS pH 7.4 and stored as a stock antigen at
-20°C in aliquots of 0.2-0.5 ml. For use in the test, stock antigen
was diluted with 0.05M carbonate/bicarbonate buffer pH 9.6 to give a
final protein concentration 1 |ig/ml.
(b) Immunoglobulin-enzyme conjugate: Goat anti-rabbit gamma¬
globulin conjugated with horse-radish peroxidase was obtained from
Nordic Immunological Laboratories (Maidenhead, Berkshire, England).
The freeze-dried conjugate was reconstituted with sterile distilled
water and centrifuged at 4°C for 20 minutes at 1500 g_ to remove in¬
soluble material. It was then stored at -20°C in aliquots of 50 |il
until used.
(c) Substrate: Orthophenylenediamine (OPD) at a concentration
of 35 mg/100 ml phosphate citrate buffer pH 6.0, containing 0.03%
hydrogen peroxidase (Analar, British Drug Houses) was used as the
substrate.
(d) Procedure for the microELISA test: MicroELISA plates (Cooke
microELISA M29 AR) were coated with trypanosomal antigen by placing
250 |_l1 of diluted antigen solution in each well and incubating the
plates overnight at 4°C. Plates were sealed with Scotch pressure
sensitive tape. Unadsorbed antigen was washed out by emptying the
wells and filling them with PBS pH 7.4 containing 0.05% Tween 20 (PBS/
Tween 20) three times for three minutes. The plates were then shaken
dry and each well filled with 250 p.1 of serum or tissue fluid sample
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diluted 1/1000 with PBS/Tween 20. Each sample was assayed in tripli¬
cate on the same plate. Controls included PBS/Tween 20, serum or
tissue fluid from uninfected rabbits and serum or tissue fluid from
a known infected rabbit collected 42 days after infection with T_.
congolense TREU 1690. The plates were sealed, wrapped in aluminium
foil and incubated at 37°C on top of a water-bath for 15 minutes.
Washing was repeated to remove unreacted antibody and then 250 p.1
of horse-radish peroxidase immunoglobulin conjugate diluted 1/1000
with PBS/Tween 20 was added and incubated for 15 minutes at 37°C.
After washing and drying the plates, 250 M-l of substrate at 4°C was
added to each well. The plate was sealed and wrapped in foil and
then incubated at 37°C for 30 minutes. The enzyme reaction was
stopped by adding 100 y.1 of 1M "Aristar" sulphuric acid (British Drug
Houses). The absorbances of the solutions in each well were measured
at 492 nm in SP 200 Pye Unicam Spectrophotometer or an MSE/Fisons
VITATRON Universal photometer adapted for microELISA.
The mean readings for the triplicate assay carried out for each
sample on the same plate were standardised according to the following
formula:-
Po — No
Corrected ELISA value = (Un - Nn) x
Pn - Nn
where Un = ELISA value of unknown test sample on day n_
Nn = ELISA value of normal serum on day n_
Po = ELISA value of positive serum control on initial day
of series of assays
No = ELISA value of normal serum control on initial day of
assays
Pn = ELISA value of positive control serum on day n
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3.15.2 Neutralization of infectivity test (NIT)
Neutralization tests were carried out by incubating trypanosomes
in diluted serum or tissue fluid and then determining the infectivity
of the suspension by mouse subinoculation. Trypanosomes were derived
from T. congolense TREU 1725 by two subpassages at 4-day intervals in
mice immunosuppressed with 300 mg/kg cyclophosphamide.
Trypanosomes from infected, immunosuppressed mice were separated
from blood elements by elution through DE52 cellulose column and con¬
centrated by centrifugation at 4°C for 15 minutes at 1500 g. The re¬
sulting trypanosome pellet was resuspended in a small amount of PBSG
with 10% fetal bovine serum (PBSG/FBS) and the trypanosome concen¬
tration estimated by counting the number of parasites in an improved
Neubauer hemocytometer (Lumsden et al_. , 1973) . It was then diluted
with more PBSG/FBS so as to contain 250,000 trypanosomes/ml. Test
samples were diluted 1/10 by mixing together 0.2 ml of serum or
tissue fluid, 1.6 ml of PBSG/FBS and 0.2 ml of trypanosome suspension.
This suspension was incubated for 30 minutes at 4°C and then 0.2 ml
amounts inoculated intraperitoneally into groups of five mice. Control
normal serum was also assayed. The mice were examined twice a week
for 35 days or until they became positive.
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Figure 3.1

































































Plate 3.1A Thin smear of mouse blood obtained at day 15
post-infection with T. congolense TREU 1457
(Giemsa, x 625)




Figure 3.3 Plastic syringe (60 ml) modified for restraining












INFECTIVITY, PATHOGENICITY AND DRUG SENSITIVITIES
4.1 Introduction
T. congolense infects most species of domestic mammals but there
are variations in infectivity and pathogenicity of different stocks
(Hoare, 1972). It is generally considered that West African stocks
of T. congolense are of lower pathogenicity to cattle than East
African stocks (Stephen, 1970; Losos and Ikede, 1972). In studies
on West African isolates of T. congolense, pathogenicity was found
to correlate with trypanosome morphology and dimensions (Godfrey,
1961). Short congolense type trypanosomes were characterised by
low infectivity, low parasitaemia and low pathogenicity, while long
dimorphon types had high infectivity, high parasitaemia and high
pathogenicity. Intermediate stocks were characterised by high
infectivity and high parasitaemias but low pathogenicity.
The infectivity and pathogenicity of stocks of T. congolense
to mice, rats, guinea pigs and rabbits is generally low on initial
isolation. Many stocks obtained from the field cannot be isolated
in laboratory animals (Godfrey, 1982). However, the infectivity and
pathogenicity of an isolate can be enhanced upon serial passage
(Losos and Ikede, 1972). The resulting infection changes in certain
important characteristics, including drug sensitivity. Thus, results
obtained in experimental work with laboratory rodents may not necess¬
arily be applicable to natural infections in livestock. This is
particularly the case with infections in mice, rats and guinea pigs
where high parasitaemias invariably leading to death, commonly occur.
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Among laboratory animals the rabbit is probably the most suit¬
able host for studies on T. congolense since low parasitaemias are
obtained and the early events after cyclical infection with the
parasite have been shown to be similar to those occurring in cattle
(Gray and Luckins, 1980).
The pathogenicity of T. congolense in rabbits and cattle has also
been compared (Holmes, 1976). The mean packed cell volume (PCV) of
the infected rabbits was observed to drop from a normal of 40% to 28%
while in cattle the PCV drop was from a normal of 30% to 14%. Both
species showed a normochromic, normocytic anaemia but whereas the
disease in cattle consistently led to death at 5-10 weeks after
infection there was rarely any mortality among rabbits.
In contrast, severe disease has been reported in rabbits inocu¬
lated with 5 x 10^ bloodstream forms of T?. congolense (Mansfield and
Kreier, 1972a). Lesions normally associated with T. brucei infections
in rabbits were seen and death always occurred unless treatment with
homidium was carried out. Even then, few or no trypanosomes were
observed microscopically although the blood was infective to rats.
For reasons of economy, mice are used for studies on drug sensi¬
tivities of T. congolense stocks, although there is the probability
that trypanosome isolates may change their drug sensitivity upon
passage. A technique for determining anti-trypanosomal activity of
new compounds in mice, described by Hawking (1963a) can also be
applied to investigations on the sensitivity of trypanosome stocks
to the commonly used trypanocides. Treatment is carried out when the
mice show a parasitaemia of 0.1-10 trypanosomes/HPF. It is necessary
to standardise the infecting dose so as to obtain uniform parasitaemias
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at the time of treatment, since it has been shown that effective and
curative doses are proportional to the numbers of trypanosomes used
in infecting the mice (Raether, 1970; Walker and Opiyo, 1973).
Trypanosome drug sensitivity in vivo is usually expressed in
terms of the minimum effective dose (MED) or the minimum curative
dose (MCD) for a particular animal species. The MED is the dose
which clears the trypanosomes from 80% of the animals treated (EDg^)
while the MCD is the dose which cures 80% of treated animals (CD )
oU
(Hawking, 1963b).
In the following experiments, preliminary studies of drug
sensitivity were carried out on two stocks of T. congolense later
used for studies on the effect of drug treatment on the development
of sterile immunity to T. congolense infection in rabbits. The two
stocks were tested in mice for their sensitivity to diminazene ace-
turate and homidium bromide and in rabbits for sensitivity to dimin¬
azene aceturate and isometamidium chloride.
Observations were also made on the possible influence of the
levels and duration of parasitaemia in mice on which tsetse flies
were fed, and the sex of the fly on trypanosome infection rates in
the flies.
The gross appearance and reproducibility of the local skin
reactions following bites by infected tsetse flies were studied in
rats, guinea pigs and rabbits and the course of infection in the
rabbit was also monitored.
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4.2 Drug Sensitivity of Trypanosoma congolense stocks
4.2.1 In mice
Experimental design: Two stocks of T. congolense, TREU
1468 and TREU 1613 were tested for their sensitivity to diminazene
aceturate and homidium bromide. The drug assay was carried out as
described by Hawking (1963a). A batch of CFl mice 6-8 weeks old and
weighing 20-25 g were divided into groups which were inoculated intra-
4
peritoneally with approximately 10 T. congolense bloodstream forms
obtained from mice. Mice inoculated with each stock were then randomly
allocated in groups of five and marked with picric acid to identify
the individual mouse, the group it belonged to and the drug to be
used for treatment. They were then examined daily for the presence of
parasites in tail blood and at 4-6 days post-infection when the para-
sitaemia was 0.1-4 parasites per HPF, the groups were again randomly
allocated for treatment at different dosage levels of the drugs.
Drugs were prepared fresh on the day of treatment and were inoculated
intraperitoneally. Parasitaemia was monitored by wet smear examination
for up to seven days after treatment and thereafter twice weekly up
to 35 days post-treatment.
Results: Tables 4.1 and 4.2 show the numbers of mice infected
with T. congolense TREU 1468 or TREU 1613 after treatment at different
dose levels with homidium bromide or diminazene aceturate. Mice in
all test groups were positive on the day of treatment (day 0). By
day 3 after treatment, trypanosomes had disappeared from some of the
treated mice, but reappeared by day 30. From the numbers of mice
parasitaemic at days 3 and 30 after treatment, the minimum curative
doses can be estimated. These are shown in Table 4.3. T. congolense
TREU 1468 appeared to be more sensitive than T. congolense TREU 1613
to both homidium bromide and diminazene aceturate. For example, the
MCD of diminazene aceturate for T. congolense TREU 1468 was 10 mg/kg
compared to 20 mg/kg for T. congolense TREU 1613.
4.2.2 In rabbits
Experimental design: The MCD value of 20 mg/kg diminazene
aceturate for mice infected with Th congolense TREU 1613 was used as
a guide in calculating the approximate MCD in rabbits, using the
dose/surface area relationship whereby dose is proportional to two-
thirds the power of the body weight (Moore, 1909; Bushby, 1963). The
calculated MCD of diminazene aceturate for the rabbit was 4.3 mg/kg.
To determine the practical MCD in rabbits experiments were done
using animals infected with T. congolense TREU 1457 from which TREU
1613 was derived. Three pairs of rabbits, which had been infected
by G. m. morsitans 24-66 days previously were treated with diminazene
aceturate at dose rates of 3.5, 4.0 and 5.0 mg/kg. The presence of
trypanosomes in the blood on the day of treatment was confirmed by the
microhaematocrit/buffy coat technique (Murray et al., 1977). After
treatment, blood was checked for trypanosomes twice a week by the
microhaematocrit/buffy coat technique until the animals became posi¬
tive again or for up to 42 days. At this time, blood was subinocul-
ated into mice to confirm the absence of trypanosomes. Animals which
were negative for trypanosomes in the blood for a period of 42 days
after treatment were considered to be cured. In another experiment
the curative dose of isometamidium chloride for T. congolense TREU
1690 infection in the rabbit was determined. Four rabbits which had
been infected by bites from G. m. morsitans 21 days previously were
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treated with isometamidium chloride at dose rates of 0.25, 0.50, 0.75
and 1.0 mg/kg. Determination of presence of trypanosomes on the day
of treatment and after treatment was carried out as described pre¬
viously .
Results: In the rabbits treated with diminazene aceturate,
5.0 mg/kg dose rate was completely curative while 3.5 mg/kg and 4.0
mg/kg were both only partially curative (Table 4.4). Thus the MCD
for T. congolense TREU 1457 is between 4.0 and 5.0 mg/kg.
In the animals treated with isometamidium chloride it was found
that treatment at 0.25 or 0.50 mg/kg dose rate resulted in relapses
in parasitaemia after treatment while there was no relapsed parasit-
aemia after treatment at 0.75 mg/kg or 1.0 mg/kg dose rates (Table 4.5).
4.3 Infectivity of Trypanosoma congolense TREU 1690 for Glossina
morsitans morsitans
Experimental design: Teneral flies were fed individually on mice
infected with T. congolense TREU 1690 within 36 hours of emergence.
Flies were offered a blood meal 2-3 times within approximately 6-18
hours of emergence, until they fed. The mice on which the teneral
flies took their first blood meal had infections of 2-8 days duration.
The parasitaemia was not quantitated daily but was of the order of
10^-10® trypanosomes/ml at 1-4 days and 10^-10® at 5-8 days as esti¬
mated by the rapid "matching" method of Herbert and Lumsden (1976)
applied to tail blood.
Flies were tested for infectivity at day 21-24 after emerging,
by being fed on the shaved backs of susceptible rabbits to induce
chancres. Flies whose bites did not induce chancres within 7-8 days
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of feeding were then dissected. Flies which induced chancres were
dissected at the end of experiments.
The flies known to be infected were maintained on normal rabbits
or on mice for testing maintenance of infectivity. Batches of in¬
fected flies were not maintained on the same rabbit for more than 14
days after the first infected fly fed.
The final fly infection rates were obtained by combining the
results from fly dissection and from observations on chancre induction.
Results: One hundred and eleven flies out of 174 (64%) were
positive, with infection of mouthparts. Table 4.6 compares the num¬
ber of infected and non-infected male and female flies fed on mice
with infections of 1-4 days or 5-8 days duration. There was no
statistically significant difference in infection rates between
these two groups. The infection rates were also analysed for the
influence of sex of fly (Table 4.7). There was no significant differ¬
ence between infection rates in male and female flies.
4.4 Gross Appearance and Reproducibility of the Local Skin Reaction
to Trypanosoma congolense
Experimental design: In preliminary studies, rats and guinea
pigs were examined for development of chancres at skin sites bitten
by G. m. morsitans infected with T. congolense TREU 1457. Up to
four infected flies were allowed to feed on shaved areas of each of
five guinea pigs and five rats. The animals were then checked for
chancre development every day for the first 14 days and three times
a week thereafter for up to 28 days after infection. They were also
examined three times a week for the presence of trypanosomes in blood
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from ear vein (guinea pig) or tail (rat).
Studies were also carried out to determine the reproducibility
of the induction of chancres in rabbits by tsetse flies infected with
T. congolense. Fourteen G. m. morsitans infected with T. congolense
TREU 1457 and five non-infected flies were fed on a number of differ¬
ent occasions on shaved areas on the backs of 13 normal rabbits. The
diameter of the erythematous and indurated area around the bite sites
was monitored daily for up to 21 days after infection. The majority
of rabbits were observed for up to 12 days after infection, when they
were killed for histological studies.
Results: No skin reaction appeared on any of the guinea pigs
or rats. All the guinea pigs were parasitaemic within 21-28 days
after infection while the rats had become parasitaemic 7-15 days
after infection.
In contrast, local skin reactions appeared in rabbits at sites
where infected flies had fed. Table 4.8 compares the frequency of
occurrence of local skin reactions _> 5 mm in diameter at sites bitten
by infected or uninfected flies. Forty-seven out of 55 (85%) bites
from infected flies gave reactions _> 5 mm diameter whereas only four
out of 35 (11%) bites from non-infected flies gave reactions _> 5 mm
diameter. The reactions from non-infected flies were of short dur¬
ation (2-3 days) and reached a maximum of less than 10 mm. In con¬
trast, the reactions from infected flies reached a maximum diameter
of 50 mm and lasted up to 11 days. Plates 4.1-4.3 show the skin
reactions at different times after infective tsetse bites on the
shaved backs of two of the rabbits.
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4.5 The Course of Infection in Rabbits Infected with Trypanosoma
congolense by Glossina morsitans morsitans
Experimental design: Rabbits which had been cyclically infected
with T. congolense TREU 1690 and then treated with diminazene acetur-
ate were monitored for changes in packed cell volume, weight and
antibody levels up to 12 weeks after infection.
Ten rabbits approximately 16 weeks old, were randomly allocated
into three groups. One group of four animals was then used for
experimental infection and treatment while the other two groups were
used as uninfected, untreated and uninfected, treated control groups.
Each animal in the experimental group was infected by bites from four
tsetse flies infected with T. congolense TREU 1690. The experimental
and uninfected treatment control groups were treated with 14 mg/kg
diminazene aceturate at seven weeks after infection of the experi¬
mental group.
All animals were weighed and bled for serum and blood once a week,
from one week before infection to 12 weeks after infection. For PCV
measurements three heparinised capillary haematocrit tubes (Heparin-
ised Benjamin Haematocrit tubes - Harshaw Chemicals Ltd., England)
were filled with blood direct from the punctured ear vein and then
sealed with vinyl plastic putty (Cristoseal, Lancer St., Louis, U.S.A.).
The sealed capillary tubes were centrifuged for four minutes on a
microhaematocrit centrifuge (Hawksley, England) and the PCV measured
on a Hawksley Microhaematocrit Reader.
The infected experimental group was monitored for chancre develop¬
ment up to 21 days after infective tsetse bite and checked for anti¬
body levels in serum, using the ELISA test. Development of parasitaemia
was monitored once a week by the microhaematocrit/buffy coat technique
from two weeks to 12 weeks after infection. Absence of trypanosomes
in blood after treatment was confirmed by the inoculation of 0.5 ml
amounts of blood into each of three mice at the end of the experiment.
Results: Mean PCV of infected, treated group dropped from a
pre-infection level of 40% to 30%, six weeks after infection, then
rapidly returned to normal one week after treatment (Figure 4.1 and
Appendix 3). Trypanosomes were detectable by the microhaematocrit/
buffy coat technique throughout the period between infection and
treatment. After treatment, no trypanosomes could be detected by
the microhaematocrit/buffy coat technique or mouse subinoculation.
The control uninfected groups maintained mean PCVs of above 40%
throughout the period of observation.
The T. congolense infection did not appear to affect growth
rate; the mean weights of experimental and treatment control groups
were virtually the same throughout (Figure 4.2 and Appendix 4). The
uninfected, untreated control group showed mean weight loss between
weeks 7 and 10.
Chancre diameters and anti-trypanosomal antibody levels as
measured by ELISA are shown in Figure 4.3. Peak chancre sizes were
attained on day 11 except for one rabbit (1069) in which the peak
appeared earlier. All infected rabbits had detectable antibody levels
from week 2 after infection. There was a gradual fall in antibody
levels after drug treatment.
Table4.1
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Plate 4.1A Chancres on rabbit 823 at day 7 after tsetse bite.
Plate 4.1B Chancres on rabbit 823 on day 10 after tsetse bite.
Note greyish white zones, also described in cattle
(Akol and Murray, 1982).
 
Plate 4.2a Chancres on rabbit 831 at day 8 after tsetse
bite.
Plate 4.2B Chancres on rabbit 831 on day 11 after tsetse
bite. Note severe reactions characterised by
depressed red centres with crust formation on
two chancres (top left and centre bottom) and
also presence of a late developing chancre (top
right hand corner).
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Plate 4.3A Chancres on rabbit 831 on day 14 after tsetse
bite. Note late developing chancre has still
not formed a greyish white or red-encrusting
centre, while two earlier developing chancres
are disappearing and are only discernible as
red encrusting areas.
Plate 4■3B Rabbit 831 on day 17 after tsetse bite. Chancres
have completely disappeared, including the late
developing skin reaction which was in the top
right hand corner.
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Figure 4.1 Packed cell volumes (PCVs) of rabbits cyclically-
infected with Trypanosoma congolense TREU 1690.
• Infected, treated group (Rabbits 1069, 1073,
1075 and 1077) .
■ Uninfected, treated group (Rabbits 1067, 1070
and 1071).
* Uninfected and untreated group (Rabbits 1072,
g 1074 and 1076) .
f Treatment with diminazene aceturate (Berenil)
 
Figure 4.2 Mean body weights of uninfected rabbits and of
rabbits cyclically infected with Trypanosoma
congolense TREU 1690.
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Figures 4.3 A-C Mean diameters of chancres and mean ELISA
values (E,jg2) °f serum anti-trypanosome
antibodies in rabbits infected with T.







































The sensitivity of the two stocks of T. congolense to treatment
with diminazene aceturate (MCD 10 mg/kg and 20 mg/kg for TREU 1468
and TREU 1613 respectively) were within the range for drug sensitive
stocks found in other studies. Hawking (1963b) reported MCD ranges
of 10-15 mg/kg for drug sensitive stocks of Th congolense whereas
T. congolense stocks which were resistant to diminazene aceturate and/
or quinapyramine, prothidium and metamidium had MCDs of 25-100 mg/kg.
Moreover, T. congolense stocks TREU 1468 and TREU 1613 had MEDs 1-5
mg/kg which are within the range of MEDs of the T. congolense stocks
considered by Hawking (1963b) as sensitive to diminazene aceturate.
Differences in levels of parasitaemia at the time of drug treat¬
ment of mice could account for the lower minimum curative dose of
Th congolense TREU 1468 compared to TREU 1613 found in this study.
Although mice had been inoculated with approximately equal numbers of
T. congolense TREU 1468 or TREU 1613, the groups inoculated with T.
congolense TREU 1613 always had higher levels of parasitaemia at the
time of treatment. Other studies have shown that MCDs and MEDs in
mice are directly proportional to parasitaemic level at the time of
treatment (Raether, 1970; Walker and Opiyo, 1973).
The MCD value of diminazene aceturate for T. congolense TREU
1613 was used to estimate the MCD for the rabbit by calculations based
on a dose-surface area relationship formula (Moore, 1909; Bushby, 1963).
A probing experiment to determine the practical MCD of diminazene
aceturate for rabbits infected with T. congolense TREU 1690 showed that
5.0 mg/kg was curative while 3.5 mg/kg and 4.0 mg/kg were only partially
curative. Diminazene aceturate at 3.5 mg/kg has previously been shown
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to be subcurative for rabbits infected with a related stock of T.
congolense (Gilbert and Newton, 1982b; Gilbert, 1983).
The recommended dose of diminazene aceturate in cattle is 3.5
mg/kg (Williamson, 1970; Anon, 1979). From this, an equivalent
dose-surface area-calculated therapeutic level of diminazene ace¬
turate for rabbits would be approximately 16 mg/kg. However, the
recommended dose for bovine trypanosomiasis is intentionally made
far higher than the MCD for sensitive stocks, as a safety measure
against, for example underestimation of animal body weight as well
as possible occurrence of slightly drug resistant stocks. Initial
studies indicated that 1 mg/kg diminazene aceturate was curative for
T. congolense infection in cattle (Bauer, 1955). It was decided that
in experiments in which efficacy of diminazene aceturate against
cyclical T. congolense infection was being studied, a minimum dose
of 7 mg/kg would be used, but higher doses would be applied where the
main objective was to abrogate the infection for other studies such as
immunity.
The number of animals used for testing sensitivity of T. congol¬
ense TREU 1690 to isometamidium chloride was too low to allow estim¬
ation of the minimum curative dose. However, the result obtained
indicates the MCD was between 0.50 mg/kg and 1.0 mg/kg. Thus it was
decided that for prophylaxis purposes, 4 mg/kg dose rate would be used.
With regard to T. congolense infection rates in G. m. morsitans
it was shown that high infection rates of up to 64% could be obtained.
This is in contrast to the low infection rates of 8-14% reported by
others in studies in which G. m. morsitans were offered infective blood
meals and maintained on mice, rabbits and goats (NantuLya et al^., 1978b;
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Luckins and Gray, 1979a;Molo9, 1981). High T. congolense infection
rates of 46% have been reported in G. m. morsitans maintained on
goats (ILRAD, 1983).
It is interesting that no significant differences were found
in infection rates of flies fed on mice with 5-8 day infections as
opposed to mice with 1-4 day infections. Mice fed upon on days 1-4
after infection had parasitaemias of 10^-10^ trypanosomes/ml while
those fed upon on days 5-8 post-infection, had parasitaemias of 10^-
3
10 trypanosomes/ml. This appears to confirm earlier findings in
which the concentration of trypanosomes in the infected blood meal
was not found to influence infection rates (Baker and Robertson,
1957; Wijers and Willett, 1960; Dipeolu, 1975). It is however in
contrast to the findings of Nantulya et_ al. (1978b) who reported
higher T. congolense-infection rates (22%) in G. m. morsitans fed
on mice with peak parasitaemia than at log phase or "falling phase"
of parasitaemia (7% in each case). Although in the studies of
Nantulya et ail. (1978b) much larger numbers of flies were used, it
is also probable that the difference is due to the use of a differ¬
ent technique of infecting and maintaining the tsetse flies.
The finding that there was no significant difference between
infection rates of male and female tsetse flies confirms previous
findings (Baker and Robertson, 1957; Dipeolu, 1972).
In the present work, flies which did not feed within 36 hours
of emergence were discarded because the earlier studies indicated
that mature flies do not become infected (Wijers, 1958). Recent
studies with T. brucei organisms have indicated that flies of up to
five days of age at first blood meal can be infected (Gingrich et al.,
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1982). There are also reports that tsetse flies can become infected
with T. congolense when their first infected blood meal is taken after
the teneral stage. However, in the present studies it was more con¬
venient to offer the infected blood meal for a limited time after the
fly emergence.
Development of chancres or local skin reactions to T. congolense
was shown to occur in rabbits but not guinea pigs or rats. This is
in agreement with earlier studies using T. brucei organisms (Willett
and Gordon, 1957) . Mice bitten by T_. brucei infected G. m. morsitans
have also been shown to fail to develop chancres (Emery and Moloo,
1981). At post-mortem of the mice it was shown that the blood pool
in which the fly fed, was located in the abdominal muscle and not
in the subcutis (Emery and Moloo, 1981) .
In rabbits, chancres developed at sites bitten by infected flies
but not at sites bitten by non-infected flies. Local skin reactions
of greater than 5 mm were obtained in over 85% of feeds. This com¬
pares with 86-91% chancre-producing rate reported by others in cattle
and rabbits (Gray and Luckins, 1980; Akol and Murray, 1982). Non-
infected flies usually produced local reactions <5 mm in diameter.
In the few cases (11%) where the local skin reactions to uninfected
tsetse bites exceeded 5 mm in diameter, the maximum diameter reached
was <10 mm and duration of reaction was 3-5 days compared to 7-12
days for reactions at infective tsetse bites. The local skin reactions
at sites bitten by uninfected flies might be due to bacteria deposited
by the probing fly since older flies were observed to contain many-
bacteria in their proboscides.
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Measurement of the diameter of hyperaemia and induration at the
site of infective tsetse bites was found to be a reliable method of
monitoring development of chancres. This method probably monitors
both the cellular and pharmacological aspects of the chancre, unlike
measurements of chancre skin thickness (Emery and Moloo, 1981; Akol
and Murray, 1982), which probably monitors the cellular aspects only.
Experiments on the course of cyclical infection with Th congo-
lense TREU 1690 in the rabbit have shown that up to seven weeks after
infection there were no serious pathogenic effects. The lowest PCV
of infected group was 30%. A similar minimum PCV has been reported




EFFICACY OF CHEMOTHERAPY AND CHEMOPROPHYLAXIS
IN ANIMALS INFECTED WITH CYCLICALLY TRANSMITTED
TRYPANOSOMA CONGOLENSE
5.1 Introduction
Chemotherapy forms an important component of control methods
used against African animal trypanosomiasis and a number of compounds
are available including curative drugs such as diminazene aceturate,
homidium, quinapyramine sulphate and suramin, and prophylactic drugs
such as quinapyramine sulphate and chloride (Antrycide - prosalt) ,
pyrithidium bromide and isometamidium chloride. Unfortunately, to a
varying extent, all trypanocidal drugs are affected by the development
of stocks of trypanosomes which are resistant to doses of drugs at
normal therapeutic levels. This is likely to become an increasingly
serious problem as no new trypanocidal drugs have been developed since
1960 (Anon, 1979).
New trypanocidal drugs are difficult to discover and costly to
develop for field use. Estimates show that 10,000 compounds have to
be screened to obtain one or two which are promising but which have
only a 10% chance of successful development (Anon, 1979). The reason
is that most of the search for new trypanocidal compounds is empirical
since little is known about the metabolism of trypanosomes. Even the
modes of action of the currently used drugs are not known with cer¬
tainty (Williamson, 1970).
Great care must therefore be exercised in the use of presently
available drugs to minimise development of drug resistance. In many
affected countries, continual surveillance for drug resistance is
82.
mounted and appropriate changes made in the drug regimen when pro¬
blems are discovered. Due to resistance problems with other try¬
panocidal drugs, diminazene aceturate and isometamidium chloride are
the most commonly used trypanocidal drugs (Finelle, 1973; Holmes and
Scott, 1982) .
5.1.1 Diminazene aceturate (Berenil)
The trypanocidal activity of diminazene aceturate, B.Vet.C.
(Berenil, Farbwerke Hoechst AG, Frankfurt-Main) was first described
nearly 30 years ago (Bauer, 1955; Fussg&nger, 1955). The drug is
available commercially as a yellow odourless powder soluble 1/14
in water at 20°C (Williamson, 1970). Prepared solutions are stable
for up to 15 days because of an added antipyrine (Fairclough, 1963a).
The recommended dosage for cattle infected with T. congolense is
3.5 mg/kg, given intramuscularly as 7% solution.
Diminazene aceturate is the most effective of the trypanocidal
drugs (Williamson, 1970). This is due to its high therapeutic index,
especially in cattle, its activity against trypanosomes resistant to
other trypanocidal drugs and in spite of widespread usage the fre¬
quency of development of trypanosomes resistant to its action is very low.
(a) Mode of action of diminazene aceturate: There are conflicting
reports on the mode of action of diminazene aceturate. Several
studies indicated that the drug has in vitro trypanocidal activity
against T. congolense and T. brucei (Bauer, 1958; Hawking, 1958;
Goodwin and Tierney, 1977). In contrast, Maxie and Losos (1977)
reported the absence of in vitro trypanocidal activity against T.
congolense in blood obtained from infected animals up to 30 minutes
after treatment with diminazene aceturate.
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Results from some studies suggest that diminazene aceturate acts
by presenting trypanosomes to the host immunological defence system.
In cattle, significant rises in parasitaemia 5-10 minutes after dim¬
inazene aceturate injection suggested that parasites localised in
the microcirculation are released into the general circulation, thus
making them available to the host defence mechanism (Maxie and Losos,
1977). This has been confirmed in studies in which diminazene ace¬
turate was compared with other trypanocidal and non-trypanocidal drugs
for the ability to disperse trypanosomes located in blood capillaries
in cattle and sheep (Mills et al. , 1980; Kalu, 1983; Kalu, Ayand'ele
and Aina, 1983) . It was observed that those trypanocidal drugs which
increased parasite concentrations in the jugular vein were the ones
which were normally effective against Th congolense (Kalu et al., 1983).
The rapidity with which trypanosomes are killed in vivo by dim¬
inazene aceturate has been the subject of several studies. Bauer (1958)
failed to isolate trypanosomes from infected cattle and dogs five hours
after intramuscular injection of 3 mg/kg diminazene aceturate.
Fairclough (1963b) isolated viable trypanosomes from a T. congolense-
infected bovine at six hours but not at 12 hours after subcutaneous
injection of 3.5 mg/kg diminazene aceturate even though parasites could
still be detected in the treated animal 24 hours after treatment.
(b) Relapses of infections after treatment with diminazene
aceturate: When an animal is treated with a curative dose of a try¬
panocidal drug and a relapse occurs in circumstances precluding re¬
infection, the development of drug resistance is to be suspected.
It is possible however that parasites residing in tissue sites may be
exposed to subcurative levels of the drug and these organisms might be
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responsible for the relapses. One such form of chemotherapeutic
failure was reported to occur in T. brucei-infected mice treated
with diminazene aceturate at periods of more than a week after in¬
fection (Jennings, Whitelaw and Urquhart, 1977). Treatment three
or seven days after infection resulted in complete cure while treat¬
ment 14 days or more after infection resulted in relapses 20-60 days
later. In subsequent work it was shown that trypanosomes could be
isolated from the brains of drug-treated mice but not from other
organs or blood (Jennings _et ad., 1979). Mice treated with a combin¬
ation of diminazene aceturate and nitroimidazole had a higher cure
rate than mice similarly treated with diminazene aceturate alone
(Jennings et ad., 1980). Since some nitroimidazoles are known to
cross the blood-brain barrier it was suggested that trypanosomes were
located in the brain beyond the blood-brain barrier. The importance
of this form of relapse in the field is unclear.
(c) Prophylactic effects: Early reports on the pharmacokinetics
of diminazene aceturate indicated that the drug was rapidly excreted
(Fussg&nger and Bauer, 1958; 1960; Hawking, 1958). As a consequence,
the drug was used in a number of field experiments in which this
property was assumed (e.g. Whiteside, 1962). This assumption led to
the belief that diminazene aceturate was unlikely to induce drug
resistance on its own since subcurative dose levels would exist in
the treated animal for only short periods (Fussganger and Bauer, 1960;
Williamson, 1970). Further studies have now indicated that the dur¬
ation of detectable prophylactic effects of diminazene aceturate may
depend on the species of trypanosomes as well as the route of inocul¬
ation used for challenge.
Hawking (1958) tested for residual trypanocidal activity by
observing the motility of bloodstream Th rhodesiense incubated for
24 hours with plasma from a drug-treated rabbit. On this criterion,
no trypanocidal activity could be detected in plasma collected 24
hours after treatment with 15 mg/kg diminazene aceturate. However,
utilising the same _in vitro technique using T. brucei and incubating
the trypanosomes for up to 48 hours, Goodwin and Tierney (1977) found
detectable trypanocidal activity in rabbit plasma for two weeks and
in tissue fluid for up to one week after intramuscular injection of
40 mg/kg diminazene aceturate. More recently, rabbits injected intra¬
muscularly with radiolabelled diminazene aceturate at 3.5 mg/kg dose
rate, were shown to retain the drug in both plasma and tissue fluid
for up to seven days after treatment (Gilbert and Newton, 1982;
Gilbert, 1983) .
In cattle, a chemical assay technique showed that after intra¬
muscular injection of 2.5 mg/kg diminazene aceturate, the drug could
not be detected in plasma taken 24 hours after treatment (Klatt and
Hajdu, 1976). Biological assay techniques utilising T. brucei have
however revealed that diminazene aceturate is retained in cattle for
long periods after treatment. By using serum from treated cattle
as diluent for carrying out infectivity titrations with a stock of
T. brucei it was shown that animals treated with 7 mg/kg diminazene
aceturate retained levels of the drug which had trypanocidal activity
for up to 21 days after treatment (van Hoeve, Cunningham and Grange,
1965a,b).
In other studies on the effect of diminazene aceturate, treated
animals were challenged with trypanosomes and the development of
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parasitaemia monitored. Results depended on the species of trypano-
somes used in the challenge. In all studies in which T. brucei sspp.
were used, diminazene aceturate was reported to have prolonged prophy¬
lactic effect. Mice treated with 91 and 45 mg/kg diminazene aceturate
were shown to be resistant to challenge with T. brucei for 42 and 33
days after treatment respectively (Lumsden, Herbert and Hardy, 1965).
In rats, treatment with 50 mg/kg diminazene aceturate conferred prophy¬
lactic effect of 49 days against T. rhodesiense (Raether et a_l. , 1972)
while at 5 mg/kg dosage rate the prophylactic effect lasted for 28 days
against T. brucei (Zahalsky and Weinberg, 1976). Also, monkeys treated
with 5-20 mg/kg diminazene aceturate were shown to be resistant to
challenge with T. rhodesiense 7-21 days after treatment (Raether, Hajdu
and Damm, 1974).
In contrast, diminazene aceturate appears to have little prophy¬
lactic effect against T?. congolense. Mice were shown to be only
partially protected when inoculated with T?. congolense five hours
after treatment with 10 mg/kg diminazene aceturate (Fink and Damm,
1974). Mice treated with 50 mg/kg diminazene aceturate were still
susceptible to cyclically transmitted T. congolense one week after
treatment (Nantulya, Doyle and Jenni, 1980b). At 40 mg/kg diminazene
aceturate did not completely protect mice against challenge with
bloodstream T. congolense three days after treatment (Whitelaw, 1982).
It thus seems that in small laboratory animals, the prophylactic
effect of diminazene aceturate against T. congolense is of much
shorter duration than that against T. brucei. James (1976) showed
that the minimum concentration of diminazene aceturate required to
abolish infectivity of T. congolense after 12 minutes exposure at 37°C
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is twice that for T. brucei. This indicates that there may be differ¬
ences between the actions of diminazene aceturate on these two try-
panosome species. The result was however complicated by the use of
two different host species, rats and mice, for testing the infectivity
of T. brucei and T. congolense respectively.
In cattle, it was found possible to infect animals with T. congo¬
lense bloodstream forms 24 hours after treatment with 3.5 mg/kg dim¬
inazene aceturate. However, when the dose was doubled, a prophylactic
effect of at least 24 hours could be detected (Fairclough, 1963b).
These observations have recently been extended by Wellde and Chumo
(1983) who found that at 7 mg/kg, diminazene aceturate protected cattle
against intravenous inoculation of 10^ bloodstream forms of Th congo¬
lense for up to 12 days after treatment.
5.1.2 Isometamidium chloride
Isometamidium chloride, B.vet.C. (Samorin, May and Baker Ltd.,
England) has been used as a prophylactic trypanocidal drug since 1961
(Williamson, 1970). It is available as a dark brown powder which
readily dissolves in cold water. For curative purposes dose rates of
0.25-0.5 mg/kg suffice in cattle. Doses of 0.5-1.0 mg/kg are claimed
by the manufacturer to give a prophylactic effect of 3-6 months in
cattle, depending on the degree of trypanosome challenge.
There are few studies on the pharmacokinetics of isometamidium.
It has been reported that it is less active _in vitro than in vivo
against T. congolense and T. rhodesiense (Hill, 1965). The importance
of depots of isometamidium chloride at the injection site in conferring
a prophylactic effect against T. congolense has been studied in rats
and mice (Hill and McFadzean, 1963) . The drug was injected subcut-
aneously into the tails of rats and within 24 hours of treatment the
tails of some animals were amputated. Rats with amputated tails were
protected against infection with 2 x 10^ T. congolense for only one
week after treatment while those with tails were protected for 16
weeks.
Further studies in rats have shown that after intravenous in¬
jection isometamidium was rapidly removed from the blood and was found
in the liver and kidney (Philips et al., 1967). These studies in
rats have been corroborated by studies in goats (Braide and Eghianruwa,
1976). Sera from animals treated with 0.5 mg/kg isometamidium intra¬
venously did not contain detectable concentrations of drug 24 hours
after treatment. On the other hand, serum from goats treated with
the same dose intramuscularly contained detectable levels of isometa¬
midium at 24 hours but not at two or more weeks after treatment. High
levels of isometamidium were detectable in liver and kidneys for up
to four weeks after intramuscular injection of 0.5 mg/kg isometamidium.
There have been several field trials on the prophylactic effect
of isometamidium chloride. In one such trial in East Africa, Robson
(1962) found that isometamidium methane sulphonate at 2.0 mg/kg dose
rate gave a mean protection period of 258 days (range 93-398 days).
Metamidium, which contains 45% isometamidium (Williamson, 1970), gave
a mean protection of 226 days (range 23-398 days). Mean time of
development of infections in control animals was 38.5 days as deter¬
mined by thick blood smear examination.
In a similar trial in West Africa, Kirkby (1964) reported a pro¬
tection period of 97-122 days after treatment with isometamidium chloride
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at 1-2 mg/kg. Subsequent studies in East Africa have shown that the
protection period in beef cattle after intramuscular injection of
1-2 mg/kg isometamidium may be as short as ten weeks (Wiesenhutter,
Turner and Kristensen, 1968) .
It is clear that few laboratory studies have been carried out
on the efficacy of diminazene aceturate and isometamidium chloride
against cyclically transmitted T. congolense. In natural infections
it is now recognised that T. congolense undergoes development extra-
vascularly at the sites of the formation of trypanosomal chancres
(Roberts, Gray and Gray, 1969; Gray and Luckins, 1980; Akol and Murray,
1982). Since drugs normally attain lower levels in tissue, it is
possible that diminazene aceturate might be less effective against
infection in which trypanosomes induce chancre formation compared
with infections in which chancres do not occur such as after intra¬
venous inoculation. Similarly, the prophylactic effect of diminazene
aceturate and isometamidium chloride might be reduced in cyclically
transmitted infections where chancre formation occurs. The following
experiments were designed to investigate the curative and prophylactic
effects of diminazene aceturate and isometamidium chloride against
cyclically transmitted T. congolense infections in rabbits.
5.2 Gross and Microscopic Effects of Trypanocidal Drug Treatment
on Trypanosoma congolense Chancres
Experimental design: Chancre development was followed in three
rabbits 826, 831 and 821 bitten by 1-3 (3. m. morsitans infected with
Th congolense TREU 1457. Rabbits 826 and 831 were killed 14 and 21
days respectively after infection to provide samples for histological
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examination. Rabbit 821 was observed for at least 42 days after
infection.
Two rabbits, 803 and 809 were treated with 7 mg/kg diminazene
aceturate at two and five days respectively after bites from 12 and
11 G. m. morsitans infected with T. congolense TREU 1457. Chancre
development at the bite sites was monitored for 21 days after the
infective tsetse bites.
Four rabbits, 823, 855, 817 and 825 were infected with T_.
congolense TREU 1457 by bites from 4-5 infected G. m. morsitans.
Rabbits 823 and 855 were treated with 7 mg/kg diminazene aceturate
and 5 mg/kg homidium bromide respectively at day 6 post-infection.
Rabbits 817 and 825 were treated with 7 mg/kg diminazene aceturate
at day 8 post-infection. Chancre development was monitored in the
four rabbits up to ten days post-infection when they were killed to
provide samples for histology.
Specimens for histological studies were obtained from another
nine infected and treated rabbits and 12 infected untreated rabbits
in addition to those rabbits mentioned above. The times of treatment
and days on which the rabbits were killed for the preparation of
histological sections are shown in Tables 5.1A and 5. IB. Sections
of skin from rabbit 1208 killed on the same day on which treatment
was carried out, were obtained three hours after treatment. Removal
of chancres and fixation in Bouin's fixative was carried out immediately
after death by cervical dislocation. The skin samples were processed,
embedded in paraffin wax and 5 |am sections were cut and stained by
the Giemsa-colophonium technique as detailed in Appendix 2.
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Results; Diameters of chancres at different times after in¬
fection in untreated control animals and in animals treated with
trypanocidal drugs at different days after infection are shown in
Figures 5.1 and 5.2. In untreated animals, chancres were first seen
five days after infection and reached maximum size 5-7 days later.
A second smaller increase in size was recorded in two rabbits, 826
and 831, 14 and 15 days after infection (Figures 5.1A and 5.IB). In
all rabbits chancres disappeared 16-18 days after infection.
Trypanocidal drug treatment prevented the development of the
trypanosomal chancre. In rabbit 803, treated on day 2 after infection,
no chancres developed at any of the sites where 12 infected flies fed
(Figure 5.2A). In rabbit 809 treated on day 5 after bites from 11
infected flies, small chancres with mean maximum diameters of 8 mm, 10
and 11 days post-infection were recorded (Figure 5.2B) . In rabbits
823 and 855 treated at seven days post-infection, the further develop¬
ment of the chancre was prevented although a slight increase in dia¬
meter was seen on the following day (Figures 5.2C and 5.2D).
Treatment on day 8 after infection produced different results in
the two rabbits examined. In one rabbit (817) the mean chancre dia¬
meter progressively decreased in the following two days while in the
other (825) there was progressive increase during the same period
(Figures 5.2E and 5.2F).
In the histological studies, in sections removed from untreated
rabbits, 5-14 days after infection, trypanosomes were readily detect¬
able within and between collagen bundles which appeared disrupted.
Trypanosomes were particularly numerous in sections obtained at 7-10
days after infection (Plates 5.2A and 5.2B). Trypanosomes could not
be detected in sections removed from rabbits on days 4 and 21 after
infection (Plates 5.1A and 5.1B). Plate 5.2A also shows that there
was an extensive cellular reaction on day 8 j' _ ' but that it
was declining after day 10 although it was still visible by day 21
(Plate 5.IB) when the chancre was not discernible macroscopically.
Trypanosomes were not seen in skin removed 2-4 days after treat¬
ment which had been carried out on days 3-9 after infection. However,
the cellular reaction was comparable in extent and composition, to
that in chancres removed at a similar period post-infection, from
untreated rabbits. Mononuclear cells were the predominant cell type
seen.
Sections removed from rabbit 1207 24 hours after treatment on
day 9 post-infection revealed degenerating trypanosomes (Plate 5.3B).
A smear made from chancre fluid obtained from this rabbit three hours
after treatment, had shown numerous trypanosomes (Plate 5.3A).
Chancres removed from another rabbit (1208), three hours after treat¬
ment on day 9 post-infection revealed the presence of numerous intact
trypanosomes in histological sections (Plates 5.4A and 5.4B).
There was no evidence of readily detectable phagocytosis in
sections from treated animals.
Table5.1















































































Figure 5.1 Mean diameters of chancres on three untreated
rabbits cyclically infected with T. congolense
TREU 1457.
Key
A = Rabbit 826
B = Rabbit 831































Figure 5.2 Mean diameters of chancres on rabbits cyclically
infected with congolense TREU 1457 and then
treated with diminazene aceturate or homidium
bromide.
Key
A = Rabbit 803
B = Rabbit 809
C = Rabbit 823
D = Rabbit 855
E = Rabbit 817
F = Rabbit 825
K = Killed
| = Infective tsetse bites (Number of flies fed
is indicated by the number above the arrow)
B
Y = Treatment with diminazene aceturate



















































4 8 12 16 20
Days after tsetse bite
Plate 5.1A Section through skin removed from site of
infective bite on Rabbit 857 at day 4 post¬
infection, showing scanty cellular reaction.
(Giemsa - colophonium x 312)
Plate 5.IB Section through area of local skin reaction
on Rabbit 831, 21 days post-tsetse bite.
(Giemsa - colophonium x 312)
 
Plate 5.2A Section through a local skin reaction removed
from rabbit 829 at day 8 post-tsetse bite,
showing massive cellular reaction particularly
in papillary dermis.
(Giemsa - colophonium x 125)
Plate 5.2B Higher magnification of Figure 5.2A showing
trypanosomes (arrowed) in collagen fibres.
(Giemsa - colophonium x 625)
 
i
Plate 5.3A Trypanosomes in smear of chancre fluid removed
from rabbit 1207, three hours after treatment
with diminazene aceturate.
(Giemsa, x 625)
Plate 5.3B Section through chancre removed from rabbit 1207,
24 hours after treatment with diminazene aceturate
showing degenerating trypanosomes (arrowed).
(Giemsa - colophonium x 312)
*
 
Plates 5.4a and b Sections through chancre removed from
rabbit 1208 three hours after treatment
with diminazene aceturate, showing
trypanosomes (arrowed) in collagen fibres.
(Giemsa - colophonium x 625)
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5.3 Assessment of Efficacy of Diminazene Aceturate Treatment
Experiment 1
Experimental design: Six rabbits were treated with 7 mg/kg
diminazene aceturate 3-8 days after cyclical infection with ]T. congo-
lense TREU 1457 or TREU 1690. For comparative purposes, one rabbit
cyclically infected with T. congolense TREU 1457 was treated with
5 mg/kg homidium bromide on day 7 after infection. To assess the
efficacy of treatment, attempts were made to isolate trypanosomes
from chancres and blood after treatment. Two to four days after
treatment, blood was inoculated in 0.5 ml amounts into each of three
mice. The hair over the site of skin reaction area was then closely
shaved with hair clippers and a razor blade, and the rabbit then killed
by cervical dislocation. The chancre was immediately removed and kept
moist with ice-cold PBSG (pH 8.0). A suspension was prepared by
scraping and teasing all layers of the chancre into 3.0 ml of cold
PBSG. The suspension was then lightly centrifuged (100 g_) for 20
minutes and the supernatant injected intraperitoneally into each of
five mice in 0.5 ml amounts. Mice were subsequently checked for the
presence of trypanosomes by the wet smear method for up to 35 days
after inoculation. Five infected, untreated control rabbits were
killed at 4-7 days after cyclical infection and attempts made to iso¬
late trypanosomes from chancres as described above.
Results: Inoculation of material from the site of tsetse bite
and from blood showed that in untreated rabbits it was possible to
isolate trypanosomes from the chancre as early as four days after
infection and from the blood as early as five days after infection
(Table 5.2). However, no trypanosomes could be isolated from chancres
or blood from any of the treated rabbits.
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Experiment 2
Experimental design: Two groups of rabbits, Group I and II com¬
prising 17 and 16 animals respectively were monitored for development
of relapse infections after treatment of cyclically transmitted T.
congolense infections with 7 mg/kg diminazene aceturate. In Group I,
nine rabbits infected with Th congolense TREU 1690 and seven rabbits
infected with T. congolense TREU 1682 were treated between day 0 and
day 42 after infection. One rabbit, 885 was infected with both T.
congolense TREU 1682 and TREU 1690 and treated 42 days after infection.
Rabbits in Group II were infected with T. congolense TREU 1690
and then treated with 7 mg/kg diminazene aceturate 7-28 days after
infection.
Prior to treatment, the number of chancres on each animal was
noted and the presence of trypanosomes in blood checked by micro-
haematocrit/buffy coat technique (Murray et al., 1977) . After treat¬
ment, blood was checked twice weekly by the microhaematocrit/buffy
coat technique from 14-42 days after which the absence of infection
was confirmed by subinoculation of 0.5 ml of blood into each of three
mice.
Results; In Group I, rabbits 878 and 883 infected with T. congo¬
lense TREU 1690 and rabbit 879 infected with T. congolense TREU 1682
treated at eight or nine days post-infection showed relapses of para-
sitaemia after treatment (Table 5.3). In Group II, two animals, 960
and 984 treated at day 10 post-infection developed relapses after
treatment (Table 5.4). All other animals were cured, irrespective of
the time of treatment.
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Experiment 3
Experimental design: Three pairs of rabbits infected with T_.
congolense TREU 1690 were treated with 14 mg/kg diminazene aceturate
eight, nine or ten days after infection. Five other pairs of rabbits
infected with T. congolense TREU 1690 were treated with 7 mg/kg dim¬
inazene aceturate at seven, eight, nine, ten or 14 days after in¬
fection. Before treatment animals were examined for chancres and the
blood checked for the presence of trypanosomes. After treatment
animals were checked for parasitaemia twice a week by the microhaema-
tocrit/buffy coat technique and the absence of trypanosomes was con¬
firmed by the inoculation of blood in 0.5 ml amounts into each of
three mice.
Results: Table 5.5 shows that two rabbits 1027 and 1037 treated
with 7 mg/kg diminazene aceturate nine and ten days after infection
respectively, had relapse infections after treatment. One rabbit,
1020 had relapse infection after treatment with 14 mg/kg diminazene
aceturate at day 9 post-infection.
In the experiments described above, seven out of 24 rabbits
treated with 7 mg/kg diminazene aceturate 5-16 days after infection
had relapse infections after treatment. No relapse infections occurred
in 19 rabbits treated with the same dose of diminazene aceturate 0-4
days or 17-42 days after infection (Table 5.6A).
Among the six rabbits treated with 14 mg/kg diminazene aceturate
eight, nine or ten days after infection, one rabbit out of two treated
at day 9 post-infection showed relapse parasitaemia after treatment
(Table 5.6B).
Table5.2
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5.4 Secondary Chancres Associated with Relapses in Parasitaemia
after Chemotherapy
Normally, trypanosome chancres in untreated rabbits disappear
between 14-19 days after infection. In experiments in determining
the efficacy of diminazene aceturate, described above,it was observed
that in some drug-treated rabbits in which relapses in parasitaemia
occurred, secondary chancres sometimes developed at or near the sites
of the primary chancres. It was therefore decided to extend the
monitoring of chancres in drug-treated rabbits beyond 21 days after
infection.
Experimental design: Sixteen rabbits treated with diminazene
aceturate at 7 mg/kg or 14 mg/kg, 7-14 days after infection (Table 5.5)
were monitored for the appearance of secondary chancre development for
up to 35 days after infection. Presence of trypanosomes in blood be¬
fore and after treatment was determined by microhaematocrit/buffy
coat technique and subinoculation of blood into mice.
Results: One rabbit, 1027 showed relapse in parasitaemia after
treatment but no evidence of secondary chancre development. Two
rabbits, 1020 and 1037 treated at days 9 and 10 after infection, were
each observed to develop one secondary chancre, followed by relapse
parasitaemia post-treatment. The secondary chancre recurred near the
centre of one of the sites of primary chancres. Figure 5.3 shows the
mean diameters of the chancres on these two rabbits, 1020 and 1037,
at different times after infection. It can be seen that in rabbit
1037 chancres had disappeared by day 15 after infection but another
chancre was observed on day 23 after infection. In rabbit 1020 on the
other hand, one chancre did not completely disappear and was observed
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to increase in size again on day 21 after infection.
The rabbits which developed secondary chancres were killed at
29 and 33 days after infection to provide histological samples.
Local skin reaction was removed, processed and tissue sections
stained with Giemsa colophorium. Plates 5.5A, 5.5B, 5.6A and 5.6B
show the cellular reaction in the secondary chancres from rabbits
1020 and 1037. When compared to the residual cellular reaction at
day 21 post-infection in an untreated rabbit (Plate 5.IB), it can
be seen that the reaction in a secondary chancre developing after
treatment is very intense. The predominant cell type is the plasma
cell (Plates 5.6A and 5.6B). However, an extensive search of histo¬
logical sections failed to reveal the presence of trypanosomes.
Figure 5.3 Mean diameters of chancres on rabbits 1020 and
1037 at different days after bites by tsetse































































Plate 5.5A Section showing massive cellular reaction in
secondary chancre removed from rabbit 1020 at
day 29 post-infection.
(Giemsa - colophonium x 125)
Plate 5.5B Section through chancre removed from rabbit
1037, 33 days post-infection. Note massive
cellular reaction particularly in papillary
dermis.
(Giemsa - colophonium x 125)
 
Plate 5.6A Higher magnification of papillary dermis shown in
Plate 5.5B above. Note preponderance of plasma
cells and absence of trypanosomes.
(Giemsa - colophonium x 312)
Plate 5.6B Higher magnification of papillary dermis shown
in Plate 5.6A above.
(Giemsa - colophonium x 625)
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5.5 Dispersive Action of Diminazene Aceturate on Trypanosomes in
Chancres
Histological sections of 5-12 day chancres removed 2-4 days
after treatment failed to reveal trypanosomes in situ (Section 5.2
above). An attempt was therefore made to determine if diminazene
aceturate acts on trypanosomes in the chancres by causing them to
disperse into the blood circulation.
Experimental design: Two rabbits, 1207 and 1208, were each in¬
fected with T. congolense TREU 1690 by bites from six infected tsetse
flies and chancre development monitored up to days 8 and 9 respect¬
ively when they were treated. In both rabbits, the parasitaemia on
day 8 was checked by microhaematocrit/buffy coat technique. Rabbit
1207 was treated with 14 mg/kg diminazene aceturate. Blood collected
from an ear vein was examined at five minute intervals from 0-60 min¬
utes post-treatment and then every 15 minutes for the next hour,
every 30 minutes for the third hour and thence every hour up to six
hours after treatment. At three hours after treatment, the chancre
was punctured with a sterile hypodermic needle and a thin smear pre¬
pared from the expressed chancre fluid. Twenty-four hours after
treatment the rabbit was killed to provide histological samples.
Rabbit 1208 was treated with 14 mg/kg diminazene aceturate on day 9
after infection and blood monitored as described previously up to
three hours after treatment when the animal was killed to provide
histological samples.
Results: Six chancres developed on rabbit 1207 and four on
rabbit 1208. The microhaematocrit/buffy coat technique revealed that
trypanosomes were present in the blood of rabbit 1207 just before
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treatment on day 8 post-infection. Thirty minutes after treatment
a wet smear preparation revealed one trypanosome per 40 HPFs. At all
other times extensive search of 40 HPFs failed to reveal trypanosomes.
No trypanosomes were found in the blood of rabbit 1208 by the
microhaematocrit/buffy coat technique before treatment and it remained
negative after treatment as judged by the wet smear method, up to
three hours after treatment when it was euthanised for histological
studies.
Histological findings on chancres from these two rabbits have
already been reported in Section 5.2. Plates 5.3 and 5.4 show that
numerous intact trypanosomes were present at three hours after treat¬
ment and degenerating trypanosomes could be seen 24 hours after
treatment.
5.6 Prophylactic Effects of Diminazene Aceturate
Experimental design
Experiment 1: Four to 16 G. m. morsitans infected with T.
congolense TREU 1690 were fed on each of six pairs of rabbits 3, 6,
24, 48 or 72 hours or 7 days after treatment with 7 mg/kg diminazene
aceturate. Three other pairs of rabbits were bitten by 2-4 similarly
infected G. m. morsitans at 3, 6 or 24 hours after treatment with 14
mg/kg diminazene aceturate. The rabbits were examined for up to 21
days after infection for evidence of chancre development. Parasit-
aemia was checked by the microhaematocrit/buffy coat technique twice
a week from day 14 up to day 28 after infection and the presence or
absence of trypanosomes confirmed by subinoculation of blood into
mice.
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Experiment 2: Nine rabbits were divided into batches of three
animals. In each batch one animal was left untreated as a control
while the others were treated with diminazene aceturate at 7 mg/kg
or 14 mg/kg. A batch of rabbits was then inoculated with 1 x 10^
cultured metacyclic trypanosomes 6, 24 or 48 hours after treatment.
The inoculation of the groups was carried out on different occasions
with different harvests of cultured metacyclics of T. congolense
TREU 1457 separated from non-infective forms as described previously.
Experiment 3: Three pairs of rabbits were treated with dim¬
inazene aceturate 24, 6 or 3 hours prior to inoculation of cultured
metacyclics of T. congolense TREU 1457. Rabbits in each pair were
treated with either 7 mg/kg or 14 mg/kg diminazene aceturate. The
two rabbits treated with diminazene aceturate 24 hours previously,
were inoculated with 1 x 10^ cultured metacyclics of T. congolense
intravenously. A control untreated rabbit was similarly inoculated
with 1 x 10^ cultured metacyclics of T. congolense. The other
treated rabbits were each inoculated with 1 x 10^ cultured meta¬
cyclics intradermally. A control untreated rabbit was similarly
inoculated with 1 x 10^ cultured metacyclics intradermally.
After challenge, all animals were monitored for the presence of
trypanosomes in the blood by the microhaematocrit/buffy coat technique,
twice a week from 7-28 days after challenge. The absence of trypano¬
somes was confirmed by subinoculation of blood in 0.5 ml amounts into
each of three mice.
116.
Results
In experiment 1, the six pairs of rabbits treated with 7 mg/kg
diminazene aceturate at different times prior to challenge were
susceptible to cyclical challenge by tsetse flies infected with Th
congolense as early as three hours after treatment. Chancres and
parasitaemia developed in all animals but in those challenged three
or six hours after treatment only a proportion of the infective fly
bites led to development of chancres (Table 5.7).
In the three other pairs cyclically challenged after treatment
with 14 mg/kg diminazene aceturate, chancres appeared at bite sites
and trypanosomes appeared in blood of the two rabbits challenged 24
hours after treatment while in the two pairs challenged at three or
six hours after treatment, no parasitaemia developed although rabbits
1132 and 1134 challenged at three and six hours after treatment re¬
spectively, developed one and four chancres respectively (Table 5.8).
In experiment 2 in which rabbits were challenged by intravenous
inoculation of cultured metacyclics, parasitaemia developed in the
control untreated rabbit 1074 and in rabbits 1136 and 1139 challenged
at 48 hours after treatment with 7 and 14 mg/kg diminazene aceturate
respectively (Table 5.9A). In rabbits 1133 and 1128, challenged at
24 hours after treatment with 7 mg/kg and 14 mg/kg diminazene aceturate
no parasitaemia developed after treatment. Unfortunately the corres¬
ponding untreated control rabbit 1071 did not develop parasitaemia.
Rabbits 1130 and 1131 challenged at six hours after treatment with 7 mg/
kg and 14 mg/kg diminazene aceturate respectively did not develop para¬
sitaemia but the corresponding control untreated rabbit 1119 developed
parasitaemia after challenge.
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In experiment 3 in which rabbits were challenged by intravenous
or intradermal inoculation of culture metacyclics, trypanosomes were
not detected in the blood of rabbits 1199 and 1200 challenged intra¬
venously 24 hours after treatment with 7 mg/kg and 14 mg/kg dimin-
azene aceturate respectively. The corresponding untreated control
rabbit 1186 developed parasitaemia after challenge. Similarly, the
control untreated rabbit 1192 challenged by intradermal inoculation,
developed parasitaemia after challenge. Rabbit 1187 challenged by
intradermal inoculation six hours after treatment with 7 mg/kg dim-
inazene aceturate developed parasitaemia after treatment, while
rabbit 1188 which had been treated at 14 mg/kg dose rate did not
develop parasitaemia following challenge six hours after treatment.
Neither rabbit 1190 nor rabbit 1191 challenged three hours after
treatment with 7 mg/kg or 14 mg/kg diminazene aceturate developed
parasitaemias (Table 5.9B).
Table5.7
















































































Development of parasitaemia in rabbits challenged with 1 x 10^ culture
metacyclics of Trypanosoma congolense TREU 1457 at different times
after treatment with DIMINAZENE ACETURATE.
A. Group 1 rabbits challenged intravenously
^ i • i ^ „ Time of Challenge „ _ mRabbit Drug Dose Presence of Trypanosomes*
. „ Post-treatment _ , ,,
Number (mg/kg) , After challenge(hours)
1074 - 48 +
1136 7 48 +
1139 14 48 +
1071 _ 24 0
1133 7 24 0
1128 14 24 0
1119 _ 6 +
1130 7 6 0
1131 14 6 0
B. Group 2 rabbits challenged intravenously or intradermally
Time of
Presence of
Rabbit Drug Dose Challenge Inoculation
Number (mg/kg) Post-treatment Route Trypanosomes
,, < After challenge(hours) ^
1186 - - Intravenous +
1199 7 24 Intravenous o
1200 14 24 Intravenous 0
1192 - - Intradermal +
1187 7 6 Intradermal +
1188 14 6 Intradermal 0
1190 7 3 Intradermal 0
1191 14 3 Intradermal 0
*0 = No trypanosomes detected by mouse subinoculation
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5.7 Prophylactic Effect of Isometamidium Chloride
Studies were also carried out to determine the prophylactic
effect of isometamidium chloride against cyclically transmitted T.
congolense TREU 1690. Animals were treated with isometamidium
chloride 4 mg/kg body weight, equivalent to 1 mg/kg in cattle as
calculated by relating the dose to body surface area (Moore, 1909;
Bushby, 1963).
Experiment 1
Experimental design: Initially 12 rabbits (Group I) were
examined for development of chancres and establishment of infection
following infective tsetse bites 5-8 weeks after treatment with
isometamidium chloride. This was followed by similar studies on
another nine rabbits (Group II) treated 1-4 weeks before challenge.
Animals in Group I were challenged in sets of three at 35, 42,
48 or 54 days after treatment. In each set of animals challenged,
one rabbit was challenged by 2-4 flies, another by 6-8 flies and the
third by 12-16 flies. This was intended to check whether the duration
of isometamidium prophylaxis depends on the number of infected tsetse
flies used in challenge.
In Group II three rabbits were challenged with 16 infected G. m.
morsitans seven days after treatment and the rest of the animals in
this group were challenged in pairs with 3-11 infected G_. m. morsitans
per animal, on days 14, 21 or 28 after treatment.
Since it was not known whether or not the presence of isometa¬
midium in blood meals affects the subsequent infectivity of G. m.
morsitans which have fed on untreated animals, each infected tsetse
fly was fed only once on a treated rabbit.
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After treatment, rabbits were monitored daily for development
of chancres for up to 56 days after challenge. The presence of try-
panosomes in blood was checked three times weekly by the microhaema-
tocrit/buffy coat technique and by subinoculation of blood in 0.5 ml
amounts in each of three mice at four, six and eight weeks after
challenge.
Results: Tables 5.10 and 5.11 show the development of chancres
and parasitaemia in rabbits in Groups I and II respectively. It can
be seen that in Group I two out of three rabbits challenged at 35
days post-treatment failed to develop a parasitaemia while only one
rabbit failed to develop parasitaemia out of each of the sets of three
rabbits challenged at 42, 48 and 54 days after treatment. All 12
rabbits in this group however, developed chancres (Figures 5.5-5.8).
The chancres in rabbits 938, 940 and 951 which did not subsequently
develop parasitaemia, were small, measuring 3-10 mm in diameter and
were seen at days 7-15 after challenge in rabbits 938 and 940 and at
days 11-16 after challenge in rabbit 951.
Two rabbits, 948 and 957 which did not develop parasitaemia,
showed large chancres of mean maximum diameter 15 mm and 20 mm respect¬
ively. Chancres which developed on rabbit 948 persisted for a shorter
period (8-13 days post-challenge) compared to those of rabbit 957 (10-
28 days after challenge).
Rabbits 941, 949, 950, 952 and 954 which became infected after
challenge had large chancres (maximum mean diameters 25-45 mm) which
appeared and persisted for 7-50 days after challenge (Figures 5.5C,
5.6B, 5.6C, 5.7B, 5.7C, 5.8A, 5.8B and 5.8C).
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In Group II (Table 5.11) rabbits 988, 989 and 990 each chall¬
enged with 16 infected tsetse flies seven days post-treatment failed
to become infected. Chancres developed at five out of 16 bite sites
on rabbit 989. These chancres appeared at day 8 post-challenge,
reached a maximum mean diameter of 8 mm on day 9 and disappeared by
day 12 (Figure 5.4A). No chancres developed on rabbits 988 and 990.
Rabbits 1084 and 1087, challenged 14 days after treatment,with
8 and 11 infected tsetse flies respectively, failed to develop chancres
and trypanosomes were not detected in either animal. In rabbits 1086
and 1089 challenged with three and four infected tsetse flies 21 days
after treatment, chancres appeared at day 5 post-challenge reaching
mean maximum diameters of 25 and 30 mm at days 9 and 10 after challenge
(Figures 5.4B and 5.4C).
Rabbit 1085, challenged on day 28 post-treatment, developed a
patent parasitaemia following the appearance of a chancre at one of
the sites bitten by six infected tsetse flies. The chancre appeared
at day 8 post-challenge, reached a maximum diameter of 25 mm on day 11
post-infection and had disappeared by day 17 post-challenge. Rabbit
1088 challenged at the same time with six infected tsetse flies was
not infected.
Experiment 2
Experimental design: T. congolense-infected tsetse flies which
had been fed once on rabbits treated 5-8 weeks previously, with iso-
metamidium, were tested for their ability to induce chancres and infect
susceptible rabbits within seven days of feeding on drug-treated
rabbits. In addition, flies which had fed on isometamidium-treated
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rabbits within 7-28 days after treatment were also tested for their
infectivity to mice within seven days of feeding on the treated
rabbit.
Results; Forty-one flies fed on susceptible rabbits on 54
occasions and caused development of chancres on 40 occasions (74%).
Twenty-six flies fed on 33 mice out of which 21 became infected (64
Table5.10
























































Developmentfchancresa dp rasitaemiai bb tschallengedwi hTrypanosomaco golenseTREU1690yt sfrominfectedtse seflies,1-4w eksaft rtr atmentwith4mg/kgISOMETAMIDIUMCHLOR DE. RabbitDayofChallenge NumberPost-treatmentNumberof/Numberftsetse chancres/fliesedPresenceof Trypanosome* AfterchallengeNumberofrabbits/Numberofrabbits withparasitaemia/challenged 98870/160 98975/160 99070/160 1084140/80 1087140/110 1086211/4+ 1089212/3+ 1085281/6+ 1088280/60
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Figures 5.4 A-D Mean diameters of chancres in rabbits
challenged with T. congolense TREU 1690
at different days after treatment with
4 mg/kg isometamidium chloride.
Key
A = Rabbit 989 challenged at day 7 post-treatment
B = Rabbit 1086 challenged at day 21 post-treatment
C = Rabbit 1089 challenged at day 21 post-treatment
D = Rabbit 1085 challenged at day 28 post-treatment
I = Bites from infected G. m. morsitans. Number
'
of flies fed is shown on top of the arrow.
[0j= Rabbit did not develop parasitaemia after
challenge




Figures 5.5 A-C Diameters of chancres on rabbits challenged
with T. congolense TREU 1690 35 days after
treatment with 4 mg/kg isometamidium chloride.
Key
A = Rabbit 938
B = Rabbit 940
C = Rabbit 941
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Figures 5.6 A-C Diameters of chancres on rabbits challenged
with T. congolense TREU 1690, 42 days after
treatment with 4 mg/kg isometamidium chloride.
Key
A = Rabbit 948
B = Rabbit 949
C = Rabbit 950
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Figures 5.7 A-C Diameters of chancres on rabbits challenged
with T?. congolense TREU 1690, 48 days after
treatment with 4 mg/kg isometamidium chloride.
A = Rabbit 951
B = Rabbit 952
C = Rabbit 954
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Figures 5.8 A-C Diameters of chancres on rabbits challenged
with T. congolense TREU 1690, 54 days after
treatment with 4 mg/kg isometamidium chloride.
Key
A = Rabbit 955
B = Rabbit 956
C = Rabbit 957
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5.8 Discussion
In studies on the development of the chancre in untreated
rabbits, monitoring chancre size by measuring the diameter of
associated induration and hyperaemia was found to be satisfactory
and convenient in the light-skinned NZW rabbit. Other workers
have monitored chancre development in goats and cattle by measur¬
ing skin thickness (Emery and Moloo, 1981; Akol and Murray, 1982).
Reactions in rabbits were, however, often very turgid, which made
measurement of skin thickness difficult. Moreover, it was possible
that chancre development may have been interfered with due to the
crushing effect of the vernier calipers used for the measurement.
The maximum diameters of trypanosome chancres in untreated
rabbits were found to vary widely. This is possibly due to varia¬
tions in the numbers of trypanosomes extruded by the tsetse fly as
it has been shown that the size and time of appearance of chancres
are often dependent on the number of metacyclic trypanosomes inocul¬
ated (Willett and Gordon, 1957; Emery et al., 1980; Luckins, Rae and
Gray, 1981) . The day on which the maximum diameter was reached varied
between 10 and 12 days after infection. These variations in size as
well as the possibility that a chancre will not appear after bites
from a single infected tsetse fly (see Section 4.4) necessitated the
application of several flies on rabbits used for experiments on early
treatment and on prophylactic effect. On rabbit 803 treated at two
days after infection for example, 12 known infected flies were fed.
Feeding several infected flies at the same time on a single host did
not appear to interfere with chancre development. For instance, it
was demonstrated that in rabbits, bites from as many as 20 infected
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flies still led to normal individual chancres. Luckins et_ al_. (1983)
also observed that local skin reactions developed at sites of each
infective fly bite even after bites from as many as eight flies on
the same rabbit.
Studies on the effects of treatment with diminazene aceturate
on gross appearance of the trypanosome chancre, showed that early
chemotherapy at two days post-infection prevented the appearance of
the local skin reaction. Treatment 5-8 days after infection usually
had the effect of reducing the maximum chancre size reached, although
in one animal treated eight days post-infection, chancre development
appeared to be unaffected.
Histological studies showed that in chancres removed 2-4 days
after treatment carried out 3-10 days after infection, trypanosomes
cannot be detected, although the"cellular reaction seen is similar
to that in sections from untreated animals at a similar period after
infection. There was no evidence of in situ phagocytosis of trypano¬
somes. It was thus postulated that diminazene aceturate either kills
chancre trypanosomes in_ situ or "flushes" them into the bloodstream
to be phagocytosed by the reticulo-endothelial system. There have
been previous suggestions that diminazene aceturate functions by
presenting trypanosomes to the phagocytic immune system (Maxie and
Losos, 1977) and it has been shown that in mice trypanosomes are
phagocytosed in the liver (MacAskill et_ al., 1980).
In one rabbit (1207) in which trypanosomes could already be
detected in blood, only a transient parasitaemia was detectable by
examination of wet blood films, 30 minutes after treatment with dimin¬
azene acturate. In another rabbit (1208) no parasites were detectable
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before or after treatment at nine days post-infection, although
chancres removed from this rabbit three hours after treatment showed
numerous trypanosomes within the collagen fibres. Hence it appears
that diminazene aceturate does not exert its activity against chancre
trypanosomes by "flushing" them into the general circulation. Since
histological studies on a chancre removed from rabbit 1207, 24 hours
after treatment showed degenerating trypanosomes, it would appear
that trypanosomes are killed _in situ.
Results from experiments on efficacy of diminazene aceturate
treatment indicate that the presence of a chancre at the time of
treatment may be associated with the occurrence of trypanosome re¬
lapses after treatment. Initial studies, in which the efficacy of
diminazene aceturate at 7 mg/kg was assessed by attempting to iso¬
late trypanosomes from the chancre 2-4 days after treatment, revealed
that the chancre is unlikely to act as a source of relapsing trypano¬
somes. This may have been due to the insensitivity of the technique
used to isolate trypanosomes since it was not even posssible to detect
parasites in a rabbit treated with a subcurative dose of homidium
chloride. However, the technique was sensitive enough to detect
trypanosomes in chancres from an untreated rabbit at four days after
infection, at which stage the trypanosome concentration is possibly
greater than that residual in a treated animal. In later experiments
in which animals were monitored for appearance of relapse parasitaemia
up to 42 days after treatment, it was found that such relapses occurred
in animals which had been treated 8-10 days after infection when
chancre size was maximal.
It is difficult to explain why relapse infections occurred only
in animals treated at 8-10 days. Since animals thus treated did not
invariably show relapse parasitaemia, the existence of tissue forms of
trypanosomes less susceptible to the trypanocidal drug cannot be
implicated. Ormerod (1979) has argued that in the case of T. brucei
a tissue form different from that occurring in the blood is unlikely
to occur in the chancre.
There is a possibility that the relapses occurring in animals
treated 8-10 days after infection are related to the fact that try-
panosome concentration in the chancre is highest between 8-13 days
post-infection. Histological studies in untreated animals revealed
numerous trypanosomes, particularly 8-10 days after infection. This
was in agreement with observations by others (Gray and Luckins, 1980;
Emery and Moloo, 1981; Akol and Murray, 1982). It has also been
suggested that in a situation where the trypanosome concentration is
high, the trypanocidal drug may be absorbed to such an extent that
the remaining drug concentration is insufficient to effect a cure
(Hawking, 1963a). This would apply to treatment with diminazene ace-
turate if, as suggested by Hawking (1958), this drug is absorbed in
large amounts by trypanosomes. Studies with radiolabelled drugs have
shown that ethidium is bound to trypanosomes - up to 79% of total
radio-activity being detected as bound to T. congolense (Gilbert and
Newton, 1982a).
It would possibly be expected that the small numbers of T.
congolense metacyclics deposited at the bite site (ILRAD, 1982) would
easily be eliminated by residual amounts of diminazene aceturate re¬
maining in the animal after treatment, since even at 3.5 mg/kg
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diminazene aceturate has been detectable for up to seven days in
rabbit tissue fluid and blood (Gilbert and Newton, 1982b; Gilbert,
1983). In fact, no prophylactic effect could be detected even three
hours after treatment with 7 mg/kg diminazene aceturate. Doubling
the dose to 14 mg/kg only marginally increased the duration of prophy¬
laxis to six hours after treatment.
It was shown that rabbits treated with 7 or 14 mg/kg diminazene
aceturate could not be infected by intravenous inoculation of 1 x 10
culture metacyclics 24 hours after treatment, while an untreated
control rabbit became infected. Similar duration of prophylaxis has been
observed in rabbits challenged with 1 x 10^ bloodstream forms of T.
congolense following treatment with 3.5 mg/kg diminazene aceturate,
a dose level which was shown to be subcurative for established T.
congolense infection in the rabbit (Gilbert and Newton, 1983). It
is possible that a slightly longer prophylactic effect is exerted
by the drug, when the challenge trypanosomes are inoculated intra¬
venously. In the present studies, a rabbit treated with 7 mg/kg
diminazene aceturate could be infected with T. congolense by intra-
dermal inoculation of 1 x 10 culture metacyclics six hours after
treatment. This is unexpected, since pharmacokinetic studies using
radiolabelled drugs have shown that three hours to seven days after
treatment tissue fluid levels of diminazene aceturate are higher than
in blood.
The finding that diminazene aceturate at either 7 or 14 mg/kg
dose rates had prophylactic effects of up to only 24 hours, is in
agreement with previous findings that diminazene aceturate has little
prophylactic effect against T. congolense in mice (Fink and Dann, 1974;
137.
Nantulya et al., 1980b; Whitelaw, 1982) and is in contrast to the
observed longer prophylactic effect against T. brucei sspp. in mice,
rats and monkeys (Lumsden et al., 1965; Raether et_ aJL_. , 1972; 1974;
Fink and Dann, 1974; Zahalsky and Weinberg, 1976; Whitelaw, 1982).
However, in cattle Wellde and Chumo (1983) have reported that dimin¬
azene aceturate also has considerable prophylatic effect against
T. congolense. Pairs of cattle could not be infected with 1 x 10^
bloodstream forms of T. congolense, two and six days after treatment
with 7 mg/kg diminazene aceturate while two out of four cattle simi¬
larly treated could not be infected with a similar infective dose of
T?. congolense 12 days after treatment. The discrepancy between these
findings and those from the present studies in rabbits could be due
to host species differences as well as the use of different stocks
and doses of T. congolense. It is however of great interest to
determine whether diminazene aceturate in cattle also exerts con¬
siderable prophylactic effect against cyclically transmitted T.
congolense.
Results obtained in the studies on prophylactic effect of iso-
metamidium were inconsistent. There was little variation in the
number of rabbits protected between three to eight weeks after
treatment with 4 mg/kg isometamidium chloride. There were variations
in the number of flies used for challenging individual rabbits, but
whether a rabbit developed parasitaemia or not did not appear to
correlate with the challenge "dose". In some cases, challenge with
four infected flies led to the development of parasitaemia while
challenge with 16 infected flies did not lead to development of para¬
sitaemia. Previous observations suggested that the duration of
trypanocidal drug prophylaxis in cattle is inversely proportional
to the tsetse challenge (Whiteside, 1962). Flies were fed only
once on isometamidium treated rabbits so that variability of results
cannot be due to reduced infectivity of flies already fed on treated
rabbits.
Rabbits could be infected by cyclical challenge with T. congo-
lense 21 days but not at 7 or 14 days after treatment with 4 mg/kg
isometamidium. Since this dose was the calculated equivalent rabbit
dose to the prophylactic dose of 1 mg/kg in cattle, and it had been
shown that 0.75 mg/kg dose is curative in rabbits (Section 4.2.2)
the results contrast with field reports that in cattle, isometamidium
chloride has a prophylactic effect of at least 10 weeks (Robson, 1962;
Kirkby, 1964; Wiesenhutter et al., 1968). This could be due to host
species differences as well as the use of different diagnostic methods,
since in the field reports there are no indications that inoculation
of blood into mice to detect subpatent infections was carried out.
Studies on infectivity of flies after they had fed on isometa-
midium-treated rabbits showed that a high proportion of flies were
still infective. Seventy-four percent of flies tested for chancre
induction were positive and 64% of flies tested for infectivity to
mice were positive. This is in contrast to reports that G. m. morsi-
tans fed as tenerals on a T. congolense-infected goat and then main¬
tained on an isometamidium-treated goat, had infection rates of only
14% compared to 46% in flies maintained on a control untreated goat
(ILRAD, 1983). However, in this case, flies were fed repeatedly on
the isometamidium-treated animal compared to the single feed allowed
in the present studies.
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CHAPTER SIX
STERILE IMMUNITY AFTER CHEMOTHERAPY OF CYCLICALLY
TRANSMITTED TRYPANOSOMA CONGOLENSE INFECTIONS
6.1 Introduction
Numerous investigations in both the field and in the laboratory
have shown that trypanosomes are antigenically complex. The infected
host harbours organisms which present an array of different antigens
even during the course of infections initiated with a single trypano-
some (Gray and Luckins, 1976; Murray and Urquhart, 1977). In the
field, within any single locality animals are likely to be exposed
to numerous serodemes of different species of African trypanosomes.
This is possibly why there are so few reports on the development of
anti-trypanosomal immunity in cattle exposed to natural infections.
The complexity of the trypanosomal antigens involved in stim¬
ulating protective immunity has prevented the development of vaccines
against African trypanosomiases. However, studies on antigenic
variation have attracted considerable interest not only in exploring
the possible development of trypanosomal vaccines but also in pro¬
viding basic knowledge of host-parasite relationships. A number of
reviews covering the fields of antigenicity, immunity and host-
parasite relationships of pathogenic trypanosomes have been produced
in the past decade (Weitz, 1970; Desowitz, 1970; Seed, 1974; de Raadt,
1974; Gray and Luckins, 1976; Terry, 1976; Doyle, 1977; Vickerman, 1974;
1978; Holmes, 1980; Vickerman et al., 1980; Vickerman and Barry, 1982).
6.1.1 Antigens of salivarian trypanosomes
The earliest observations on antigenic variation in trypanosomes
are those of Franke (1905) who found that trypanosomes in the blood of
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a monkey infected with T. equinum were not affected by antibodies
in the serum from the same animal and concluded that trypanosomes
are liable to change immunologically during infection. Massaglia
(1907) suggested that in experimental trypanosome infections of
rodents each parasitaemic remission was due to the destruction of
trypanosomes by host antibodies and each recrudescence in parasit-
aemia was due to proliferation of parasites with a different anti¬
genic constitution to their predecessors. In man, early observ¬
ations on the relapsing course of parasitaemia in trypanosome in¬
fections were reported by Ross and Thomson (1910) who made a daily
record of parasite numbers in a sleeping sickness patient undergoing
treatment.
Antigenic variation is a highly efficient way in which parasites
may ensure survival in the immunologically intact host but there are
various other ways in which parasites may survive. Schistosoma spp.,
for example, are known to exhibit concomitant immunity whereby the
immune response has little effect on established adult worms although
it can act against the invading Schistosomula of new infections.
This evasion of the immune response by adult worms is due to host-like
antigenic determinants found on the surface membranes of the schisto¬
somes which block attachment of antibodies directed against the para¬
site (Clegg, 1974; Smithers and Doenhoff, 1982).
Trypanosomes have also been shown to acquire host protein on
their surfaces but it is not known whether this has immunologically
protective function in the natural hosts. Thus, although there is
evidence for the binding of host protein by a T. vivax strain adapted
to rodents, no host-protein binding by T. vivax in the natural ungulate
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host has been reported (Vickerman, 1974). In addition, De Gee and
Rovis (1981) failed to demonstrate host protein on a tsetse-trans¬
missible, mouse-infective strain of T. vivax. Diffley and Honigberg
(1977, 1978) showed,by means of quantitative immunofluoresence, that
in T. congolense infections in rats,the parasites acquire host protein
on their surface. They did not however proceed to show whether or
not the acquisition of host protein interferes with antibody attach¬
ment to the surface of the trypanosome.
Variation in antigens of trypanosomes during the course of
infection has been shown to be associated with a surface glycoprotein
coat covering the whole of the trypanosome, including the flagellum.
This compact, 12-15 mm thick coat was first described in ultrastruc-
tural studies of T_. brucei, T. congolense and T. vivax (Vickerman,
1969a,b). It is seen in bloodstream forms and in metacyclic forms
from the tsetse fly but is absent from trypanosomes found in the mid¬
gut of the insect vector and similar developmental stages obtained by
in vitro cultivation (Vickerman, 1969a). It has been argued that the
surface coat in T. brucei and T_. congolense bloodstream forms is un¬
likely to represent host protein since a similar coat is present in
metacyclics within the tsetse fly (Vickerman, 1974).
Evidence that antigenic variation is associated with change in
the surface coat has been summarised by Turner (1982). Firstly, pro-
cyclic trypomastigotes which have no surface coat are incapable of
antigenic variation and assume a common surface antigenicity irre¬
spective of the antigenic variant from which they were derived (Seed,
1964). Secondly, the loss of surface coat is paralleled by loss of the
ability of variant specific antibodies to agglutinate the trypanosomes
(Barry and Vickerman, 1979). Thirdly, variant specific antibodies
have been shown by electron microscopy to bind to the surface coat
of homologous but not heterologous trypanosomes (Vickerman and
Luckins, 1969). Lastly, Cross (1975) has purified a single variable
surface glycoprotein from the trypanosome surface membrane and used
this to produce variant specific antisera which reacted with the
surface coat of homologous but not heterologous trypanosomes.
The number of variable antigen types (VATs) which can be pro¬
duced by salivarian trypanosomes is a subject of much research inter¬
est. Various serological tests have been used for VAT identification.
The agglutination test has been widely used in the case of T. brucei
organisms (Cunningham and Vickerman, 1962; Gray, 1962; 1965a,b;
Capbern et_ al_., 1977). The neutralization of infectivity test was
found more suitable for T. congolense (Wilson and Cunningham, 1972;
Uilenberg and Giret, 1972), while the immunolysis test has been applied
in the case of T. vivax (Dar, 1972; Jones and Clarkson, 1972). Early
studies indicated that a clone of T.. brucei could produce at least
15-23 VATs (Ritz, 1916; Osaki, 1959; Gray, 1965b). Recently a clone
of T. equiperdum has been shown to produce 101 VATs (Capbern et al.,
1977), and it is possible that there is no limit to the number of
antigens which could be produced by a clone of T\ brucei other than
that imposed by the time for which the infected host survives (Gray,
1965b).
There are problems in attempting to assess the full capacity of
a strain to produce different antigens since in the serological tests
used, although trypanosome populations may react as discrete serological
entities with homologous antisera, the population may consist of
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trypanosomes of several different antigen types. Hence, the anti¬
genic character of a relapse variant can result from a combination
of the characteristics of several different antigens (Gray and
Luckins, 1976). Indirect fluorescent antibody tests utilising
monoclonal antibodies have enabled a more comprehensive determination
of individual antigenic types comprising mixed populations of try¬
panosomes (Hajduk and Vickerman, 1981).
There is a tendency for trypanosomes of any single serodeme to
revert to a limited number of characteristic VATs whenever they are
transmitted cyclically. Early studies on T. brucei indicated that
with each strain, populations of trypanosomes transmitted by different
tsetse flies were more closely related to each other than to the
variants the flies originally ingested (Broom and Brown, 1946). This
observation has been confirmed in a number of subsequent studies using
T. brucei sspp. (Gray and Luckins, 1976). The term "basic antigen"
has been applied to the antigen which appeared to be common between
cyclically transmitted trypanosomes (Gray, 1965a).
The existence o"f a basic antigen in a T. congolense stock has
also been demonstrated (Uilenberg and Giret, 1972). Trypanosomes iso¬
lated by mouse subinoculation from sheep during a short febrile period
before patent parasitaemia had what was considered as the basic anti¬
gen. Wilson and Cunningham (1970) however, failed to demonstrate the
existence of a basic antigen in T. congolense. In their study, stabi-
lates used in neutralization tests were prepared from mice infected
for 17-20 days. During this time antigenic variation may have taken
place. More recent studies have shown that cyclical transmission of
different VATs of a stock of T. congolense in mice results in metacyclic
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populations which are similar in VAT composition as judged by immuno-
f luoresence and neutralization of infectivity tests (Nantulya et al_.,
1980a).
Evidence that metacyclic trypanosomes bear a basic antigen was
provided by Cunningham (1966) who prepared populations of metacyclics
for neutralization test by allowing T. rhodesiense-infected flies to
feed on pools of blood. Sera collected from sheep within 14 days of
infection contained neutralizing antibodies against the metacyclic
trypanosomes. Some flies were shown to transmit metacyclics of more
than one antigenic type. Similarly, Gray (1965a) found that although
some flies transmitted only the "basic antigen" others transmitted a
mixture of "basic" and other variable antigens. Hajduk and Vickerman
(1981) using immunofluoresence and trypanolysis tests, provided fur¬
ther evidence that a tsetse fly ingesting a particular VAT of T. brucei
may transmit several metacyclic VATs. From these findings it was
concluded that serodemes of trypanosomes are cyclically transmitted
as repertoires of metacyclic VATs.
In addition to the existence of basic antigen, there are anti¬
gens which tend to appear predictably in the early stages of infection
in each new host whenever a stock is passaged from host to host by
syringe. These have been termed "predominant antigens" (Gray, 1962).
The mechanism of induction of antigenic variation is not known
with certainty (Gray and Luckins, 1976; Vickerman, 1978). It is widely
held that antigenic variation is genetically controlled but mutation,
which could account for the variation, can be ruled out on account of
the predictable appearance of some antigenic types (Gray, 1965a).
There is evidence that antigenic variation results from alternate
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gene expression rather than changes in the genes themselves (Vickerman,
1978).
6.1.2 Immunity to salivarian trypanosomes
Animals suffering from African trypanosomiasis produce large
amounts of trypanosomal antibodies but their presence is not corre¬
lated with immunity. There is a pronounced hypergammaglobulinaemia
(Kobayashi and Tizard, 1976; Luckins and Mehlitz, 1976; Masake et al.,
1983), and while it was initially shown that some of the immunoglobulins
may be non-specific for trypanosomes (Houba et_ al_. , 1969) , more recent
evidence has shown that antibodies produced are specific to the infect¬
ing organisms (Musoke et al., 1981; Masake et al., 1983).
Studies on antigenic variation in African trypanosomiasis have
made vaccination against trypanosomiasis appear to be an unattainable
goal. However, it must be remembered that most of the studies have
involved serological tests, results of which may or may not correlate
with protective immunity. Weitz (1970) has stressed the importance of
deliberate infection with live organisms to demonstrate development of
immunity against trypanosomiases. Laboratory and field studies involv¬
ing deliberate infections or exposure to natural challenge have indi¬
cated that both laboratory and domestic animals acquire immunity to
trypanosomiasis, although it appears to be variant specific.
Several procedures have been used to induce active immunity against
trypanosomiasis (Gray and Luckins, 1976; Murray and Urquhart, 1977).
The most successful methods have been inoculation of live irradiated
organisms and infection and treatment. In one study in which cattle
were inoculated with killed trypanosomes or minimal doses of live T.
brucei, T. congolense and T. vivax equivocal results were obtained
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when the animals were exposed to field challenge (Schilling, 1935;
Hornby, 1941) . Half the number of animals so treated survived in an
enzootic area (Schilling, 1935). However, when the same animals were
moved to a different area with adverse conditions and heavier trypano-
some challenge, they succumbed to trypanosomiasis (Hornby, 1941) .
Attempts have been made to induce immunity to Th congolense in
cattle, dogs and mice (Duxbury et_ al_. , 1972). Cattle and dogs were
8 10
immunised with 10 -10 irradiated trypanosomes and challenged with
10^-10^ trypanosomes. Mice were immunised with 10^-10^ irradiated
trypanosomes and challenged with 10^ trypanosomes. Whereas the mice
showed resistance, the cattle and dogs were fully susceptible. As it
appears that the T. congolense used was an uncloned stock it is poss¬
ible that the larger dose used to challenge cattle and dogs contained
more antigenic variants than that used in mice.
In a subsequent experiment, Wellde et al. (1973) attempted
immunisation of cattle with gamma-irradiated T. rhodesiense. Cattle
9 10
which were inoculated with six immunising doses of 10 -10 irradiated
4
trypanosomes showed resistance to challenge with 10 viable trypano¬
somes at one week and eight months after immunisation but not at 14
months. Animals which underwent self-cure after infection were re¬
sistant to challenge 14 months later. Infections with this stock of
T. rhodesiense were mild even in control cattle. However, Wellde et
al. (1973) did not relate the mild nature of T_. rhodesiense infections
in cattle, to the ease with which protective immunity could be induced
as compared to induction of immunity to T. congolense (Duxbury et al.,
1972).
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More recently, Morrison et ad. (1982a) immunised cattle with
irradiated T. brucei and showed that cattle immunised with at least
7 3
10 irradiated organisms were immune to challenge with 10 infective
trypanosomes 14 days later. Antibody detected by various serological
•
tests including neutralization of infectivity, correlated with immun¬
ity. No similar studies have been carried out with T. congolense.
The earliest observations on development of immunity following
chemotherapeutic treatment of trypanosomal infections were probably
those of Bevan (1928, 1936) who noted that clinical cases of bovine
trypanosomiasis which recovered after treatment frequently remained
in good health despite reinfection. Whiteside (1962) reported a
lengthening of the intervals between the development of new infections
in cattle treated with diminazene aceturate while under moderate field
challenge. Higher challenge resulted in a decrease in the interval
between the appearance of overt parasitaemia. Fiennes (1970) noted
that after three years of chemotherapy a herd of beef cattle showed
few cases of trypanosomiasis.
The trypanocidal drug regime used has been found to be import¬
ant in development of immunity. Animals treated with diminazene ace¬
turate upon development of clinical disease (or a PCV of 20%) have been
shown to develop partial immunity (Wilson et al. ,■ 1975, 1976). In
contrast, in the same study, animals treated as a group with dimin¬
azene aceturate whenever patent parasitaemia developed in any one
animal in the group, did not develop immunity.
Sterile immunity has been claimed to develop in animals under
antrycide prophylaxis (Soltys, 1955). However, other studies could not
confirm this, as it was shown that antrycide given repeatedly can leave
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residues which can provide prophylactic effect long after treatment
has ceased (Smith, 1958).
There have been few laboratory studies on the development of
immunity in association with chemotherapy. Cunningham (1968) treated
six cattle at 14 days after infection with T. brucei and then chall¬
enged them in pairs at one, two and three months after treatment.
It was shown that such animals resisted challenge for up to three
months after treatment while controls were susceptible.
Immunity has also been reported to develop after treatment of
T. congolense infection in cattle (Wilson, 1971). Cattle were inoc¬
ulated with two doses of T. congolense bloodstream forms at intervals
of 11 weeks, each inoculation being followed by treatment with dimin-
azene aceturate at 21 days after each infection. The five cattle
were shown to be immune to challenge 22 weeks after the first immuni¬
sation. In contrast, animals which were bitten by wild-caught flies
infected with T. congolense on five occasions over a period of 320 days,
each infection being treated at 21 days, were still susceptible when
challenged on a sixth occasion with the same metacyclics (Wilson, 1971).
It was concluded that sterile immunity was achieved when immunising
and challenge infection consisted of one well defined antigenic type.
In sheep, Uilenberg and Giret (1973) demonstrated that immunity
can develop against metacyclics of T. congolense after treatment of
cyclically transmitted infection with diminazene aceturate. One sheep
treated three weeks after cyclical infection was shown to be immune
to cyclical challenge with the same stock 9-15 weeks after the first
infection. In another sheep similarly treated, immunity to cyclical
challenge was demonstrated 9-11 weeks but not 14 weeks after first
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infection. In contrast, three sheep treated 3-4 weeks after cyclical
7
infection with T. congolense were not immune to challenge with 10
bloodstream forms isolated from 4-6 different animals cyclically in¬
fected with the same stock.
An interesting aspect of immunisation by infection and treatment
of cyclically transmitted infections is whether animals develop immun¬
ity when treated during the periods when trypanosomal chancres were
present but before patent parasitaemia had developed. Early treatment
may not allow the full development of immunity. Field studies by
Wilson et al. (1975, 1976) showed that animals treated with diminazene
aceturate on a herd basis when one animal in the group became infected
did not develop immunity whereas animals treated individually, after
development of disease, were immune. More recently, Emery et al_. (1980)
reported development of immunity to homologous cyclical challenge with
T_. congolense in cattle treated with diminazene aceturate at day 15
after primary cyclical infection but not in those similarly treated
five or ten days after primary infection. These animals were chall¬
enged at 21 days post-treatment of primary infection.
Studies on the development of immunity to cyclically transmitted
T. congolense infections-in rabbits following treatment with homidium
chloride have also been reported (Luckins et. ad. , 1983) . In contrast
to the finding of Emery et al. (1980) it was shown that rabbits treated
seven days after infection were immune to homologous cyclical chall¬
enge 75 days after treatment. One out of eight rabbits and two out of
four rabbits challenged at 125 and 300 days after treatment respectively
were also shown to be immune. Levels of serum antibodies measured by
ELISA and neutralization of infectivity were low in the treated immune
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rabbits as in susceptible rabbits.
There is obviously a need for more information on the develop¬
ment of immunity after abrogation of cyclically transmitted T. congo-
lense infections in both the laboratory and in the field. In the
work to be described, immunity and serological responses in rabbits
infected with T. congolense were studied in relation to the timing
of chemotherapeutic treatment and the development of chancres.
5.2 The Effect of Early Chemotherapy on the Serological Response
in Animals Infected with Trypanosoma congolense
Experimental design: Two rabbits were treated with diminazene
aceturate after bites by G. m. morsitans infected with T. congolense
TREU 1457. The development of serum antibodies was monitored by
ELISA and was compared to that in an infected, untreated rabbit.
Rabbits 803 and 809 bitten by 12 and 11 infected flies respectively
were treated with 7 mg/kg diminazene aceturate at two and five days
after infection. Rabbit 821, bitten by one infected fly, was left
untreated.
Chancre development was monitored by measuring the diameter of
induration and erythema at the tsetse bite sites for up to 21 days
post-infection. Serum samples for estimation of anti-trypanosomal
antibodies were collected at 2-3 day intervals for the first week
after infection and thereafter at weekly intervals up to day 53.
Results: Rabbit 803 treated on day 2 post-infection showed no
serological evidence of trypanosomiasis (Figure 6.1A). This corres¬
ponded with complete lack of chancre development at sites bitten by
infected tsetse flies. No anti-trypanosomal antibodies were detected
151.
in rabbit 809 treated at day 5 post-infection, although small chancres
developed between day 6 and 11 days after the flies had fed (Figure
6.IB). In contrast, rabbit 821 bitten by one infected tsetse fly
and left untreated showed high ELISA values beginning on day 14 and
reaching a maximum by day 42 after infection (Figure 6.1C).
Figure 6.1 Mean diameters of chancres and mean ELISA values
of serum anti-trypanosome antibodies in rabbits
803, 809 and 821 at different days after infection
with ]T. congolense TREU 1457.
A = Rabbit 803 treated at day 2 post-infection
B = Rabbit 809 treated at day 5 post-infection
C = Rabbit 821 left untreated
B
Y = Treatment with diminazene aceturate
Bites from infected tsetse flies»































6.3 Immunity in Rabbits Treated at Different Times after Infection
with Trypanosoma congolense
Experimental design: Two groups of rabbits, Group I and II each
with 14 animals were used in studies on sterile immunity following
abrogation of cyclical Th congolense infections with 7 mg/kg dimin-
azene aceturate. In the first group of animals tissue chambers were
implanted to allow the collection and assay of tissue fluids.
Group I - Rabbits 896, 893, 892, 889, 886 and 887 were bitten
by 1-2 G. m. morsitans infected with T. congolense TREU 1682 and then
treated at 0, 4, 8, 12, 21 and 42 days post-infection respectively.
Rabbits 882, 881, 880, 877, 876, 884 and 874 were bitten by 1-2 (3. m.
morsitans infected with T. congolense TREU 1690 and then treated at
2, 4, 6, 10, 21, 27 and 42 days after infection respectively. One
rabbit, 885, was bitten simultaneously by two flies infected with T.
congolense TREU 1682 and two flies infected with T. congolense TREU
1690 and then treated at day 42 after infection.
All rabbits were challenged 40-43 days post-treatment, by bites
from 1-3 G. m. morsitans infected with the homologous stock of T.
congolense. Rabbit 885 which had received dual primary infection was
challenged with G. m. morsitans infected with T. congolense TREU 1690.
Flies which were fed on rabbits which subsequently failed to develop
chancres were allowed to feed on susceptible rabbits to ascertain that
they were still capable of infecting animals and causing chancres.
All flies used in challenge studies were less than 77 days old. Animals
treated up to seven days after primary infection were challenged with
the same batch of flies used in primary infection while those challenged
at later times were bitten by another batch of flies newly infected
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with the homologous stock of T. congolense.
Chancre development was monitored up to 21 days after either
primary or challenge infection. Development of parasitaemia prior
to treatment was checked by the microhaematocrit/buffy coat technique
in all animals except those treated up to four days after infection.
After treatment, development of parasitaemia was monitored by the
microhaematocrit/buffy coat technique twice weekly from 14 days post-
treatment to the day of challenge. Prior to challenge it was con¬
firmed that each animal was not infected, by subinoculation of blood
in 0.5 ml amounts into each of three mice. After challenge, develop¬
ment of parasitaemia was monitored by the microhaematocrit/buffy coat
technique twice weekly, 14-28 days after challenge. The absence of
trypanosomes in blood was confirmed by subinoculation of blood in
0.5 ml amounts into each of three mice.
Serum was collected from all animals at 2-3 day intervals up to
day 14 after primary tsetse bite and thereafter at weekly intervals
up to four weeks after challenge. For comparative assay of anti¬
trypanosomal antibodies tissue fluid was collected at 2-3 day inter¬
vals up to 14 days post-primary challenge and thereafter at weekly
intervals up to the day of treatment with diminazene aceturate.
Tissue fluid was collected from tissue chambers created by implant¬
ing hair curlers subcutaneously 21 days prior to primary tsetse bite,
according to methods described by Goodwin and Guy (1973). Hair curlers
used were 6.0 cm long by 1.8 cm outer diameter. They were covered
with a belt of silicone rubber tubing to discourage the growth of
tissue over the inner surface. Implantations were carried out under
halothane anaesthesia. One hair curler was implanted on each flank
(Plate 6.1). For the primary infection, tsetse flies were allowed to
feed directly on top of the tissue chamber.
In the course of collecting tissue fluid, care was taken to avoid
trauma which would result in contamination of the tissue fluid with
blood. Fluid was withdrawn into a 1 ml syringe through a 21 gauge,
38 mm needle inserted through the silicone belt area of the hair
curler. It was diluted 1:4 with sterile PBS pH 7.4 and centrifuged
at 1500 g_ for 30 minutes to remove cellular debris and then stored
at-20°C until used.
Tissue fluid and sera were assayed for anti-trypanosomal anti¬
bodies using ELISA and Neutralization of Infectivity test. For the
Neutralization of Infectivity test, pooled sera and tissue fluid from
rabbits 874 and 885 were used.
A local skin reaction was removed from one rabbit (879) under
halothane anaesthesia, at day 9 post-infection. Half of the chancre
was macerated in cold, sterile PBS (pH 7.4) and the fluid extract
assayed for trypanosomal antibodies using the ELISA test.
Group II - Primary and challenge infections were made using
G_. m. morsitans infected with T. congolense TREU 1690. Three rabbits,
937, 975 and 971 were treated on days 7, 7 and 8 after bites from
23, 4 and 19 infected tsetse flies respectively. They were then chall¬
enged by bites from eight infected tsetse flies 42 days postr-treatment.
Two rabbits, 959 and 970 were treated 14 days after bites from 15 and
9 infected tsetse flies respectively and challenged with eight infected
tsetse flies 42 days post-treatment. Three other rabbits, 958, 962
and 961 were treated on days 17, 18 and 20 after bites from 11, 8 and
21 infected tsetse flies and then challenged with eight infected tsetse
flies 42 days post-treatment. Six rabbits numbered 939, 942, 943, 944
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945 and 947, were treated at day 28 after bites from 2-5 infected
tsetse flies and then challenged using 4-16 infected tsetse flies,
40 days after treatment.
All rabbits were checked for chancre and parasitaemia develop¬
ment as described above for Group I.
Results:
(a) Resistance to challenge - In group I only one animal (877)
out of eight treated 0-12 days after primary tsetse bite was immune
to homologous challenge. In contrast, all six rabbits treated at
21-42 days after primary tsetse challenge failed to develop parasit-
aemia (Table 6.1).
In group II, rabbits 937, 975 and 971, treated at 7 or 8 days
after primary tsetse bite, were susceptible to homologous challenge
whereas all 11 animals treated at 14-28 days after primary tsetse
bite were immune (Table 6.2).
(b) Chancre development and serological reactions - Mean chancre
diameters and serological reactions in rabbits from group I are shown
in Figures 6.2-6.8. In the following description, chancre and anti¬
body development in treated animals are compared to that in rabbit
821 (Figure 6.1C) which was a fully susceptible, untreated animal.
Treatment on day 0 and 2 in rabbits 896 and 882 resulted in com¬
plete suppression of the chancre development following the primary
tsetse bite (Figure 6.2). After challenge, chancre development and
serological reaction were similar to those of susceptible rabbits
(Figure 6.1C).
When treatment was carried out four days after primary infection
in rabbits 881 and 893 (Figure 6.3) there was no detectable serological
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response although small chancres were observed to develop at the bite
sites. Homologous challenge resulted in normal chancre development
and serological reaction similar to that seen in susceptible rabbits.
Treatment at 6 and 8 days after primary infections (rabbit 880
and 892) resulted in the appearance of chancres with mean diameters
similar to those of untreated rabbits but there was no indication of
antibody development in these animals (Figure 6.4). On challenge,
both rabbits showed an accelerated chancre development in which re¬
actions appeared as early as day 3 post-challenge. The serological
reactions were similar to that of a susceptible, untreated rabbit on
primary infection (Figure 6.1).
Rabbit 877, treated 10 days post-primary infection showed an
apparently normal chancre development and rising antibody titre reach¬
ing maximum levels 25 days after treatment (Figure 6.5A). However,
neither microhaematocrit/buffy coat technique nor mouse subinocul-
ation revealed the presence of trypanosomes in the blood. Following
challenge, only small reactions were observed and although there was
a rise in antibody levels trypanosomes were not detected in the
peripheral blood.
In another instance, rabbit 889 (Figure 6.5A) treated on day 12,
showed normal chancre development but no evidence of anti-trypanosomal
antibodies after treatment. In homologous challenge there was accel¬
erated chancre development and rapid rise in antibody levels.
Rabbits treated at 21-42 days after infection (876, 886, 884,
874, 887 and 885) showed normal chancre and antibody development up to
the time of treatment. Thereafter, antibody levels dropped gradually
(Figures 6.6-6.8). At the time of challenge, antibody levels were
similar to or only slightly higher than pre-infection levels. After
challenge, all six rabbits developed only small chancres and the
antibody levels remained low. No trypanosomes were found in the
blood.
(c) Antibody levels in tissue fluids and serum - The ELISA values
obtained using tissue fluid and serum samples collected from rabbits
876, 886, 874, 887 and 885 are shown in Figure 6.9. In all rabbits
antibody levels in tissue fluid were lower than those in serum.
The lower antibody levels in tissue fluid compared to serum
were confirmed by the neutralization of infectivity test using T.
congolense TREU 1725 and pooled serial sera and tissue fluid from
rabbits 874 and 885 (Table 6.3). Sera collected 35, 42 and 49 days
after infection showed complete neutralization of infectivity while
sera collected at 21, 28, 56 and 63 days after infection showed
partial neutralization. Tissue fluid on the other hand had only
partial neutralizing activity at days 35, 42 and 49 after infection.
No neutralizing activity could be detected in tissue fluid collected
at other times. Fluid extract from a chancre removed from rabbit
879 was also negative for trypanosomal antibodies
Plate 6.1 Rabbit with implanted hair curlers and regressing
chancres near the implantations. Sample hair
curlers are shown on the bottom of the picture.
The middle bulging on each implantation is due
to a silicone rubber ring.
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Figure 6.2 Mean diameters of chancres and mean ELISA values
of serum anti-trypanosome antibodies in rabbits
treated at 0 or 2 days post-primary infection
with T. congolense TREU 1682 or TREU 1690.
Key
A = Rabbit 896
B = Rabbit 882
ff = Treatment with diminazene aceturate
I = Bites from infected G. m. morsitans.
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Days after primary tsetse bite
Figure 6.3 Mean diameters of chancre and mean ELISA values
of serum anti-trypanosome antibodies in rabbits
treated at 4 days after primary tsetse-bite,
using flies infected with T. congolense TREU 1682
or TREU 1690.
Key
A = Rabbit 881
B = Rabbit 893




Days after primary tsetse bite
Figure 6.4 Mean diameters of chancres and mean ELISA values
of serum anti-trypanosome antibodies in rabbits
treated at 6 and 8 days after primary infection,
using tsetse flies infected with T. congolense
TREU 1682 or TREU 1690.
Key
A = Rabbit 880
B = Rabbit 892




Days after primary tsetse bite
Figure 6.5 Mean diameters of chancres and mean ELISA values
of serum anti-trypanosome antibodies in rabbits
treated at 10 and 12 days after primary tsetse-
bite with flies infected with T. congolense TREU
1682 or 1690.
Key
A = Rabbit 877
B = Rabbit 889




Days after primary tsetse bite
Figure 6.6 Mean diameters of chancres and mean ELISA values
of serum anti-trypanosome antibodies in rabbits
treated at 21 days after primary tsetse bite,
using flies infected with T. congolense TREU 1682
or TREU 1690.
Key
A = Rabbit 876
B = Rabbit 886
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Figure 6.7 Mean diameters of chancres and mean ELISA values
of serum anti-trypanosome antibodies in rabbits
treated at 27 and 42 days after primary tsetse
bite, using flies infected with T. congolense
TREU 1690.
Key
A = Rabbit 884
B = Rabbit 874
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Figure 6.8 Mean diameters of chancres and mean ELISA values
of serum anti-trypanosome antibodies in rabbits
treated at 42 days after primary tsetse bite,
using flies infected with T. congolense TREU 1682
or TREU 1690.
Key
A = Rabbit 887
B = Rabbit 885



































Days after primary tsetse bite
Figure 6.9 Mean ELISA values of anti-trypanosome antibodies
in serum and tissue fluid from rabbits cyclically
infected with T. congolense TREU 1682 or TREU 1690,
A - Rabbit 876) Treated with diminazene aceturate
B = Rabbit 886 ( at 21 da^s Post-infection
C = Rabbit 874
D = Rabbit 887
E = Rabbit 885
| = Infective tsetse bite. Each arrow represents
one tsetse fly which fed.
>■ = Serum
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6.4 Sterile Immunity in Rabbits after Chemotherapy of Trypanosoma
congolense Infections Induced by Cultured Metacyclic Trypanosomes
Experimental design; Eighteen rabbits were each inoculated intra-
dermally with 5 x 10^ cultured metacyclics of T. congolense TREU 1690
and then divided into two groups to be treated with 14 mg/kg dimin-
azene aceturate at either seven or 14 days after infection. Chancre
development at the time of treatment was noted and the presence of
trypanosomes in the blood checked by microhaematocrit/buffy coat
technique and mouse subinoculation. After treatment, each group was
again randomly divided into three smaller groups of three rabbits
which were challenged 28, 42 or 56 days after treatment. Three unin¬
fected rabbits treated with 14 mg/kg diminazene aceturate and challenged
at either 28, 42 or 56 days after treatment acted as controls.
Serum samples were collected at day 0 and then twice weekly up
to four weeks after challenge for evaluation of anti-trypanosomal anti¬
bodies using ELISA and Neutralization of Infectivity test. All rabbits
were challenged by bites from tsetse flies infected with T. congolense
TREU 1690.
Results: Homologous challenge of rabbits treated at seven days
after infection resulted in infections developing in all animals
except rabbit 1098 challenged on day 56 (Table 6.4). Serial sera
from these rabbits were negative for anti-trypanosomal antibodies
by both ELISA and Neutralization of Infectivity test (Table 6.5).
Serum samples from rabbit 1098 which had shown resistance on challenge
were also negative for trypanosomal antibodies (Table 6.8).
In contrast, seven out of nine rabbits treated 14 days after
infection showed resistance to homologous challenge (Table 6.6).
Small chancres developed in three of these immune rabbits (1095, 1103
and 1105). One rabbit from each of the groups challenged at 42 and
56 days after treatment showed development of chancres and became
infected after challenge (rabbits 1099 and 1100). Control uninfected
rabbits (1114, 1126 and 1127) challenged at 28, 42 and 56 days after
treatment showed typical development of chancres and parasitaemia
similar to untreated susceptible animals (rabbit 821, Figure 6.1C).
Results of ELISA and Neutralization of Infectivity tests for the
rabbits treated at 14 days after infection except 1099 and 1100, are
shown in Table 6.7. ELISA values of 0.10-0.27, which would be regarded
as positive for anti-trypanosomal antibodies, were obtained from serum
samples collected at 14, 28, 42 and 56 days after treatment. Sera
collected 28, 42 and 56 days after treatment completely neutralized
the infectivity of T. congolense TREU 1725. Sera from rabbits 1099
and 1100 which were not immune, did not show anti-trypanosomal anti¬
bodies by either ELISA test or Neutralization of Infectivity test
(Table 6.8).
Table6.4
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6.5 Discussion
The measurement of anti-trypanosomal antibodies by means of
ELISA showed that in animals cyclically infected with T. congolense
the development of serum antibodies is associated with the presence
of trypanosomes in the blood. Thus, ELISA values greater than pre-
infection values were detected in sera obtained from rabbits 14 or
more days after infection. Following successful treatment with
diminazene aceturate, values invariably decreased gradually.
In contrast, low ELISA values were found in serum samples from
all rabbits in which cyclical infection was abrogated by treatment
with diminazene aceturate 0-12 days post-infection, a period during
which trypanosomes could not readily be detected in blood.
There were indications that animals infected with T. congolense
TREU 1690 showed higher ELISA values at an earlier stage of infection
than rabbits infected with T. congolense TREU 1682. It is possible
that this is related to the development of higher parasitaemias at
earlier stages of infection in those rabbits infected. Regular
quantitation of parasitaemia in rabbits was not carried out since the
numbers of organisms present were too few for estimation using either
a haemocytometer or the rapid "matching" technique of Herbert and
Lumsden (1976). However, it had been observed that in mice, T. congo¬
lense TREU 1690 always produced higher parasitaemias than T. congolense
TREU 1682. It is also possible that the use in the ELISA test, of
antigen prepared from T. congolense TREU 1690 could have contributed
to higher ELISA values for sera from rabbits infected with the homolo¬
gous stock of trypanosomes.
The finding that antibody production in trypanosome infection may
be related to the degree of parasitaemia has been shown to occur in
other animals. In sera from cattle infected with T. brucei, peak
levels of antibody assayed by Neutralization of Infectivity test,
Indirect Fluorescent-antibody test (IFAT), Farr assay and Solid Radio¬
immunoassay (S-RIA) were shown to be proportional to the number of
irradiated viable organisms inoculated intravenously (Morrison et al_.,
1982a).
In the present study, it was shown that in an infected untreated
animal antibodies were first detectable by ELISA on day 14 post¬
infection. This is in agreement with the findings of Luckins and
Gray (1979) who also reported that in rabbits cyclically infected with
|T. congolense, serum antibodies were detectable by ELISA and IFAT at
14 days post-infection. However, Morrison et al. (1982a) who inocul¬
ated cattle with irradiated T. brucei organisms intravenously, showed
that peak antibody levels could be detected by Neutralization of
Infectivity, IFAT, Farr Assay and S-RIA at nine or 11 days post-
inoculation. While the use of more sensitive techniques and a differ¬
ent trypanosome species could account for this different finding, it
is probable that the intravenous inoculation of large numbers of try-
panosomes contributed to earlier stimulation of immunity.
An attempt to determine whether tissue fluid in the vicinity of
the trypanosome chancre may contain antibodies when none could be
detected in serum revealed that antibody levels in tissue fluid were
always lower than serum antibody levels. In tissue fluid, ELISA
values were 10-30% of those obtained for serum. This is consistent
with the findings of Goodwin and Tierney (1977) who showed that in
rabbits infected with syringe-transmitted T. brucei, tissue fluid
antibodies attained only 15-30% of plasma antibody levels.
The presence of low antibody levels in tissue fluid was confirmed
by the Neutralization of Infectivity test. None of the tissue fluid
samples could neutralize infectivity of the homologous stock of Th
congolense whereas serum samples from the same animals at days 35, 42
and 49 after infection completely neutralized the homologous T. congo¬
lense suspension.
It is possible that the source of tissue fluids assayed in these
experiments does not represent the body tissue fluid. However, Calnan
et al. (1972) presented evidence from studies on albumin movement,
protein and electrolyte levels that in rabbits, fluid within a tissue
cage is not an inactive collection of isolated fluid but is represent¬
ative of body interstitial fluid. Lower antibody levels in tissue
fluid would be consistent with the predominance of IgM in trypanosom¬
iasis in the early stages of infection. This class of immunoglobulin
is largely confined to the bloodstream (Terry, 1976).
Nevertheless, results obtained with tissue fluid may not apply
to events in the local skin reaction where large numbers of mononuclear
cells including plasma cells have been observed at certain stages of
the trypanosome chancre in rabbits, cattle and goats (Gray and Luckins,
1980; Emery and Moloo, 1981). Plasma cells are likely to be producing
antibodies locally as trypanosome lysis and degeneration thought to be
antibody-mediated, has been observed in local skin reaction to T?.
congolense (Luckins and Gray, 1980). Although in the present study,
tsetse flies were fed on the skin directly above the tissue cage, so
that local skin reactions would be directly above the tissue chamber,
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it is possible that the method is not sensitive enough to detect
locally produced antibodies. Attempts to detect the presence of
locally produced antibodies by applying ELISA to fluid obtained
after macerating trypanosome chancre at day 9 post-infection, were
unsuccessful. More sensitive methods such as immunohistological
techniques would be required for detection of antibody production in
the chancre.
It appears that local expression of immunity is responsible for
the destruction of trypanosomes deposited at the skin bite site when
immune animals are challenged by infected tsetse flies. This is
indicated by the differences in chancre and parasitaemia development
in immune and susceptible animals. In all cases, immune animals
developed only small skin reactions of 4-7 mm diameter within three
days of challenge, and no trypanosomes could be detected at any time
after challenge. In contrast, after challenge of non-immune rabbits,
chancres appeared at tsetse bite sites and trypanosomes appeared in
blood in a similar manner to that seen in primary infections.
The possibility that metacyclic trypanosomes deposited in immunised
animals multiplied at the bite site and then entered the bloodstream
where they were destroyed is not tenable for two reasons. Firstly,
any multiplication would inevitably have led to the appearance of
larger reactions. Secondly, serum antibody levels in immune rabbits
were consistently low, almost at pre-infection levels at the time of
challenge. A rise in antibody might be expected if trypanosomes entered
the bloodstream in appreciable numbers.
It has been shown in the present work, that early trypanocidal
drug treatment of cyclically transmitted T. congolense infections in
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the rabbit can modify immunity against homologous challenge. Only
one out of 11 rabbits treated with diminazene aceturate at 0-12 days
after infection was immune to homologous challenge at 42 days after
treatment. In contrast all 17 rabbits treated at 14 or more days
after infection were immune to homologous challenge. This finding
was corroborated by results from experiments in rabbits which had
been treated with diminazene aceturate at either 7 or 14 days after
intradermal inoculation of cultured metacyclics of Th congolense.
Only one of nine rabbits treated at seven days after infection re¬
sisted infection upon cyclical homologous challenge by tsetse bite
4-8 weeks after treatment while seven out of nine rabbits treated
at 14 days after infection were immune to similar homologous challenge.
In animals treated after infective tsetse bite or after intra¬
dermal inoculation of cultured metacyclics, immunity correlated with
the presence of antibodies at the time of and soon after treatment,
although antibody levels were invariably low at the time of challenge.
Thus in animals which were treated 14 days after intradermal inocul¬
ation of cultured metacyclics, seven rabbits which were immune had
shown evidence of trypanosome neutralizing antibodies post-treatment,
whereas in two other susceptible animals which became infected follow¬
ing challenge, no serum neutralizing antibodies were detected. Anti¬
bodies could not be detected in any of the nine animals treated at
seven days after intradermal inoculation of cultured metacyclics, al¬
though one rabbit (1098) subsequently showed resistance to homologous
challenge.
The finding that immunity develops in animals treated with dimin¬
azene aceturate at 14 or more days post-infection but not in those
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treated earlier is in agreement with findings from studies in cattle,
in which immunity to homologous challenge was shown to develop in
animals treated at 15 days post-infection, but not in those treated
at five or 10 days after infection (Emery et al., 1980). In contrast,
rabbits treated with homidium chloride at seven days after infection
with T. congolense have been shown to be immune to homologous chall¬
enge (Luckins et al., 1983).
The different result on immunity developing after chemotherapy
of cyclical T. congolense infections in rabbits as obtained by Luckins
et al. (1983) compared to those obtained in the present studies is
difficult to explain since the trypanosome stocks used in the two studies
are related. There is a possibility that use of different trypanocidal
drugs may account for the difference. Diminazene aceturate is rapid
in action while homidium, like all phenanthridium drugs is slower in
action allowing 3-5 cell divisions to take place after treatment
(Hawking, 1958, 1963). Thus, trypanosomes in a homidium-treated animal
would be available in larger numbers and for a longer time after
treatment than in an animal similarly treated with diminazene aceturate.
Other studies have shown that rabbits treated with homidium
chloride at seven days after intradermal inoculation of cultured meta-
cyclics of T. congolense are not immune to challenge at 28-56 days
after treatment in contrast to rabbits similarly challenged after
treatment at 14 days after infection (Luckins, unpublished).
Some findings on immunity developing in mice treated with dimin¬
azene aceturate after cyclical T. congolense infection, support the
findings from the present studies in rabbits. Nantulya et al. (1980b)
reported that mice given a single course of 5-12 bites from T. congolense
infected flies and then treated with diminazene aceturate at 10 days
after first infectious bite, were not immune to homologous challenge
one week later. In contrast, mice given two courses of infection and
treatment separated by three-week intervals were immune to homologous
challenge. Since patent parasitaemia in control mice was not esta¬
blished until 10-12 days after infection, it is possible that when
treatment was carried out at 10 days post-infection, parasitaemia
had not reached the requisite level for induction of comprehensive
immunity. Mice treated with diminazene aceturate at seven days after
a single intraperitoneal inoculation of 10^ cultured metacyclics of
T. congolense have been shown to be immune to homologous challenge
even though no parasitaemia could be detected at the time of treatment
(Varma, 1983). It has also been shown that mice infected with blood¬
stream forms of T. brucei and then treated with diminazene aceturate
at seven days post-infection when they were parasitaemic, resisted
homologous challenge 42-370 days after treatment (Herbert and Lumsden,
1968).
While the results presented above showed that rabbits treated at
< 14 days after cyclical infection are not immune to homologous chall¬
enge, limited observations show that two courses of infection and
treatment at less than 14 days post-infection may lead to the develop¬
ment of sterile immunity. Two rabbits which had been infected by bites
from five infected flies each, on two consecutive occasions, each
followed by treatment at less than seven days after tsetse bite, were
shown to be immune to homologous challenge 40-42 days after the second
treatment (Luckins, Silayo and Rae, 1982). This is in agreement with
the findings of Nantulya et al. (1980b) who reported that mice were
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immune after two consecutive infections and treatments when single
infection and treatment did not lead to the development of immunity.
There is however, a need for further studies to confirm the above
observations. If such development of immunity after two consecutive
infections and treatments also occurs in cattle, it is difficult to
explain why Wilson et ad. (1975, 1976) failed to observe the develop¬
ment of immunity in animals treated with diminazene aceturate
as a group whenever one individual was positive for trypanosomiasis.
Since Wilson et al. (1975, 1976) found that animals treated only after
they were positive for infection acquired immunity, a plausible explan¬
ation based on the findings of Morrison e_t al_. (1982a) in cattle and
from the present studies in rabbits is that most of the animals treated
as a group whenever one animal was found infected, were treated at too
early a stage of infection and a comprehensive immunity against the




The present studies in rabbits have shown that the local skin
reaction or chancre, in which TL congolense initially develops extra-
vascular ly after infective tsetse bite, may influence the efficacy
of chemotherapy and subsequent development of sterile immunity. In
addition it was shown that early chemotherapy abrogates further
development of the trypanosome chancre.
It would appear that one of the reasons why trypanosome chancres
have not been reported to occur in cattle under natural field con¬
ditions is mass application of chemotherapy. In the present studies
it was shown that rabbits treated with diminazene aceturate up to
three days after infective tsetse bite did not develop chancres.
When treatment was carried out 4-7 days after the infective tsetse
bite, the effect was to reduce the size of the chancre compared to
those on normal untreated animals at the same period after treatment.
Animals treated at eight or more days after infective tsetse bite
had chancres which did not differ appreciably from those on normal
untreated rabbits. Histological examination of chancres after treat¬
ment revealed that, although trypanosomes could not be detected 2-4
days after treatment, the cellular reaction in composition and extent
was similar to that in untreated animals at the same time after in¬
fection .
It is not clear why the trypanosome chancre in untreated animals
disappears at 14-18 days after infection. It has been suggested that
in the case of the Th congolense chancre, this may be related to a
biological change associated with maturation of inoculated metacyclic
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trypanosomes into bloodstream forms (Akol and Murray, 1982). How¬
ever this would be incompatible with the observation that blood¬
stream forms of T. brucei when inoculated intradermally, also
elicit chancre formation (Willett, 1956; Awad et_ al., 1969; Emery
et al., 1980) .
It is suggested that the chancre in untreated rabbits dis¬
appears at 14-18 days post-infection because of appearance of serum
antibodies at 14 days after infection. This theory would be com¬
patible with previous suggestions that the chancre is a type of
Arthus reaction (de Raadt, 1974) and that immune complex reactions
are most severe when antigen is in excess (Herbert and Parratt, 1979).
Thus the effect of increasing antibody production would be destruction
of trypanosomes and a change in the ratio of antigen to antibody,
eventually leading to disappearance of the chancre. Some observations
on chancre development in animals treated with isometamidium chloride
would tend to support this theory. It was observed in the present
studies that in some rabbits treated with isometamidium chloride and
then cyclically challenged with T. congolense.chancres which appeared,
remained up to 50 days after challenge. Although serum antibody
levels in these rabbits were not determined, it is possible that
residual drug in plasma would initially have prevented establishment
of parasitaemia essential for initiation of antibody production.
The view that the trypanosome chancre is a type of Arthus reaction
is supported by the finding that an Arthus type reaction can be elicited
in infected rabbits or infected treated rabbits by intradermal inocul¬
ation of sonicated T. congolense antigen, and in normal rabbits by
intradermal inoculation of antigen-antibody complex (Mansfield and
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Kreier, 1972b). Further support comes from the observation that
chancre size is proportional to the number of metacyclics inoculated
intradermally (Luckins et al. , 1981). Argument that such a propor¬
tionality could be due to a phospholipase activity resulting from
trypanolysis in tissues (Losos and Chouinard, 1979) is not tenable
because if this were the case it would be expected that the appear¬
ance of antibodies at 14-18 days post-infection would result in an
increase in the reaction size as more trypanosomes are destroyed 14
days post-infection.
Argument against ascribing the chancre to Arthus-type reaction
solely, is that in the classical Arthus reaction (Ranadive and Mowat,
1979) antibody and antigen occur on opposite sides of the vascular
wall. This is clearly not the case at days 6-14 post-infection since
antibody levels in serum were low at that stage. Thus any antibody
involved in immune complex formation would be in the same tissues in
which the antigen is present. It may therefore be that the chancre
is characterised by an initial weak Arthus reaction in which the pre¬
sence of trypanosomes in collagen, leads to infiltration with poly¬
morphonuclear cells, vasodilation and mononuclear cell infiltration.
Thus the chancre may be taken as both an immediate hypersensitivity
and inflammatory reaction. The role of delayed hypersensitivity re¬
action also needs to be investigated since it has been shown that a
delayed-type skin reaction can be elicited in T. congolense-infected
cattle inoculated with ultrasonicated or formalin fixed T. congolense
(Emery, Wells and Tenywa, 1980).
The effectiveness of chemotherapy appears to depend on the
stage of development of T. congolense chancres at the time at which
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trypanocidal drug is administered. Thus a high incidence of relapse
parasitaemias developed when treatment was carried out at 8-10 days
after infection when chemotherapy was found to be ineffective in 50%
of the treated animals. Even when the dose of diminazene aceturate
was increased to 14 mg/kg one out of six treated rabbits had relapse
parasitaemia. In contrast, 29 rabbits treated with 7 mg/kg dimin¬
azene aceturate at 0-4 or 12-42 days were completely cured.
A finding of considerable importance in relation to chemotherapy
was the observation that extravascular foci of trypanosomes might be
responsible for relapses in parasitaemia following treatment of drug
sensitive stocks of T. congolense with therapeutic doses of dimin¬
azene aceturate. Treatment carried out 8-10 days post-infection pro¬
bably precludes the involvement of parasites in the general circulation
as a source of relapses, since firstly the numbers present are low
and secondly, treatmentscarried out much later when systemic infections
have been fully established have been shown to be effective. Thus,
under certain conditions, the extravascular foci of Th congolense
development in the chancre might present a source of trypanosomes which
have evaded the effects of the drug. It is suggested that relapses
occur due to drug concentration in tissue fluid being insufficient for
the high concentration of trypanosomes in some chancres at 8-10 days
post-infection. There have been previous studies which indicated that
the efficacy of trypanocidal drug treatment may be affected by concen¬
tration of trypanosomes at the time of treatment (Reviewed by Davey,
1957; Hawking, 1963a). More recently, it has been shown that in mice
the minimum curative dose of diminazene aceturate for T. congolense
infection is proportional to the infecting dose of trypanosomes (Raether,
1970; Walker and Opiyo, 1973).
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A number of relapse infections were accompanied by the develop¬
ment of secondary chancres. Histological studies of skin sections
from chancres removed at 29 and 33 days post-infection in two rabbits
showing such secondary chancres failed to reveal the presence of
trypanosomes but the cellular reaction observed consisted of massive
proliferation of plasma cells. There is clearly a need to carry out
more studies on this form of drug failure particularly with cattle
as the experimental animals to determine the importance and patho¬
genesis of the secondary chancres.
The finding that rabbits were always cured when treated at 12
days or more after infection contrasts with recent findings that in
mice infected with Th brucei, relapse infections attributable to brain
inhabiting trypanosomes occurred when treatment with diminazene ace-
turate was carried out at 14 days or more after infection (Jennings
et al. , 1977; 1979; 1980). It is not clear whether such relapse
infections occur in natural infections in cattle although there have
been reports of T_. congolense isolated from the brain but not from the
organs or blood of an ox treated with diminazene aceturate after triple
infection with T. brucei, T. congolense and T. vivax (Haase, Bernard
and Guidot, 1981).
Diminazene aceturate has little prophylactic effect against T.
congolense cyclically transmitted by tsetse-fly or by intradermal inoc¬
ulation of cultured metacyclics. When metacyclics of T. congolense
were inoculated intravenously, it was shown that the drug has a prophy¬
lactic effect of up to 24 hours only. Similar findings have been re¬
ported by other workers using mice and rabbits (Frank and Dann, 1974;
Nantulya et al., 1980b; Whitelaw, 1982; Gilbert, 1983). This is in
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contrast to reports that in cattle challenged with T. congolense
bloodstream forms inoculated intravenously, diminazene aceturate
exerts a prophylactic effect of up to 12 days after treatment (Wellde
and Chumo, 1983). The discrepancy could be due to host species
differences, as well as use of different trypanosome stocks and
inoculum doses. Wellde and Chumo (1983) did not state whether ab¬
sence of parasitaemia was confirmed by subinoculation of blood into
mice as was carried out in the present studies. It is likely that
parasitaemias in animals in which residual levels of trypanocidal
drugs were present would be low and not easily detected by conventional
microscopy.
The lack of prophylactic activity of diminazene aceturate against
T. congolense in mice and rabbits contrasts with reported prolonged
prophylactic effect against T. brucei in mice, rats and monkeys
(Lumsden et al., 1965; Raether et_ al. , 1972; 1974; Fink and Dann, 1974;
Zahalsky and Weinberg, 1976; Whitelaw, 1982). This is possibly due
to different actions of the drug on the two trypanosome species since
it has been shown that higher doses of diminazene aceturate are re¬
quired to abolish infectivity of T. congolense compared to T. brucei
(James, 1976).
Isometamidium chloride at 4 mg/kg dose rate in the rabbit has
a prophylactic effect of less than three weeks against cyclically
transmitted 17. congolense. This drug dose was calculated to be
equivalent to a dose of 1 mg/kg used for prophylaxis in cattle. It
had been shown that 0.75 mg/kg isometamidium chloride is curative for
established infections of T. congolense TREU 1690 in the rabbit. The
result is therefore in contrast to reports from field studies which
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showed that 1-2 mg/kg isometamidium chloride has a prophylactic effect
which persists for 10-13 weeks (Robson, 1962; Kirkby, 1964; Wiesenhutter,
Turner and Kristensen, 1968). It is not clear whether this discrepancy
is due to host-species variation or due to differing diagnostic methods.
In the field trials the methods used for detecting trypanosomes do not
appear to have included subinoculation of blood into mice.
An interesting finding from studies on prophylactic effect of
isometamidium chloride and diminazene aceturate against cyclically
transmitted T. congolense was that chancres sometimes appeared without
subsequent systemic establishment of infections. This would indicate
that drug levels in serum but not in tissue fluid were sufficient to
prevent infection. However, it has been shown that three hours to
seven days after treatment of rabbits with radio-labelled diminazene
aceturate tissue fluid contains higher residue drug levels than plasma
(Gilbert and Newton, 1982b; Gilbert, 1983). No similar radio-isotope
studies have been carried out on isometamidium chloride but Goodwin
and Tierney (1977), using a biological assay technique,showed that
isometamidium levels which were detectable in tissue fluid and plasma
for only one week after intramuscular injection of 10 mg/kg dose rate,
were higher in tissue fluid than plasma. More recently, using a
chemical assay technique, Braide and Eghianruwa (1980) were able to
detect isometamidium chloride in serum at 24 hours but not seven or
more days after intramuscular injection of therapeutic dose of 0.5 mg/kg
in goats.
It is possible that transient parasitaemia occurring after chall¬
enge of drug treated animals could have occurred but remain undetected
by microhaematocrit/buffy coat technique and mouse subinoculation.
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This problem has been highlighted by Gray, Jennings and Hajduk (1982)
who showed that in mice, following diminazene treatment of pleomorphic
T. brucei infections initiated with fly-derived metacyclics, early
transient relapses occurred which were characterised by low numbers
of uninfective trypanosomes. It would be interesting to determine
whether such transient infections occur in animals challenged while
under chemoprophylaxis and whether sterile immunity can subsequently
be demonstrated. Preliminary results (not included here) from appli¬
cation of ELISA test on a few serial serum samples from some of the
isometamidium treated rabbits which developed chancres but not para-
sitaemia indicate that these animals do not develop anti-trypanosome
antibodies.
In the present studies, it was shown that rabbits treated with
diminazene aceturate at up to 12 days after cyclical infection were
found to be susceptible to homologous challenge while those treated
at 14 or more days after infection were immune. This result was
corroborated by findings from studies in which rabbits were infected
by intradermal inoculation of large numbers of cultured metacyclic
forms of T_. congolense and treated with diminazene aceturate at seven
or 14 days post-infection. Sterile immunity to homologous challenge
by tsetse bite 28-56 days after treatment was demonstrated only in
rabbits treated at 14 days post-infection. This result is in agree¬
ment with findings in cattle, in which it was shown that treatment
with diminazene aceturate at 15 days post-infection with cyclically
transmitted T. congolense conferred sterile immunity, while similar
treatment at five or 10 days post-infection did not confer immunity
(Emery et al., 1980).
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In contrast, rabbits treated with homidium chloride seven days
after cyclical infection with T. congolense were shown to be immune
to homologous challenge up to 300 days post treatment (Luckins et
al. , 1983) .
The discrepancy between results obtained in rabbits treated
with diminazene aceturate in the present studies and those obtained
by Luckins et al. (1983) in rabbits treated with homidium chloride
is difficult to explain. In the present studies it was shown that
acquisition of immunity was associated with the presence of trypano¬
cidal antibodies detectable by ELISA at treatment but not necessarily
at the time of challenge. Luckins et al. (1983) also reported that
at the time of challenge, immune animals did not necessarily have
detectable antibody levels in serum.
The acquisition of immunity in animals treated with diminazene
aceturate at 14 days post-infection but not in those treated at seven
day post-infection can be related to differences in level of parasit-
aemia at these two different times after infection. In the present
studies, it was found that parasitaemia in cyclically infected rabbits
could be detected by microhaematocrit/buffy coat technique at 12-14
days but usually not before. Antibody was also first detected at 14
days post-infection. It can thus be argued that for development of
sterile immunity to T. congolense a certain minimal blood parasitaemia
is required. This suggestion is supported by studies in cattle immun¬
ised with irradiated T. brucei organisms (Morrison et al., 1982a).
7
Animals immunised by inoculation of 10 or more irradiated T. brucei
organisms intravenously were immune to challenge with 10"^ homologous
trypanosomes while those inoculated with 10^ organisms or less were
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not completely immune. The duration of time during which the inocu¬
lated irradiated trypanosomes circulated was not determined but is
most likely to have been less than seven days. Thus it is possible
to immunise animals by infection and treatment if a high enough para-
sitaemia is achieved before treatment.
It is possible that the differences in acquisition of immunity,
in rabbits treated with either diminazene aceturate or homidium chlor¬
ide is due to differences in drug action. Diminazene aceturate is
known to act rapidly while homidium chloride acts slowly, allowing
2-3 cell divisions to take place after treatment. Thus in the
homidium treated animals antigen is available for a longer time and
in larger amounts than similarly infected animals treated with dimin¬
azene aceturate at the same time.
If as suggested above, immunity develops only when a certain
blood parasitaemia is attained, it is still not clear whether this
requisite level of parasitaemia provides an essential antigen mass
or the essential VAT composition for development of comprehensive
serodeme-specific immunity. Most likely it is a combination of both.
It is interesting to speculate on why in spite of there being a
7
trypanosome population exceeding 10 in the chancre at peak chancre
size stage, 8-13 days post-infection (Willett and Gordon, 1957; Emery
and Moloo, 1981) no comprehensive immunity has developed by day 12
post-infection. It could be that in the chancre only limited number
of VATs are expressed. It may also be that limited antigen processing
takes place in the chancre and the regional lymph node up to 14 days
post-infection due to inaccessibility of trypanosome antigen within
the collagen in spite of the massive cellular reaction seen in the
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chancre. However the situation may be more complicated than that,
in view of the finding that homidium treated animals develop com¬
prehensive immunity when treatment is carried out at seven days post¬
infection (Luckins et al., 1981).
Since the initial VATs to which the animal is exposed after
cyclical challenge are the metacyclic VATs, comprehensive sterile
immunity against particular serodemes must include immunity against
all the metacyclic VATs. Recent studies have shown that the VAT
repertoire of metacyclic forms of T. congolense TREU 1457 (from which
T. congolense TREU 1690 used in the immunity studies was derived) is
limited to 12 VATs (Crowe et al., 1983). It is possible, therefore,
that within 14 days of infection by tsetse-fly bite or intradermal
inoculation of cultured metacyclic trypanosomes, the immune system
has been exposed to trypanosomes of 12 different metacyclic VATs
either concurrently or consecutively, in sufficient numbers for immune
stimulation. However it may also be that not all the metacyclic VAT
repertoire need be expressed for stimulation of serodeme specific
immunity. There is thus a clear need for more studies to determine
what proportion or which sequence of VAT repertoire need develop
systemically for serodeme-specific immunity to develop.
After homologous challenge of immune animals with tsetse flies
no trypanosome chancres developed at the sites of tsetse bites although
in some rabbits small reactions were observed to develop 2-5 days post¬
infection. No attempt was made to determine whether these small re¬
actions contained trypanosomes, but they were most likely similar to
reactions observed in cattle and goats even at sites where non-infected
flies had fed on animals previously bitten by tsetse flies (Emery et al.,
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1980; Akol and Murray, 1983) and which resembled typical Arthus re¬
actions . This lack of typical chancre development would indicate
that immunity is elicited at the skin level, against the metacyclic
VATs.
Studies in cattle have shown that immunity induced by infection
and treatment is not dependent on the VAT composition of the infective
blood meal offered to the flies used for primary or subsequent chall¬
enge infection (Akol and Murray, 1983). This was also the case in
the present work; trypanosomes used for initiating infections in
flies originated from different stabilates and different passages of
the same trypanosome stock and infections in host mice were of vary¬
ing duration (2-8 days). However no attempt was made to determine
the degree of homogeneity or otherwise of the trypanosomes in different
infective feeds.
The finding that animals immunised with cultured metacyclics
were also immune to challenge with tsetse transmitted metacyclics
points to the potential use of such antigens for immunisation pro¬
grammes. Further studies would have to be carried out to determine
how many different serodemes could be inoculated simultaneously and
yet lead to development of sterile immunity against all inoculated
stocks.
The present studies indicate that, failure of chemotherapy
regimes to engender development of sterile immunity in the field may
be due to treatments carried out too soon after infection thus pre¬
venting development of immunity as was seen in animals treated at less
than 14 days post-infection. The findings from the field studies of
Wilson et al. (1975; 1976) can be interpreted in this way. Animals
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which were treated with diminazene aceturate only when they developed
infection, acquired immunity in contrast to those treated as a group
whenever one individual in the group was infected. Hence attempts
to develop a more rational approach to chemotherapy taking account
of tsetse challenge and frequency of infection may enhance protect¬
ive immunity in herds at risk.
It is clear that there are many aspects of development of immun¬
ity in relation to chemotherapy of cyclically transmitted infections
which should have been studied. Unfortunately the experiments on
development of sterile immunity were of long duration, occasioned by
an interval of six weeks between treatment and challenge of animals,
to allow relapse infections to be detected. Thus limited time and
animal housing space, precluded more in-depth studies.
Nevertheless the studies have been useful in pointing out the
significance of the trypanosome chancres on efficacy of chemotherapy
and in showing that diminazene aceturate has little prophylactic
activity against cyclically transmitted T. congolense in rabbits.
Since the results were in agreement with those obtained in T_. congo¬
lense-infected cattle treated with diminazene aceturate, the rabbit
could be a suitable cheap model laboratory animal for studies on
cyclically transmitted Th congolense infections. The serodeme-
specificity of the chancre (Emery et al_. , 1980; Luckins et al., 1983;
Luckins and Gray, 1983; Akol and Murray, 1983) is allowing serodeme
identification by chancre induction (ILRAD, 1983). The rabbit would
be particularly useful for this purpose.
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FORMULAE FOR PREPARING BUFFER SOLUTIONS IN ONE LITRE AMOUNTS
Phosphate Buffered Saline Glucose (PBSG), pH 8.0
di-sodium hydrogen orthophosphate, anhydrous (Na^HPO^)







up to 1000 ml
1% in PBS
Bicarbonate/carbonate Buffer pH 9.6
(ELISA antigen-coating buffer)
Sodium carbonate (Na^CO^)






up to 1000 ml
Phosphate Buffered Saline (PBS) pH 7.4
Potassium chloride KC1
Potassium di-hydrogen orthophosphate (KH^PO^)








up to 1000 ml
Phosphate Citrate Buffer pH 6.0
0.1M Citric acid






1. Place sections in La Manna's* Fluid and leave overnight.
2. Stain in 3% Giemsa stain overnight.
3. Differentiate in colophonium (1% in 95% Methyl alcohol)
observing under the microscope until desired degree of
differentiation has been achieved.
4. Dehydrate in isopropyl alcohol, clean and mount.
*La Manna1s Fluid
Potassium dichromate 9.5 g
Zinc chloride 4.5 g
Distilled water to 100 ml
APPENDIX3
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Meanweights(k )ofT.congolense-infecteda dnon-i ctedrabbi s.
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